id	sid	tid	token	lemma	pos
aiua-11242	1	1	stesura	stesura	PROPN
aiua-11242	1	2	seveso	seveso	PROPN
aiua-11242	1	3	archivio	archivio	PROPN
aiua-11242	1	4	italiano	italiano	X
aiua-11242	1	5	di	di	X
aiua-11242	1	6	urologia	urologia	PROPN
aiua-11242	1	7	e	e	PROPN
aiua-11242	1	8	andrologia	andrologia	NOUN
aiua-11242	1	9	2023	2023	NUM
aiua-11242	1	10	;	;	PUNCT
aiua-11242	1	11	95(3):11242	95(3):11242	NUM
aiua-11242	1	12	1	1	NUM
aiua-11242	1	13	original	original	ADJ
aiua-11242	1	14	paper	paper	NOUN
aiua-11242	1	15	disease	disease	NOUN
aiua-11242	1	16	(	(	PUNCT
aiua-11242	1	17	3	3	NUM
aiua-11242	1	18	)	)	PUNCT
aiua-11242	1	19	.	.	PUNCT
aiua-11242	2	1	despite	despite	SCONJ
aiua-11242	2	2	a	a	DET
aiua-11242	2	3	substantial	substantial	ADJ
aiua-11242	2	4	shift	shift	NOUN
aiua-11242	2	5	to	to	ADP
aiua-11242	2	6	a	a	DET
aiua-11242	2	7	more	more	ADV
aiua-11242	2	8	favourable	favourable	ADJ
aiua-11242	2	9	stage	stage	NOUN
aiua-11242	2	10	at	at	ADP
aiua-11242	2	11	presentation	presentation	NOUN
aiua-11242	2	12	of	of	ADP
aiua-11242	2	13	newly	newly	ADV
aiua-11242	2	14	diagnosed	diagnose	VERB
aiua-11242	2	15	disease	disease	NOUN
aiua-11242	2	16	,	,	PUNCT
aiua-11242	2	17	average	average	ADJ
aiua-11242	2	18	age	age	NOUN
aiua-11242	2	19	of	of	ADP
aiua-11242	2	20	death	death	NOUN
aiua-11242	2	21	from	from	ADP
aiua-11242	2	22	prostate	prostate	NOUN
aiua-11242	2	23	cancer	cancer	NOUN
aiua-11242	2	24	is	be	AUX
aiua-11242	2	25	77	77	NUM
aiua-11242	2	26	years	year	NOUN
aiua-11242	2	27	of	of	ADP
aiua-11242	2	28	age	age	NOUN
aiua-11242	2	29	and	and	CCONJ
aiua-11242	2	30	has	have	AUX
aiua-11242	2	31	remained	remain	VERB
aiua-11242	2	32	stable	stable	ADJ
aiua-11242	2	33	over	over	ADP
aiua-11242	2	34	the	the	DET
aiua-11242	2	35	past	past	ADJ
aiua-11242	2	36	three	three	NUM
aiua-11242	2	37	decades	decade	NOUN
aiua-11242	2	38	(	(	PUNCT
aiua-11242	2	39	3	3	NUM
aiua-11242	2	40	,	,	PUNCT
aiua-11242	2	41	4	4	NUM
aiua-11242	2	42	)	)	PUNCT
aiua-11242	2	43	.	.	PUNCT
aiua-11242	3	1	since	since	SCONJ
aiua-11242	3	2	huggins	huggins	PROPN
aiua-11242	3	3	reported	report	VERB
aiua-11242	3	4	that	that	SCONJ
aiua-11242	3	5	surgical	surgical	ADJ
aiua-11242	3	6	castration	castration	NOUN
aiua-11242	3	7	is	be	AUX
aiua-11242	3	8	an	an	DET
aiua-11242	3	9	effective	effective	ADJ
aiua-11242	3	10	treatment	treatment	NOUN
aiua-11242	3	11	for	for	ADP
aiua-11242	3	12	advanced	advanced	ADJ
aiua-11242	3	13	prostate	prostate	NOUN
aiua-11242	3	14	cancer	cancer	NOUN
aiua-11242	3	15	(	(	PUNCT
aiua-11242	3	16	5	5	NUM
aiua-11242	3	17	)	)	PUNCT
aiua-11242	3	18	,	,	PUNCT
aiua-11242	3	19	hormonal	hormonal	ADJ
aiua-11242	3	20	manipulation	manipulation	NOUN
aiua-11242	3	21	with	with	ADP
aiua-11242	3	22	the	the	DET
aiua-11242	3	23	suppression	suppression	NOUN
aiua-11242	3	24	of	of	ADP
aiua-11242	3	25	gonadal	gonadal	ADJ
aiua-11242	3	26	testosterone	testosterone	NOUN
aiua-11242	3	27	is	be	AUX
aiua-11242	3	28	a	a	DET
aiua-11242	3	29	cornerstone	cornerstone	NOUN
aiua-11242	3	30	for	for	ADP
aiua-11242	3	31	systemic	systemic	ADJ
aiua-11242	3	32	treatment	treatment	NOUN
aiua-11242	3	33	of	of	ADP
aiua-11242	3	34	metastatic	metastatic	ADJ
aiua-11242	3	35	prostate	prostate	NOUN
aiua-11242	3	36	cancer	cancer	NOUN
aiua-11242	3	37	(	(	PUNCT
aiua-11242	3	38	3	3	NUM
aiua-11242	3	39	)	)	PUNCT
aiua-11242	3	40	.	.	PUNCT
aiua-11242	4	1	however	however	ADV
aiua-11242	4	2	,	,	PUNCT
aiua-11242	4	3	the	the	DET
aiua-11242	4	4	disease	disease	NOUN
aiua-11242	4	5	eventually	eventually	ADV
aiua-11242	4	6	evolves	evolve	VERB
aiua-11242	4	7	into	into	ADP
aiua-11242	4	8	mcrpc	mcrpc	NOUN
aiua-11242	4	9	and	and	CCONJ
aiua-11242	4	10	death	death	NOUN
aiua-11242	4	11	(	(	PUNCT
aiua-11242	4	12	3	3	NUM
aiua-11242	4	13	)	)	PUNCT
aiua-11242	4	14	.	.	PUNCT
aiua-11242	5	1	in	in	ADP
aiua-11242	5	2	recent	recent	ADJ
aiua-11242	5	3	years	year	NOUN
aiua-11242	5	4	,	,	PUNCT
aiua-11242	5	5	the	the	DET
aiua-11242	5	6	addition	addition	NOUN
aiua-11242	5	7	of	of	ADP
aiua-11242	5	8	several	several	ADJ
aiua-11242	5	9	newly	newly	ADV
aiua-11242	5	10	approved	approve	VERB
aiua-11242	5	11	combination	combination	NOUN
aiua-11242	5	12	therapies	therapy	NOUN
aiua-11242	5	13	to	to	ADP
aiua-11242	5	14	androgen	androgen	NOUN
aiua-11242	5	15	deprivation	deprivation	NOUN
aiua-11242	5	16	therapy	therapy	NOUN
aiua-11242	5	17	(	(	PUNCT
aiua-11242	5	18	adt	adt	NOUN
aiua-11242	5	19	)	)	PUNCT
aiua-11242	5	20	for	for	ADP
aiua-11242	5	21	treatment	treatment	NOUN
aiua-11242	5	22	in	in	ADP
aiua-11242	5	23	metastatic	metastatic	ADJ
aiua-11242	5	24	hormone	hormone	NOUN
aiua-11242	5	25	-	-	PUNCT
aiua-11242	5	26	sensitive	sensitive	ADJ
aiua-11242	5	27	prostate	prostate	NOUN
aiua-11242	5	28	cancer	cancer	NOUN
aiua-11242	5	29	(	(	PUNCT
aiua-11242	5	30	mhspc	mhspc	PROPN
aiua-11242	5	31	)	)	PUNCT
aiua-11242	5	32	,	,	PUNCT
aiua-11242	5	33	such	such	ADJ
aiua-11242	5	34	as	as	ADP
aiua-11242	5	35	abiraterone	abiraterone	NOUN
aiua-11242	5	36	,	,	PUNCT
aiua-11242	5	37	docetaxel	docetaxel	NOUN
aiua-11242	5	38	,	,	PUNCT
aiua-11242	5	39	apalutamide	apalutamide	ADV
aiua-11242	5	40	,	,	PUNCT
aiua-11242	5	41	enzalutamide	enzalutamide	ADV
aiua-11242	5	42	or	or	CCONJ
aiua-11242	5	43	darolutamide	darolutamide	ADV
aiua-11242	5	44	,	,	PUNCT
aiua-11242	5	45	have	have	AUX
aiua-11242	5	46	shown	show	VERB
aiua-11242	5	47	improvements	improvement	NOUN
aiua-11242	5	48	in	in	ADP
aiua-11242	5	49	os	os	NOUN
aiua-11242	5	50	and	and	CCONJ
aiua-11242	5	51	pfs	pfs	PROPN
aiua-11242	5	52	(	(	PUNCT
aiua-11242	5	53	6	6	NUM
aiua-11242	5	54	-	-	SYM
aiua-11242	5	55	11	11	NUM
aiua-11242	5	56	)	)	PUNCT
aiua-11242	5	57	.	.	PUNCT
aiua-11242	6	1	despite	despite	SCONJ
aiua-11242	6	2	being	be	AUX
aiua-11242	6	3	extremely	extremely	ADV
aiua-11242	6	4	effective	effective	ADJ
aiua-11242	6	5	initially	initially	ADV
aiua-11242	6	6	,	,	PUNCT
aiua-11242	6	7	almost	almost	ADV
aiua-11242	6	8	all	all	DET
aiua-11242	6	9	patients	patient	NOUN
aiua-11242	6	10	under	under	ADP
aiua-11242	6	11	adt	adt	NOUN
aiua-11242	6	12	for	for	ADP
aiua-11242	6	13	mhspc	mhspc	NOUN
aiua-11242	6	14	eventually	eventually	ADV
aiua-11242	6	15	develop	develop	VERB
aiua-11242	6	16	biochemical	biochemical	ADJ
aiua-11242	6	17	and/or	and/or	CCONJ
aiua-11242	6	18	clinical	clinical	ADJ
aiua-11242	6	19	evidence	evidence	NOUN
aiua-11242	6	20	of	of	ADP
aiua-11242	6	21	treatment	treatment	NOUN
aiua-11242	6	22	resistance	resistance	NOUN
aiua-11242	6	23	.	.	PUNCT
aiua-11242	7	1	median	median	PROPN
aiua-11242	7	2	os	os	PROPN
aiua-11242	7	3	after	after	SCONJ
aiua-11242	7	4	mcrpc	mcrpc	PROPN
aiua-11242	7	5	diagnosis	diagnosis	NOUN
aiua-11242	7	6	is	be	AUX
aiua-11242	7	7	estimated	estimate	VERB
aiua-11242	7	8	to	to	PART
aiua-11242	7	9	be	be	AUX
aiua-11242	7	10	between	between	ADP
aiua-11242	7	11	13.2	13.2	NUM
aiua-11242	7	12	to	to	PART
aiua-11242	7	13	23.2	23.2	NUM
aiua-11242	7	14	months	month	NOUN
aiua-11242	7	15	depending	depend	VERB
aiua-11242	7	16	on	on	ADP
aiua-11242	7	17	the	the	DET
aiua-11242	7	18	burden	burden	NOUN
aiua-11242	7	19	of	of	ADP
aiua-11242	7	20	metastasis	metastasis	NOUN
aiua-11242	7	21	at	at	ADP
aiua-11242	7	22	presentation	presentation	NOUN
aiua-11242	7	23	(	(	PUNCT
aiua-11242	7	24	12	12	NUM
aiua-11242	7	25	)	)	PUNCT
aiua-11242	7	26	.	.	PUNCT
aiua-11242	8	1	mcrpc	mcrpc	PROPN
aiua-11242	8	2	is	be	AUX
aiua-11242	8	3	a	a	DET
aiua-11242	8	4	very	very	ADV
aiua-11242	8	5	heterogeneous	heterogeneous	ADJ
aiua-11242	8	6	disease	disease	NOUN
aiua-11242	8	7	,	,	PUNCT
aiua-11242	8	8	representing	represent	VERB
aiua-11242	8	9	a	a	DET
aiua-11242	8	10	vast	vast	ADJ
aiua-11242	8	11	group	group	NOUN
aiua-11242	8	12	of	of	ADP
aiua-11242	8	13	patients	patient	NOUN
aiua-11242	8	14	with	with	ADP
aiua-11242	8	15	a	a	DET
aiua-11242	8	16	wide	wide	ADJ
aiua-11242	8	17	range	range	NOUN
aiua-11242	8	18	of	of	ADP
aiua-11242	8	19	characteristics	characteristic	NOUN
aiua-11242	8	20	and	and	CCONJ
aiua-11242	8	21	prognosis	prognosis	NOUN
aiua-11242	8	22	.	.	PUNCT
aiua-11242	9	1	many	many	ADJ
aiua-11242	9	2	factors	factor	NOUN
aiua-11242	9	3	have	have	AUX
aiua-11242	9	4	been	be	AUX
aiua-11242	9	5	pointed	point	VERB
aiua-11242	9	6	out	out	ADP
aiua-11242	9	7	to	to	PART
aiua-11242	9	8	stratify	stratify	VERB
aiua-11242	9	9	these	these	DET
aiua-11242	9	10	patients	patient	NOUN
aiua-11242	9	11	,	,	PUNCT
aiua-11242	9	12	such	such	ADJ
aiua-11242	9	13	as	as	ADP
aiua-11242	9	14	psa	psa	NOUN
aiua-11242	9	15	,	,	PUNCT
aiua-11242	9	16	metastatic	metastatic	ADJ
aiua-11242	9	17	burden	burden	NOUN
aiua-11242	9	18	,	,	PUNCT
aiua-11242	9	19	age	age	NOUN
aiua-11242	9	20	,	,	PUNCT
aiua-11242	9	21	gleason	gleason	PROPN
aiua-11242	9	22	score	score	NOUN
aiua-11242	9	23	and	and	CCONJ
aiua-11242	9	24	time	time	NOUN
aiua-11242	9	25	to	to	ADP
aiua-11242	9	26	castration	castration	NOUN
aiua-11242	9	27	resistance	resistance	NOUN
aiua-11242	9	28	(	(	PUNCT
aiua-11242	9	29	13	13	NUM
aiua-11242	9	30	)	)	PUNCT
aiua-11242	9	31	.	.	PUNCT
aiua-11242	10	1	however	however	ADV
aiua-11242	10	2	,	,	PUNCT
aiua-11242	10	3	new	new	ADJ
aiua-11242	10	4	methods	method	NOUN
aiua-11242	10	5	or	or	CCONJ
aiua-11242	10	6	biomarkers	biomarker	NOUN
aiua-11242	10	7	to	to	PART
aiua-11242	10	8	help	help	VERB
aiua-11242	10	9	clinicians	clinician	NOUN
aiua-11242	10	10	sub	sub	VERB
aiua-11242	10	11	-	-	VERB
aiua-11242	10	12	classify	classify	VERB
aiua-11242	10	13	and	and	CCONJ
aiua-11242	10	14	manage	manage	VERB
aiua-11242	10	15	these	these	DET
aiua-11242	10	16	patients	patient	NOUN
aiua-11242	10	17	are	be	AUX
aiua-11242	10	18	still	still	ADV
aiua-11242	10	19	needed	need	VERB
aiua-11242	10	20	.	.	PUNCT
aiua-11242	11	1	some	some	DET
aiua-11242	11	2	inflammation	inflammation	NOUN
aiua-11242	11	3	-	-	PUNCT
aiua-11242	11	4	based	base	VERB
aiua-11242	11	5	and/or	and/or	CCONJ
aiua-11242	11	6	nutritional	nutritional	ADJ
aiua-11242	11	7	markers	marker	NOUN
aiua-11242	11	8	have	have	AUX
aiua-11242	11	9	been	be	AUX
aiua-11242	11	10	studied	study	VERB
aiua-11242	11	11	with	with	ADP
aiua-11242	11	12	this	this	DET
aiua-11242	11	13	goal	goal	NOUN
aiua-11242	11	14	,	,	PUNCT
aiua-11242	11	15	such	such	ADJ
aiua-11242	11	16	as	as	ADP
aiua-11242	11	17	neutrophil	neutrophil	ADJ
aiua-11242	11	18	/	/	SYM
aiua-11242	11	19	lymphocyte	lymphocyte	ADJ
aiua-11242	11	20	ratio	ratio	NOUN
aiua-11242	11	21	(	(	PUNCT
aiua-11242	11	22	14	14	NUM
aiua-11242	11	23	)	)	PUNCT
aiua-11242	11	24	,	,	PUNCT
aiua-11242	11	25	platelet	platelet	ADJ
aiua-11242	11	26	/	/	SYM
aiua-11242	11	27	lymphocyte	lymphocyte	ADJ
aiua-11242	11	28	ratio	ratio	NOUN
aiua-11242	11	29	(	(	PUNCT
aiua-11242	11	30	plr	plr	NOUN
aiua-11242	11	31	)	)	PUNCT
aiua-11242	11	32	(	(	PUNCT
aiua-11242	11	33	15	15	NUM
aiua-11242	11	34	)	)	PUNCT
aiua-11242	11	35	,	,	PUNCT
aiua-11242	11	36	prognostic	prognostic	ADJ
aiua-11242	11	37	nutritional	nutritional	ADJ
aiua-11242	11	38	index	index	NOUN
aiua-11242	11	39	(	(	PUNCT
aiua-11242	11	40	pni	pni	NOUN
aiua-11242	11	41	)	)	PUNCT
aiua-11242	11	42	(	(	PUNCT
aiua-11242	11	43	16	16	NUM
aiua-11242	11	44	)	)	PUNCT
aiua-11242	11	45	,	,	PUNCT
aiua-11242	11	46	among	among	ADP
aiua-11242	11	47	others	other	NOUN
aiua-11242	11	48	(	(	PUNCT
aiua-11242	11	49	17	17	NUM
aiua-11242	11	50	-	-	SYM
aiua-11242	11	51	22	22	NUM
aiua-11242	11	52	)	)	PUNCT
aiua-11242	11	53	.	.	PUNCT
aiua-11242	12	1	serum	serum	PROPN
aiua-11242	12	2	c	c	NOUN
aiua-11242	12	3	-	-	PUNCT
aiua-11242	12	4	reactive	reactive	ADJ
aiua-11242	12	5	protein	protein	NOUN
aiua-11242	12	6	(	(	PUNCT
aiua-11242	12	7	crp	crp	PROPN
aiua-11242	12	8	)	)	PUNCT
aiua-11242	12	9	,	,	PUNCT
aiua-11242	12	10	and	and	CCONJ
aiua-11242	12	11	acute	acute	ADJ
aiua-11242	12	12	phase	phase	NOUN
aiua-11242	12	13	reactant	reactant	NOUN
aiua-11242	12	14	,	,	PUNCT
aiua-11242	12	15	has	have	AUX
aiua-11242	12	16	been	be	AUX
aiua-11242	12	17	used	use	VERB
aiua-11242	12	18	as	as	ADP
aiua-11242	12	19	a	a	DET
aiua-11242	12	20	surrogate	surrogate	ADJ
aiua-11242	12	21	marker	marker	NOUN
aiua-11242	12	22	of	of	ADP
aiua-11242	12	23	systemic	systemic	ADJ
aiua-11242	12	24	inflammation	inflammation	NOUN
aiua-11242	12	25	(	(	PUNCT
aiua-11242	12	26	17	17	NUM
aiua-11242	12	27	-	-	SYM
aiua-11242	12	28	19	19	NUM
aiua-11242	12	29	)	)	PUNCT
aiua-11242	12	30	.	.	PUNCT
aiua-11242	13	1	systemic	systemic	ADJ
aiua-11242	13	2	inflammatory	inflammatory	ADJ
aiua-11242	13	3	response	response	NOUN
aiua-11242	13	4	has	have	AUX
aiua-11242	13	5	been	be	AUX
aiua-11242	13	6	shown	show	VERB
aiua-11242	13	7	to	to	PART
aiua-11242	13	8	be	be	AUX
aiua-11242	13	9	associated	associate	VERB
aiua-11242	13	10	with	with	ADP
aiua-11242	13	11	carcinogenesis	carcinogenesis	NOUN
aiua-11242	13	12	,	,	PUNCT
aiua-11242	13	13	tumour	tumour	NOUN
aiua-11242	13	14	progression	progression	NOUN
aiua-11242	13	15	and	and	CCONJ
aiua-11242	13	16	metastasis	metastasis	NOUN
aiua-11242	13	17	(	(	PUNCT
aiua-11242	13	18	20	20	NUM
aiua-11242	13	19	)	)	PUNCT
aiua-11242	13	20	.	.	PUNCT
aiua-11242	14	1	serum	serum	PROPN
aiua-11242	14	2	albumin	albumin	PROPN
aiua-11242	14	3	(	(	PUNCT
aiua-11242	14	4	alb	alb	PROPN
aiua-11242	14	5	)	)	PUNCT
aiua-11242	14	6	is	be	AUX
aiua-11242	14	7	accepted	accept	VERB
aiua-11242	14	8	as	as	ADP
aiua-11242	14	9	a	a	DET
aiua-11242	14	10	marker	marker	NOUN
aiua-11242	14	11	of	of	ADP
aiua-11242	14	12	the	the	DET
aiua-11242	14	13	nutritional	nutritional	ADJ
aiua-11242	14	14	status	status	NOUN
aiua-11242	14	15	of	of	ADP
aiua-11242	14	16	the	the	DET
aiua-11242	14	17	body	body	NOUN
aiua-11242	14	18	(	(	PUNCT
aiua-11242	14	19	18	18	NUM
aiua-11242	14	20	)	)	PUNCT
aiua-11242	14	21	.	.	PUNCT
aiua-11242	15	1	the	the	PRON
aiua-11242	15	2	lower	low	ADJ
aiua-11242	15	3	the	the	DET
aiua-11242	15	4	serum	serum	NOUN
aiua-11242	15	5	albumin	albumin	NOUN
aiua-11242	15	6	,	,	PUNCT
aiua-11242	15	7	the	the	DET
aiua-11242	15	8	more	more	ADV
aiua-11242	15	9	frail	frail	ADJ
aiua-11242	15	10	the	the	DET
aiua-11242	15	11	patients	patient	NOUN
aiua-11242	15	12	tend	tend	VERB
aiua-11242	15	13	to	to	PART
aiua-11242	15	14	be	be	AUX
aiua-11242	15	15	.	.	PUNCT
aiua-11242	16	1	several	several	ADJ
aiua-11242	16	2	recent	recent	ADJ
aiua-11242	16	3	studies	study	NOUN
aiua-11242	16	4	have	have	AUX
aiua-11242	16	5	reported	report	VERB
aiua-11242	16	6	the	the	DET
aiua-11242	16	7	utility	utility	NOUN
aiua-11242	16	8	of	of	ADP
aiua-11242	16	9	the	the	DET
aiua-11242	16	10	car	car	NOUN
aiua-11242	16	11	as	as	ADP
aiua-11242	16	12	a	a	DET
aiua-11242	16	13	prognosis	prognosis	NOUN
aiua-11242	16	14	factor	factor	NOUN
aiua-11242	16	15	in	in	ADP
aiua-11242	16	16	cancer	cancer	NOUN
aiua-11242	16	17	patients	patient	NOUN
aiua-11242	16	18	(	(	PUNCT
aiua-11242	16	19	20	20	NUM
aiua-11242	16	20	-	-	SYM
aiua-11242	16	21	22	22	NUM
aiua-11242	16	22	)	)	PUNCT
aiua-11242	16	23	.	.	PUNCT
aiua-11242	17	1	a	a	DET
aiua-11242	17	2	higher	high	ADJ
aiua-11242	17	3	car	car	NOUN
aiua-11242	17	4	corresponds	correspond	VERB
aiua-11242	17	5	to	to	ADP
aiua-11242	17	6	a	a	DET
aiua-11242	17	7	status	status	NOUN
aiua-11242	17	8	of	of	ADP
aiua-11242	17	9	elevated	elevated	ADJ
aiua-11242	17	10	systemic	systemic	ADJ
aiua-11242	17	11	inflammation	inflammation	NOUN
aiua-11242	17	12	and	and	CCONJ
aiua-11242	17	13	lower	low	ADJ
aiua-11242	17	14	nutritional	nutritional	ADJ
aiua-11242	17	15	status	status	NOUN
aiua-11242	17	16	,	,	PUNCT
aiua-11242	17	17	suggesting	suggest	VERB
aiua-11242	17	18	that	that	SCONJ
aiua-11242	17	19	the	the	DET
aiua-11242	17	20	patient	patient	NOUN
aiua-11242	17	21	’s	’s	PART
aiua-11242	17	22	overall	overall	ADJ
aiua-11242	17	23	condition	condition	NOUN
aiua-11242	17	24	is	be	AUX
aiua-11242	17	25	poor	poor	ADJ
aiua-11242	17	26	(	(	PUNCT
aiua-11242	17	27	18	18	NUM
aiua-11242	17	28	)	)	PUNCT
aiua-11242	17	29	.	.	PUNCT
aiua-11242	18	1	car	car	NOUN
aiua-11242	18	2	value	value	NOUN
aiua-11242	18	3	as	as	ADP
aiua-11242	18	4	a	a	DET
aiua-11242	18	5	prognostic	prognostic	ADJ
aiua-11242	18	6	marker	marker	NOUN
aiua-11242	18	7	has	have	AUX
aiua-11242	18	8	been	be	AUX
aiua-11242	18	9	previously	previously	ADV
aiua-11242	18	10	reported	report	VERB
aiua-11242	18	11	in	in	ADP
aiua-11242	18	12	some	some	DET
aiua-11242	18	13	cancers	cancer	NOUN
aiua-11242	18	14	,	,	PUNCT
aiua-11242	18	15	such	such	ADJ
aiua-11242	18	16	as	as	ADP
aiua-11242	18	17	hepaobjective	hepaobjective	ADJ
aiua-11242	18	18	:	:	PUNCT
aiua-11242	18	19	to	to	PART
aiua-11242	18	20	assess	assess	VERB
aiua-11242	18	21	the	the	DET
aiua-11242	18	22	association	association	NOUN
aiua-11242	18	23	of	of	ADP
aiua-11242	18	24	c	c	PROPN
aiua-11242	18	25	reactive	reactive	ADJ
aiua-11242	18	26	protein	protein	NOUN
aiua-11242	18	27	/	/	SYM
aiua-11242	18	28	albumin	albumin	ADJ
aiua-11242	18	29	ratio	ratio	NOUN
aiua-11242	18	30	(	(	PUNCT
aiua-11242	18	31	car	car	NOUN
aiua-11242	18	32	)	)	PUNCT
aiua-11242	18	33	with	with	ADP
aiua-11242	18	34	progression	progression	NOUN
aiua-11242	18	35	free	free	ADJ
aiua-11242	18	36	survival	survival	NOUN
aiua-11242	18	37	(	(	PUNCT
aiua-11242	18	38	pfs	pfs	PROPN
aiua-11242	18	39	)	)	PUNCT
aiua-11242	18	40	and	and	CCONJ
aiua-11242	18	41	overall	overall	ADJ
aiua-11242	18	42	survival	survival	NOUN
aiua-11242	18	43	(	(	PUNCT
aiua-11242	18	44	os	os	NOUN
aiua-11242	18	45	)	)	PUNCT
aiua-11242	18	46	in	in	ADP
aiua-11242	18	47	castration	castration	NOUN
aiua-11242	18	48	resistant	resistant	ADJ
aiua-11242	18	49	metastatic	metastatic	ADJ
aiua-11242	18	50	prostate	prostate	NOUN
aiua-11242	18	51	cancer	cancer	NOUN
aiua-11242	18	52	(	(	PUNCT
aiua-11242	18	53	mcrpc	mcrpc	NOUN
aiua-11242	18	54	)	)	PUNCT
aiua-11242	18	55	patients	patient	NOUN
aiua-11242	18	56	.	.	PUNCT
aiua-11242	19	1	materials	material	NOUN
aiua-11242	19	2	and	and	CCONJ
aiua-11242	19	3	methods	method	NOUN
aiua-11242	19	4	:	:	PUNCT
aiua-11242	19	5	a	a	DET
aiua-11242	19	6	transversal	transversal	ADJ
aiua-11242	19	7	study	study	NOUN
aiua-11242	19	8	was	be	AUX
aiua-11242	19	9	conducted	conduct	VERB
aiua-11242	19	10	,	,	PUNCT
aiua-11242	19	11	including	include	VERB
aiua-11242	19	12	all	all	DET
aiua-11242	19	13	patients	patient	NOUN
aiua-11242	19	14	diagnosed	diagnose	VERB
aiua-11242	19	15	with	with	ADP
aiua-11242	19	16	mcrpc	mcrpc	NOUN
aiua-11242	19	17	within	within	ADP
aiua-11242	19	18	a	a	DET
aiua-11242	19	19	central	central	ADJ
aiua-11242	19	20	hospital	hospital	NOUN
aiua-11242	19	21	urological	urological	ADJ
aiua-11242	19	22	oncology	oncology	NOUN
aiua-11242	19	23	consultation	consultation	NOUN
aiua-11242	19	24	between	between	ADP
aiua-11242	19	25	december	december	PROPN
aiua-11242	19	26	2019	2019	NUM
aiua-11242	19	27	and	and	CCONJ
aiua-11242	19	28	december	december	PROPN
aiua-11242	19	29	2021	2021	NUM
aiua-11242	19	30	(	(	PUNCT
aiua-11242	19	31	n	n	NOUN
aiua-11242	19	32	=	=	SYM
aiua-11242	19	33	178	178	NUM
aiua-11242	19	34	)	)	PUNCT
aiua-11242	19	35	and	and	CCONJ
aiua-11242	19	36	that	that	PRON
aiua-11242	19	37	were	be	AUX
aiua-11242	19	38	submitted	submit	VERB
aiua-11242	19	39	to	to	ADP
aiua-11242	19	40	systemic	systemic	ADJ
aiua-11242	19	41	therapy	therapy	NOUN
aiua-11242	19	42	.	.	PUNCT
aiua-11242	20	1	crp	crp	PROPN
aiua-11242	20	2	and	and	CCONJ
aiua-11242	20	3	albumin	albumin	ADJ
aiua-11242	20	4	results	result	NOUN
aiua-11242	20	5	were	be	AUX
aiua-11242	20	6	collected	collect	VERB
aiua-11242	20	7	at	at	ADP
aiua-11242	20	8	the	the	DET
aiua-11242	20	9	beginning	beginning	NOUN
aiua-11242	20	10	of	of	ADP
aiua-11242	20	11	the	the	DET
aiua-11242	20	12	systemic	systemic	ADJ
aiua-11242	20	13	treatment	treatment	NOUN
aiua-11242	20	14	for	for	ADP
aiua-11242	20	15	mcrpc	mcrpc	NOUN
aiua-11242	20	16	in	in	ADP
aiua-11242	20	17	103	103	NUM
aiua-11242	20	18	patients	patient	NOUN
aiua-11242	20	19	and	and	CCONJ
aiua-11242	20	20	,	,	PUNCT
aiua-11242	20	21	in	in	ADP
aiua-11242	20	22	75	75	NUM
aiua-11242	20	23	patients	patient	NOUN
aiua-11242	20	24	already	already	ADV
aiua-11242	20	25	under	under	ADP
aiua-11242	20	26	treatment	treatment	NOUN
aiua-11242	20	27	at	at	ADP
aiua-11242	20	28	the	the	DET
aiua-11242	20	29	start	start	NOUN
aiua-11242	20	30	of	of	ADP
aiua-11242	20	31	the	the	DET
aiua-11242	20	32	study	study	NOUN
aiua-11242	20	33	,	,	PUNCT
aiua-11242	20	34	on	on	ADP
aiua-11242	20	35	that	that	DET
aiua-11242	20	36	occasion	occasion	NOUN
aiua-11242	20	37	(	(	PUNCT
aiua-11242	20	38	december	december	PROPN
aiua-11242	20	39	2019	2019	NUM
aiua-11242	20	40	)	)	PUNCT
aiua-11242	20	41	.	.	PUNCT
aiua-11242	21	1	all	all	DET
aiua-11242	21	2	patients	patient	NOUN
aiua-11242	21	3	were	be	AUX
aiua-11242	21	4	then	then	ADV
aiua-11242	21	5	followed	follow	VERB
aiua-11242	21	6	.	.	PUNCT
aiua-11242	22	1	car	car	NOUN
aiua-11242	22	2	was	be	AUX
aiua-11242	22	3	correlated	correlate	VERB
aiua-11242	22	4	with	with	ADP
aiua-11242	22	5	pfs	pfs	PROPN
aiua-11242	22	6	and	and	CCONJ
aiua-11242	22	7	os	os	NOUN
aiua-11242	22	8	.	.	PUNCT
aiua-11242	23	1	os	os	PROPN
aiua-11242	23	2	and	and	CCONJ
aiua-11242	23	3	pfs	pfs	PROPN
aiua-11242	23	4	were	be	AUX
aiua-11242	23	5	measured	measure	VERB
aiua-11242	23	6	from	from	ADP
aiua-11242	23	7	the	the	DET
aiua-11242	23	8	day	day	NOUN
aiua-11242	23	9	the	the	DET
aiua-11242	23	10	crp	crp	NOUN
aiua-11242	23	11	and	and	CCONJ
aiua-11242	23	12	alb	alb	PROPN
aiua-11242	23	13	were	be	AUX
aiua-11242	23	14	collected	collect	VERB
aiua-11242	23	15	until	until	ADP
aiua-11242	23	16	the	the	DET
aiua-11242	23	17	event	event	NOUN
aiua-11242	23	18	of	of	ADP
aiua-11242	23	19	interest	interest	NOUN
aiua-11242	23	20	or	or	CCONJ
aiua-11242	23	21	the	the	DET
aiua-11242	23	22	final	final	ADJ
aiua-11242	23	23	date	date	NOUN
aiua-11242	23	24	of	of	ADP
aiua-11242	23	25	follow	follow	NOUN
aiua-11242	23	26	-	-	PUNCT
aiua-11242	23	27	up	up	NOUN
aiua-11242	23	28	.	.	PUNCT
aiua-11242	24	1	the	the	DET
aiua-11242	24	2	sample	sample	NOUN
aiua-11242	24	3	was	be	AUX
aiua-11242	24	4	divided	divide	VERB
aiua-11242	24	5	in	in	ADP
aiua-11242	24	6	two	two	NUM
aiua-11242	24	7	groups	group	NOUN
aiua-11242	24	8	according	accord	VERB
aiua-11242	24	9	to	to	ADP
aiua-11242	24	10	an	an	DET
aiua-11242	24	11	optimal	optimal	ADJ
aiua-11242	24	12	cutoff	cutoff	NOUN
aiua-11242	24	13	point	point	NOUN
aiua-11242	24	14	found	find	VERB
aiua-11242	24	15	in	in	ADP
aiua-11242	24	16	a	a	DET
aiua-11242	24	17	roc	roc	PROPN
aiua-11242	24	18	curve	curve	NOUN
aiua-11242	24	19	.	.	PUNCT
aiua-11242	25	1	results	result	NOUN
aiua-11242	25	2	:	:	PUNCT
aiua-11242	25	3	the	the	DET
aiua-11242	25	4	sample	sample	NOUN
aiua-11242	25	5	showed	show	VERB
aiua-11242	25	6	a	a	DET
aiua-11242	25	7	median	median	ADJ
aiua-11242	25	8	age	age	NOUN
aiua-11242	25	9	of	of	ADP
aiua-11242	25	10	75.76	75.76	NUM
aiua-11242	25	11	±	±	NUM
aiua-11242	25	12	9.17	9.17	NUM
aiua-11242	25	13	years	year	NOUN
aiua-11242	25	14	old	old	ADJ
aiua-11242	25	15	.	.	PUNCT
aiua-11242	26	1	using	use	VERB
aiua-11242	26	2	a	a	DET
aiua-11242	26	3	cut	cut	VERB
aiua-11242	26	4	-	-	PUNCT
aiua-11242	26	5	off	off	ADP
aiua-11242	26	6	point	point	NOUN
aiua-11242	26	7	of	of	ADP
aiua-11242	26	8	0.22	0.22	NUM
aiua-11242	26	9	,	,	PUNCT
aiua-11242	26	10	patients	patient	NOUN
aiua-11242	26	11	with	with	ADP
aiua-11242	26	12	a	a	DET
aiua-11242	26	13	car	car	NOUN
aiua-11242	26	14	≤	≤	NOUN
aiua-11242	26	15	0.22	0.22	NUM
aiua-11242	26	16	(	(	PUNCT
aiua-11242	26	17	63.2	63.2	NUM
aiua-11242	26	18	%	%	NOUN
aiua-11242	26	19	)	)	PUNCT
aiua-11242	26	20	showed	show	VERB
aiua-11242	26	21	,	,	PUNCT
aiua-11242	26	22	compared	compare	VERB
aiua-11242	26	23	to	to	ADP
aiua-11242	26	24	car	car	NOUN
aiua-11242	26	25	>	>	X
aiua-11242	26	26	0.22	0.22	NUM
aiua-11242	26	27	,	,	PUNCT
aiua-11242	26	28	longer	long	ADV
aiua-11242	26	29	pfs	pfs	PROPN
aiua-11242	26	30	(	(	PUNCT
aiua-11242	26	31	15.92	15.92	NUM
aiua-11242	26	32	vs.	vs.	ADP
aiua-11242	26	33	9.46	9.46	NUM
aiua-11242	26	34	months	month	NOUN
aiua-11242	26	35	,	,	PUNCT
aiua-11242	26	36	r	r	NOUN
aiua-11242	26	37	=	=	SYM
aiua-11242	26	38	-0.13	-0.13	NUM
aiua-11242	26	39	,	,	PUNCT
aiua-11242	26	40	p	p	X
aiua-11242	26	41	<	<	X
aiua-11242	26	42	0.05	0.05	NUM
aiua-11242	26	43	)	)	PUNCT
aiua-11242	26	44	and	and	CCONJ
aiua-11242	26	45	os	os	INTJ
aiua-11242	26	46	(	(	PUNCT
aiua-11242	26	47	p	p	X
aiua-11242	26	48	=	=	X
aiua-11242	26	49	<	<	X
aiua-11242	26	50	0.05	0.05	NUM
aiua-11242	26	51	,	,	PUNCT
aiua-11242	26	52	25,72	25,72	NUM
aiua-11242	26	53	vs.	vs.	ADP
aiua-11242	26	54	15.79	15.79	NUM
aiua-11242	26	55	months	month	NOUN
aiua-11242	26	56	,	,	PUNCT
aiua-11242	26	57	r	r	NOUN
aiua-11242	26	58	=	=	PUNCT
aiua-11242	26	59	-0,24	-0,24	PROPN
aiua-11242	26	60	,	,	PUNCT
aiua-11242	26	61	p	p	X
aiua-11242	26	62	<	<	X
aiua-11242	26	63	0.05	0.05	NUM
aiua-11242	26	64	)	)	PUNCT
aiua-11242	26	65	.	.	PUNCT
aiua-11242	27	1	better	well	ADV
aiua-11242	27	2	os	os	ADV
aiua-11242	27	3	in	in	ADP
aiua-11242	27	4	patients	patient	NOUN
aiua-11242	27	5	with	with	ADP
aiua-11242	27	6	car	car	NOUN
aiua-11242	27	7	≤	≤	NOUN
aiua-11242	27	8	0.22	0.22	NUM
aiua-11242	27	9	vs	vs	ADP
aiua-11242	27	10	>	>	X
aiua-11242	27	11	0.22	0.22	NUM
aiua-11242	27	12	was	be	AUX
aiua-11242	27	13	detected	detect	VERB
aiua-11242	27	14	on	on	ADP
aiua-11242	27	15	both	both	CCONJ
aiua-11242	27	16	the	the	DET
aiua-11242	27	17	group	group	NOUN
aiua-11242	27	18	evaluated	evaluate	VERB
aiua-11242	27	19	at	at	ADP
aiua-11242	27	20	the	the	DET
aiua-11242	27	21	beginning	beginning	NOUN
aiua-11242	27	22	of	of	ADP
aiua-11242	27	23	systemic	systemic	ADJ
aiua-11242	27	24	treatment	treatment	NOUN
aiua-11242	27	25	(	(	PUNCT
aiua-11242	27	26	26.96	26.96	NUM
aiua-11242	27	27	vs	vs	ADP
aiua-11242	27	28	17.63	17.63	NUM
aiua-11242	27	29	months	month	NOUN
aiua-11242	27	30	,	,	PUNCT
aiua-11242	27	31	p	p	X
aiua-11242	27	32	<	<	X
aiua-11242	27	33	0.05	0.05	NUM
aiua-11242	27	34	)	)	PUNCT
aiua-11242	27	35	and	and	CCONJ
aiua-11242	27	36	the	the	DET
aiua-11242	27	37	group	group	NOUN
aiua-11242	27	38	of	of	ADP
aiua-11242	27	39	patients	patient	NOUN
aiua-11242	27	40	already	already	ADV
aiua-11242	27	41	under	under	ADP
aiua-11242	27	42	treatment	treatment	NOUN
aiua-11242	27	43	(	(	PUNCT
aiua-11242	27	44	23.90	23.90	NUM
aiua-11242	27	45	vs	vs	ADP
aiua-11242	27	46	11.54	11.54	NUM
aiua-11242	27	47	months	month	NOUN
aiua-11242	27	48	,	,	PUNCT
aiua-11242	27	49	p	p	X
aiua-11242	27	50	<	<	X
aiua-11242	27	51	0.05	0.05	NUM
aiua-11242	27	52	)	)	PUNCT
aiua-11242	27	53	.	.	PUNCT
aiua-11242	28	1	dividing	divide	VERB
aiua-11242	28	2	the	the	DET
aiua-11242	28	3	sample	sample	NOUN
aiua-11242	28	4	according	accord	VERB
aiua-11242	28	5	to	to	ADP
aiua-11242	28	6	the	the	DET
aiua-11242	28	7	first	first	ADJ
aiua-11242	28	8	line	line	NOUN
aiua-11242	28	9	treatment	treatment	NOUN
aiua-11242	28	10	chosen	choose	VERB
aiua-11242	28	11	,	,	PUNCT
aiua-11242	28	12	we	we	PRON
aiua-11242	28	13	found	find	VERB
aiua-11242	28	14	os	os	NOUN
aiua-11242	28	15	of	of	ADP
aiua-11242	28	16	26.25	26.25	NUM
aiua-11242	28	17	vs	vs	ADP
aiua-11242	28	18	5.9	5.9	NUM
aiua-11242	28	19	months	month	NOUN
aiua-11242	28	20	(	(	PUNCT
aiua-11242	28	21	p	p	X
aiua-11242	28	22	<	<	X
aiua-11242	28	23	0.05	0.05	NUM
aiua-11242	28	24	)	)	PUNCT
aiua-11242	28	25	,	,	PUNCT
aiua-11242	28	26	27.71	27.71	NUM
aiua-11242	28	27	vs	vs	ADP
aiua-11242	28	28	22.57	22.57	NUM
aiua-11242	28	29	months	month	NOUN
aiua-11242	28	30	(	(	PUNCT
aiua-11242	28	31	p	p	X
aiua-11242	28	32	<	<	X
aiua-11242	28	33	0.05	0.05	NUM
aiua-11242	28	34	)	)	PUNCT
aiua-11242	28	35	and	and	CCONJ
aiua-11242	28	36	27.36	27.36	NUM
aiua-11242	28	37	vs	vs	ADP
aiua-11242	28	38	23.75	23.75	NUM
aiua-11242	28	39	months	month	NOUN
aiua-11242	28	40	(	(	PUNCT
aiua-11242	28	41	p	p	NOUN
aiua-11242	28	42	=	=	NOUN
aiua-11242	28	43	0.12	0.12	NUM
aiua-11242	28	44	)	)	PUNCT
aiua-11242	28	45	,	,	PUNCT
aiua-11242	28	46	for	for	ADP
aiua-11242	28	47	docetaxel	docetaxel	NOUN
aiua-11242	28	48	,	,	PUNCT
aiua-11242	28	49	abiraterone	abiraterone	NOUN
aiua-11242	28	50	and	and	CCONJ
aiua-11242	28	51	enzalutamide	enzalutamide	ADV
aiua-11242	28	52	,	,	PUNCT
aiua-11242	28	53	respectively	respectively	ADV
aiua-11242	28	54	.	.	PUNCT
aiua-11242	29	1	conclusions	conclusion	NOUN
aiua-11242	29	2	:	:	PUNCT
aiua-11242	29	3	according	accord	VERB
aiua-11242	29	4	to	to	ADP
aiua-11242	29	5	this	this	DET
aiua-11242	29	6	study	study	NOUN
aiua-11242	29	7	,	,	PUNCT
aiua-11242	29	8	higher	high	ADJ
aiua-11242	29	9	values	value	NOUN
aiua-11242	29	10	of	of	ADP
aiua-11242	29	11	car	car	NOUN
aiua-11242	29	12	are	be	AUX
aiua-11242	29	13	associated	associate	VERB
aiua-11242	29	14	with	with	ADP
aiua-11242	29	15	lower	low	ADJ
aiua-11242	29	16	pfs	pfs	PROPN
aiua-11242	29	17	and	and	CCONJ
aiua-11242	29	18	os	os	NOUN
aiua-11242	29	19	in	in	ADP
aiua-11242	29	20	mcrpc	mcrpc	PROPN
aiua-11242	29	21	patients	patient	NOUN
aiua-11242	29	22	.	.	PUNCT
aiua-11242	30	1	we	we	PRON
aiua-11242	30	2	found	find	VERB
aiua-11242	30	3	a	a	DET
aiua-11242	30	4	cut	cut	VERB
aiua-11242	30	5	-	-	PUNCT
aiua-11242	30	6	off	off	ADP
aiua-11242	30	7	value	value	NOUN
aiua-11242	30	8	of	of	ADP
aiua-11242	30	9	0.22	0.22	NUM
aiua-11242	30	10	providing	provide	VERB
aiua-11242	30	11	the	the	DET
aiua-11242	30	12	best	good	ADJ
aiua-11242	30	13	discrimination	discrimination	NOUN
aiua-11242	30	14	for	for	ADP
aiua-11242	30	15	prognosis	prognosis	NOUN
aiua-11242	30	16	.	.	PUNCT
aiua-11242	31	1	car	car	NOUN
aiua-11242	31	2	is	be	AUX
aiua-11242	31	3	a	a	DET
aiua-11242	31	4	good	good	ADJ
aiua-11242	31	5	prognosis	prognosis	NOUN
aiua-11242	31	6	biomarker	biomarker	NOUN
aiua-11242	31	7	,	,	PUNCT
aiua-11242	31	8	irrespective	irrespective	ADV
aiua-11242	31	9	of	of	ADP
aiua-11242	31	10	the	the	DET
aiua-11242	31	11	moment	moment	NOUN
aiua-11242	31	12	of	of	ADP
aiua-11242	31	13	evaluation	evaluation	NOUN
aiua-11242	31	14	and	and	CCONJ
aiua-11242	31	15	chosen	choose	VERB
aiua-11242	31	16	treatment	treatment	NOUN
aiua-11242	31	17	option	option	NOUN
aiua-11242	31	18	.	.	PUNCT
aiua-11242	32	1	key	key	ADJ
aiua-11242	32	2	words	word	NOUN
aiua-11242	32	3	:	:	PUNCT
aiua-11242	32	4	prostatic	prostatic	ADJ
aiua-11242	32	5	cancer	cancer	NOUN
aiua-11242	32	6	;	;	PUNCT
aiua-11242	32	7	c	c	X
aiua-11242	32	8	-	-	PUNCT
aiua-11242	32	9	reactive	reactive	ADJ
aiua-11242	32	10	protein	protein	NOUN
aiua-11242	32	11	;	;	PUNCT
aiua-11242	32	12	albumin	albumin	NOUN
aiua-11242	32	13	;	;	PUNCT
aiua-11242	32	14	biomarker	biomarker	NOUN
aiua-11242	32	15	;	;	PUNCT
aiua-11242	32	16	prognosis	prognosis	NOUN
aiua-11242	32	17	.	.	PUNCT
aiua-11242	32	18	submitted	submit	VERB
aiua-11242	32	19	6	6	NUM
aiua-11242	32	20	february	february	NOUN
aiua-11242	32	21	2023	2023	NUM
aiua-11242	32	22	;	;	PUNCT
aiua-11242	32	23	accepteed	accepteed	VERB
aiua-11242	32	24	25	25	NUM
aiua-11242	32	25	february	february	PROPN
aiua-11242	32	26	2023	2023	NUM
aiua-11242	32	27	introduction	introduction	NOUN
aiua-11242	32	28	prostate	prostate	NOUN
aiua-11242	32	29	cancer	cancer	NOUN
aiua-11242	32	30	(	(	PUNCT
aiua-11242	32	31	pca	pca	PROPN
aiua-11242	32	32	)	)	PUNCT
aiua-11242	32	33	is	be	AUX
aiua-11242	32	34	the	the	DET
aiua-11242	32	35	most	most	ADV
aiua-11242	32	36	common	common	ADJ
aiua-11242	32	37	non	non	ADJ
aiua-11242	32	38	cutaneous	cutaneous	ADJ
aiua-11242	32	39	malignancy	malignancy	NOUN
aiua-11242	32	40	among	among	ADP
aiua-11242	32	41	men	man	NOUN
aiua-11242	32	42	(	(	PUNCT
aiua-11242	32	43	1	1	NUM
aiua-11242	32	44	)	)	PUNCT
aiua-11242	32	45	,	,	PUNCT
aiua-11242	32	46	and	and	CCONJ
aiua-11242	32	47	the	the	DET
aiua-11242	32	48	second	second	ADJ
aiua-11242	32	49	leading	lead	VERB
aiua-11242	32	50	cause	cause	NOUN
aiua-11242	32	51	of	of	ADP
aiua-11242	32	52	death	death	NOUN
aiua-11242	32	53	from	from	ADP
aiua-11242	32	54	cancer	cancer	NOUN
aiua-11242	32	55	in	in	ADP
aiua-11242	32	56	this	this	DET
aiua-11242	32	57	population	population	NOUN
aiua-11242	32	58	(	(	PUNCT
aiua-11242	32	59	2	2	NUM
aiua-11242	32	60	)	)	PUNCT
aiua-11242	32	61	.	.	PUNCT
aiua-11242	33	1	it	it	PRON
aiua-11242	33	2	is	be	AUX
aiua-11242	33	3	estimated	estimate	VERB
aiua-11242	33	4	that	that	SCONJ
aiua-11242	33	5	approximately	approximately	ADV
aiua-11242	33	6	1	1	NUM
aiua-11242	33	7	in	in	ADP
aiua-11242	33	8	8	8	NUM
aiua-11242	33	9	men	man	NOUN
aiua-11242	33	10	(	(	PUNCT
aiua-11242	33	11	12.9	12.9	NUM
aiua-11242	33	12	%	%	NOUN
aiua-11242	33	13	)	)	PUNCT
aiua-11242	33	14	will	will	AUX
aiua-11242	33	15	be	be	AUX
aiua-11242	33	16	diagnosed	diagnose	VERB
aiua-11242	33	17	with	with	ADP
aiua-11242	33	18	prostate	prostate	NOUN
aiua-11242	33	19	cancer	cancer	NOUN
aiua-11242	33	20	,	,	PUNCT
aiua-11242	33	21	and	and	CCONJ
aiua-11242	33	22	1	1	NUM
aiua-11242	33	23	in	in	ADP
aiua-11242	33	24	40	40	NUM
aiua-11242	33	25	(	(	PUNCT
aiua-11242	33	26	2.5	2.5	NUM
aiua-11242	33	27	%	%	NOUN
aiua-11242	33	28	)	)	PUNCT
aiua-11242	33	29	will	will	AUX
aiua-11242	33	30	die	die	VERB
aiua-11242	33	31	from	from	ADP
aiua-11242	33	32	this	this	DET
aiua-11242	33	33	c	c	NOUN
aiua-11242	33	34	reactive	reactive	ADJ
aiua-11242	33	35	protein	protein	NOUN
aiua-11242	33	36	/	/	SYM
aiua-11242	33	37	albumin	albumin	NOUN
aiua-11242	33	38	ratio	ratio	NOUN
aiua-11242	33	39	as	as	ADP
aiua-11242	33	40	predictor	predictor	NOUN
aiua-11242	33	41	of	of	ADP
aiua-11242	33	42	prognosis	prognosis	NOUN
aiua-11242	33	43	in	in	ADP
aiua-11242	33	44	castration	castration	NOUN
aiua-11242	33	45	resistant	resistant	ADJ
aiua-11242	33	46	metastatic	metastatic	ADJ
aiua-11242	33	47	prostate	prostate	NOUN
aiua-11242	33	48	cancer	cancer	NOUN
aiua-11242	33	49	joão	joão	PROPN
aiua-11242	33	50	lorigo	lorigo	PROPN
aiua-11242	33	51	1	1	NUM
aiua-11242	33	52	,	,	PUNCT
aiua-11242	33	53	edgar	edgar	PROPN
aiua-11242	33	54	tavares	tavare	NOUN
aiua-11242	33	55	silva	silva	PROPN
aiua-11242	33	56	1	1	NUM
aiua-11242	33	57	,	,	PUNCT
aiua-11242	33	58	2	2	NUM
aiua-11242	33	59	,	,	PUNCT
aiua-11242	33	60	joão	joão	PROPN
aiua-11242	33	61	pedroso	pedroso	PROPN
aiua-11242	33	62	lima	lima	PROPN
aiua-11242	33	63	1	1	NUM
aiua-11242	33	64	,	,	PUNCT
aiua-11242	33	65	2	2	NUM
aiua-11242	33	66	,	,	PUNCT
aiua-11242	33	67	vasco	vasco	PROPN
aiua-11242	33	68	quaresma	quaresma	PROPN
aiua-11242	33	69	1	1	NUM
aiua-11242	33	70	,	,	PUNCT
aiua-11242	33	71	rui	rui	PROPN
aiua-11242	33	72	pedrosa	pedrosa	PROPN
aiua-11242	33	73	1	1	NUM
aiua-11242	33	74	,	,	PUNCT
aiua-11242	33	75	arnaldo	arnaldo	PROPN
aiua-11242	33	76	figueiredo	figueiredo	PROPN
aiua-11242	33	77	1	1	NUM
aiua-11242	33	78	,	,	PUNCT
aiua-11242	33	79	2	2	NUM
aiua-11242	33	80	1	1	NUM
aiua-11242	33	81	department	department	NOUN
aiua-11242	33	82	of	of	ADP
aiua-11242	33	83	urology	urology	NOUN
aiua-11242	33	84	,	,	PUNCT
aiua-11242	33	85	centro	centro	PROPN
aiua-11242	33	86	hospitalar	hospitalar	PROPN
aiua-11242	33	87	e	e	PROPN
aiua-11242	33	88	universitário	universitário	PROPN
aiua-11242	33	89	de	de	X
aiua-11242	33	90	coimbra	coimbra	PROPN
aiua-11242	33	91	,	,	PUNCT
aiua-11242	33	92	coimbra	coimbra	PROPN
aiua-11242	33	93	,	,	PUNCT
aiua-11242	33	94	portugal	portugal	PROPN
aiua-11242	33	95	;	;	PUNCT
aiua-11242	33	96	2	2	NUM
aiua-11242	33	97	university	university	NOUN
aiua-11242	33	98	,	,	PUNCT
aiua-11242	33	99	coimbra	coimbra	PROPN
aiua-11242	33	100	,	,	PUNCT
aiua-11242	33	101	portugal	portugal	PROPN
aiua-11242	33	102	.	.	PUNCT
aiua-11242	34	1	doi	doi	PROPN
aiua-11242	34	2	:	:	PUNCT
aiua-11242	34	3	10.4081	10.4081	NUM
aiua-11242	34	4	/	/	SYM
aiua-11242	34	5	aiua.2023.11242	aiua.2023.11242	PROPN
aiua-11242	34	6	summary	summary	VERB
aiua-11242	34	7	archivio	archivio	NOUN
aiua-11242	34	8	italiano	italiano	X
aiua-11242	34	9	di	di	X
aiua-11242	34	10	urologia	urologia	PROPN
aiua-11242	34	11	e	e	PROPN
aiua-11242	34	12	andrologia	andrologia	NOUN
aiua-11242	34	13	2023	2023	NUM
aiua-11242	34	14	;	;	PUNCT
aiua-11242	34	15	95(3):11242	95(3):11242	NUM
aiua-11242	34	16	j.	j.	PROPN
aiua-11242	34	17	lorigo	lorigo	PROPN
aiua-11242	34	18	,	,	PUNCT
aiua-11242	34	19	e.	e.	PROPN
aiua-11242	34	20	tavares	tavares	PROPN
aiua-11242	34	21	silva	silva	PROPN
aiua-11242	34	22	,	,	PUNCT
aiua-11242	34	23	j.	j.	PROPN
aiua-11242	34	24	pedroso	pedroso	PROPN
aiua-11242	34	25	lima	lima	PROPN
aiua-11242	34	26	,	,	PUNCT
aiua-11242	34	27	v.	v.	PROPN
aiua-11242	34	28	quaresma	quaresma	PROPN
aiua-11242	34	29	,	,	PUNCT
aiua-11242	34	30	r.	r.	PROPN
aiua-11242	34	31	pedrosa	pedrosa	PROPN
aiua-11242	34	32	,	,	PUNCT
aiua-11242	34	33	a.	a.	PROPN
aiua-11242	34	34	figueiredo	figueiredo	PROPN
aiua-11242	34	35	2	2	NUM
aiua-11242	34	36	tocellular	tocellular	ADJ
aiua-11242	34	37	,	,	PUNCT
aiua-11242	34	38	colorectal	colorectal	ADJ
aiua-11242	34	39	,	,	PUNCT
aiua-11242	34	40	esophageal	esophageal	ADJ
aiua-11242	34	41	,	,	PUNCT
aiua-11242	34	42	pancreatic	pancreatic	ADJ
aiua-11242	34	43	,	,	PUNCT
aiua-11242	34	44	small	small	ADJ
aiua-11242	34	45	cell	cell	NOUN
aiua-11242	34	46	lung	lung	NOUN
aiua-11242	34	47	and	and	CCONJ
aiua-11242	34	48	cervical	cervical	ADJ
aiua-11242	34	49	neoplasia	neoplasia	NOUN
aiua-11242	34	50	(	(	PUNCT
aiua-11242	34	51	14	14	NUM
aiua-11242	34	52	-	-	SYM
aiua-11242	34	53	16	16	NUM
aiua-11242	34	54	,	,	PUNCT
aiua-11242	34	55	20	20	NUM
aiua-11242	34	56	-	-	SYM
aiua-11242	34	57	22	22	NUM
aiua-11242	34	58	)	)	PUNCT
aiua-11242	34	59	.	.	PUNCT
aiua-11242	35	1	however	however	ADV
aiua-11242	35	2	,	,	PUNCT
aiua-11242	35	3	there	there	PRON
aiua-11242	35	4	is	be	VERB
aiua-11242	35	5	only	only	ADV
aiua-11242	35	6	limited	limited	ADJ
aiua-11242	35	7	data	datum	NOUN
aiua-11242	35	8	in	in	ADP
aiua-11242	35	9	prostate	prostate	NOUN
aiua-11242	35	10	cancer	cancer	NOUN
aiua-11242	35	11	patients	patient	NOUN
aiua-11242	35	12	.	.	PUNCT
aiua-11242	36	1	the	the	DET
aiua-11242	36	2	objective	objective	NOUN
aiua-11242	36	3	of	of	ADP
aiua-11242	36	4	this	this	DET
aiua-11242	36	5	study	study	NOUN
aiua-11242	36	6	was	be	AUX
aiua-11242	36	7	to	to	PART
aiua-11242	36	8	assess	assess	VERB
aiua-11242	36	9	the	the	DET
aiua-11242	36	10	association	association	NOUN
aiua-11242	36	11	of	of	ADP
aiua-11242	36	12	car	car	NOUN
aiua-11242	36	13	with	with	ADP
aiua-11242	36	14	pfs	pfs	PROPN
aiua-11242	36	15	and	and	CCONJ
aiua-11242	36	16	os	os	NOUN
aiua-11242	36	17	in	in	ADP
aiua-11242	36	18	a	a	DET
aiua-11242	36	19	group	group	NOUN
aiua-11242	36	20	of	of	ADP
aiua-11242	36	21	mcrpc	mcrpc	PROPN
aiua-11242	36	22	patients	patient	NOUN
aiua-11242	36	23	.	.	PUNCT
aiua-11242	37	1	materials	material	NOUN
aiua-11242	37	2	and	and	CCONJ
aiua-11242	37	3	methods	method	NOUN
aiua-11242	37	4	a	a	DET
aiua-11242	37	5	transversal	transversal	ADJ
aiua-11242	37	6	study	study	NOUN
aiua-11242	37	7	was	be	AUX
aiua-11242	37	8	conducted	conduct	VERB
aiua-11242	37	9	,	,	PUNCT
aiua-11242	37	10	including	include	VERB
aiua-11242	37	11	all	all	DET
aiua-11242	37	12	patients	patient	NOUN
aiua-11242	37	13	diagnosed	diagnose	VERB
aiua-11242	37	14	with	with	ADP
aiua-11242	37	15	mcrpc	mcrpc	NOUN
aiua-11242	37	16	with	with	ADP
aiua-11242	37	17	a	a	DET
aiua-11242	37	18	follow	follow	NOUN
aiua-11242	37	19	-	-	PUNCT
aiua-11242	37	20	up	up	NOUN
aiua-11242	37	21	in	in	ADP
aiua-11242	37	22	a	a	DET
aiua-11242	37	23	urological	urological	ADJ
aiua-11242	37	24	oncology	oncology	NOUN
aiua-11242	37	25	consultation	consultation	NOUN
aiua-11242	37	26	at	at	ADP
aiua-11242	37	27	a	a	DET
aiua-11242	37	28	central	central	ADJ
aiua-11242	37	29	hospital	hospital	NOUN
aiua-11242	37	30	in	in	ADP
aiua-11242	37	31	portugal	portugal	PROPN
aiua-11242	37	32	,	,	PUNCT
aiua-11242	37	33	between	between	ADP
aiua-11242	37	34	december	december	PROPN
aiua-11242	37	35	2019	2019	NUM
aiua-11242	37	36	and	and	CCONJ
aiua-11242	37	37	december	december	PROPN
aiua-11242	37	38	2021	2021	NUM
aiua-11242	37	39	(	(	PUNCT
aiua-11242	37	40	n	n	NOUN
aiua-11242	37	41	=	=	SYM
aiua-11242	37	42	178	178	NUM
aiua-11242	37	43	)	)	PUNCT
aiua-11242	37	44	and	and	CCONJ
aiua-11242	37	45	that	that	PRON
aiua-11242	37	46	were	be	AUX
aiua-11242	37	47	submitted	submit	VERB
aiua-11242	37	48	to	to	ADP
aiua-11242	37	49	systemic	systemic	ADJ
aiua-11242	37	50	therapy	therapy	NOUN
aiua-11242	37	51	(	(	PUNCT
aiua-11242	37	52	74	74	NUM
aiua-11242	37	53	abiraterone	abiraterone	NOUN
aiua-11242	37	54	,	,	PUNCT
aiua-11242	37	55	56	56	NUM
aiua-11242	37	56	enzalutamide	enzalutamide	NOUN
aiua-11242	37	57	and	and	CCONJ
aiua-11242	37	58	48	48	NUM
aiua-11242	37	59	docetaxel	docetaxel	NOUN
aiua-11242	37	60	)	)	PUNCT
aiua-11242	37	61	.	.	PUNCT
aiua-11242	38	1	twenty	twenty	NUM
aiua-11242	38	2	-	-	PUNCT
aiua-11242	38	3	two	two	NUM
aiua-11242	38	4	patients	patient	NOUN
aiua-11242	38	5	had	have	AUX
aiua-11242	38	6	received	receive	VERB
aiua-11242	38	7	docetaxel	docetaxel	NOUN
aiua-11242	38	8	before	before	ADV
aiua-11242	38	9	for	for	ADP
aiua-11242	38	10	metastatic	metastatic	ADJ
aiua-11242	38	11	hormone	hormone	NOUN
aiua-11242	38	12	-	-	PUNCT
aiua-11242	38	13	sensitive	sensitive	ADJ
aiua-11242	38	14	prostate	prostate	NOUN
aiua-11242	38	15	cancer	cancer	NOUN
aiua-11242	38	16	(	(	PUNCT
aiua-11242	38	17	mhspc	mhspc	PROPN
aiua-11242	38	18	)	)	PUNCT
aiua-11242	38	19	.	.	PUNCT
aiua-11242	39	1	seventy	seventy	NUM
aiua-11242	39	2	-	-	PUNCT
aiua-11242	39	3	five	five	NUM
aiua-11242	39	4	patients	patient	NOUN
aiua-11242	39	5	were	be	AUX
aiua-11242	39	6	already	already	ADV
aiua-11242	39	7	under	under	ADP
aiua-11242	39	8	treatment	treatment	NOUN
aiua-11242	39	9	and	and	CCONJ
aiua-11242	39	10	follow	follow	VERB
aiua-11242	39	11	-	-	PUNCT
aiua-11242	39	12	up	up	NOUN
aiua-11242	39	13	in	in	ADP
aiua-11242	39	14	december	december	PROPN
aiua-11242	39	15	2019	2019	NUM
aiua-11242	39	16	and	and	CCONJ
aiua-11242	39	17	this	this	DET
aiua-11242	39	18	group	group	NOUN
aiua-11242	39	19	had	have	VERB
aiua-11242	39	20	the	the	DET
aiua-11242	39	21	crp	crp	PROPN
aiua-11242	39	22	and	and	CCONJ
aiua-11242	39	23	albumin	albumin	ADJ
aiua-11242	39	24	data	datum	NOUN
aiua-11242	39	25	collected	collect	VERB
aiua-11242	39	26	at	at	ADP
aiua-11242	39	27	that	that	DET
aiua-11242	39	28	date	date	NOUN
aiua-11242	39	29	.	.	PUNCT
aiua-11242	40	1	the	the	DET
aiua-11242	40	2	remaining	remain	VERB
aiua-11242	40	3	103	103	NUM
aiua-11242	40	4	patients	patient	NOUN
aiua-11242	40	5	had	have	VERB
aiua-11242	40	6	the	the	DET
aiua-11242	40	7	biochemical	biochemical	ADJ
aiua-11242	40	8	data	datum	NOUN
aiua-11242	40	9	collected	collect	VERB
aiua-11242	40	10	in	in	ADP
aiua-11242	40	11	the	the	DET
aiua-11242	40	12	beginning	beginning	NOUN
aiua-11242	40	13	of	of	ADP
aiua-11242	40	14	the	the	DET
aiua-11242	40	15	systemic	systemic	ADJ
aiua-11242	40	16	treatment	treatment	NOUN
aiua-11242	40	17	(	(	PUNCT
aiua-11242	40	18	between	between	ADP
aiua-11242	40	19	december	december	PROPN
aiua-11242	40	20	2019	2019	NUM
aiua-11242	40	21	and	and	CCONJ
aiua-11242	40	22	december	december	PROPN
aiua-11242	40	23	2021	2021	NUM
aiua-11242	40	24	)	)	PUNCT
aiua-11242	40	25	.	.	PUNCT
aiua-11242	41	1	the	the	DET
aiua-11242	41	2	participants	participant	NOUN
aiua-11242	41	3	’	'	PUNCT
aiua-11242	41	4	characteristics	characteristic	NOUN
aiua-11242	41	5	were	be	AUX
aiua-11242	41	6	gathered	gather	VERB
aiua-11242	41	7	from	from	ADP
aiua-11242	41	8	the	the	DET
aiua-11242	41	9	medical	medical	ADJ
aiua-11242	41	10	records	record	NOUN
aiua-11242	41	11	including	include	VERB
aiua-11242	41	12	age	age	NOUN
aiua-11242	41	13	,	,	PUNCT
aiua-11242	41	14	histological	histological	ADJ
aiua-11242	41	15	grade	grade	NOUN
aiua-11242	41	16	,	,	PUNCT
aiua-11242	41	17	disease	disease	NOUN
aiua-11242	41	18	risk	risk	NOUN
aiua-11242	41	19	and	and	CCONJ
aiua-11242	41	20	volume	volume	NOUN
aiua-11242	41	21	,	,	PUNCT
aiua-11242	41	22	treatment	treatment	NOUN
aiua-11242	41	23	modality	modality	NOUN
aiua-11242	41	24	,	,	PUNCT
aiua-11242	41	25	crp	crp	PROPN
aiua-11242	41	26	,	,	PUNCT
aiua-11242	41	27	alb	alb	PROPN
aiua-11242	41	28	,	,	PUNCT
aiua-11242	41	29	progression	progression	NOUN
aiua-11242	41	30	free	free	ADJ
aiua-11242	41	31	survival	survival	NOUN
aiua-11242	41	32	and	and	CCONJ
aiua-11242	41	33	overall	overall	ADJ
aiua-11242	41	34	survival	survival	NOUN
aiua-11242	41	35	.	.	PUNCT
aiua-11242	42	1	the	the	DET
aiua-11242	42	2	follow	follow	VERB
aiua-11242	42	3	up	up	ADP
aiua-11242	42	4	data	datum	NOUN
aiua-11242	42	5	were	be	AUX
aiua-11242	42	6	collected	collect	VERB
aiua-11242	42	7	until	until	ADP
aiua-11242	42	8	august	august	PROPN
aiua-11242	42	9	of	of	ADP
aiua-11242	42	10	2022	2022	NUM
aiua-11242	42	11	.	.	PUNCT
aiua-11242	43	1	a	a	DET
aiua-11242	43	2	taxane	taxane	NOUN
aiua-11242	43	3	-	-	PUNCT
aiua-11242	43	4	based	base	VERB
aiua-11242	43	5	chemotherapy	chemotherapy	NOUN
aiua-11242	43	6	was	be	AUX
aiua-11242	43	7	chosen	choose	VERB
aiua-11242	43	8	in	in	ADP
aiua-11242	43	9	the	the	DET
aiua-11242	43	10	presence	presence	NOUN
aiua-11242	43	11	of	of	ADP
aiua-11242	43	12	clinical	clinical	ADJ
aiua-11242	43	13	criteria	criterion	NOUN
aiua-11242	43	14	of	of	ADP
aiua-11242	43	15	poor	poor	ADJ
aiua-11242	43	16	prognosis	prognosis	NOUN
aiua-11242	43	17	(	(	PUNCT
aiua-11242	43	18	short	short	ADJ
aiua-11242	43	19	period	period	NOUN
aiua-11242	43	20	of	of	ADP
aiua-11242	43	21	response	response	NOUN
aiua-11242	43	22	under	under	ADP
aiua-11242	43	23	adt	adt	NOUN
aiua-11242	43	24	,	,	PUNCT
aiua-11242	43	25	high	high	ADJ
aiua-11242	43	26	metastatic	metastatic	ADJ
aiua-11242	43	27	burden	burden	NOUN
aiua-11242	43	28	,	,	PUNCT
aiua-11242	43	29	visceral	visceral	ADJ
aiua-11242	43	30	metastasis	metastasis	NOUN
aiua-11242	43	31	or	or	CCONJ
aiua-11242	43	32	poor	poor	ADJ
aiua-11242	43	33	prognostic	prognostic	ADJ
aiua-11242	43	34	genetic	genetic	ADJ
aiua-11242	43	35	mutations	mutation	NOUN
aiua-11242	43	36	)	)	PUNCT
aiua-11242	43	37	or	or	CCONJ
aiua-11242	43	38	in	in	ADP
aiua-11242	43	39	patients	patient	NOUN
aiua-11242	43	40	progressing	progress	VERB
aiua-11242	43	41	after	after	ADP
aiua-11242	43	42	novel	novel	ADJ
aiua-11242	43	43	hormonal	hormonal	ADJ
aiua-11242	43	44	agents	agent	NOUN
aiua-11242	43	45	(	(	PUNCT
aiua-11242	43	46	nha	nha	NOUN
aiua-11242	43	47	;	;	PUNCT
aiua-11242	43	48	abiraterone	abiraterone	NOUN
aiua-11242	43	49	or	or	CCONJ
aiua-11242	43	50	enzalutamide	enzalutamide	NOUN
aiua-11242	43	51	)	)	PUNCT
aiua-11242	43	52	.	.	PUNCT
aiua-11242	44	1	nha	nha	NOUN
aiua-11242	44	2	were	be	AUX
aiua-11242	44	3	preferred	prefer	VERB
aiua-11242	44	4	in	in	ADP
aiua-11242	44	5	patients	patient	NOUN
aiua-11242	44	6	with	with	ADP
aiua-11242	44	7	less	less	ADV
aiua-11242	44	8	aggressive	aggressive	ADJ
aiua-11242	44	9	features	feature	NOUN
aiua-11242	44	10	(	(	PUNCT
aiua-11242	44	11	asymptomatic	asymptomatic	ADJ
aiua-11242	44	12	,	,	PUNCT
aiua-11242	44	13	durable	durable	ADJ
aiua-11242	44	14	response	response	NOUN
aiua-11242	44	15	under	under	ADP
aiua-11242	44	16	previous	previous	ADJ
aiua-11242	44	17	adt	adt	NOUN
aiua-11242	44	18	,	,	PUNCT
aiua-11242	44	19	low	low	ADJ
aiua-11242	44	20	metastatic	metastatic	ADJ
aiua-11242	44	21	burden	burden	NOUN
aiua-11242	44	22	and	and	CCONJ
aiua-11242	44	23	no	no	DET
aiua-11242	44	24	visceral	visceral	ADJ
aiua-11242	44	25	metastases	metastasis	NOUN
aiua-11242	44	26	)	)	PUNCT
aiua-11242	44	27	,	,	PUNCT
aiua-11242	44	28	and	and	CCONJ
aiua-11242	44	29	as	as	ADP
aiua-11242	44	30	second	second	ADJ
aiua-11242	44	31	line	line	NOUN
aiua-11242	44	32	therapy	therapy	NOUN
aiua-11242	44	33	in	in	ADP
aiua-11242	44	34	patients	patient	NOUN
aiua-11242	44	35	that	that	PRON
aiua-11242	44	36	progressed	progress	VERB
aiua-11242	44	37	under	under	ADP
aiua-11242	44	38	taxane	taxane	NOUN
aiua-11242	44	39	-	-	PUNCT
aiua-11242	44	40	based	base	VERB
aiua-11242	44	41	chemotherapy	chemotherapy	NOUN
aiua-11242	44	42	.	.	PUNCT
aiua-11242	45	1	in	in	ADP
aiua-11242	45	2	the	the	DET
aiua-11242	45	3	absence	absence	NOUN
aiua-11242	45	4	of	of	ADP
aiua-11242	45	5	contraindication	contraindication	NOUN
aiua-11242	45	6	for	for	ADP
aiua-11242	45	7	either	either	DET
aiua-11242	45	8	pharmaceutical	pharmaceutical	ADJ
aiua-11242	45	9	drugs	drug	NOUN
aiua-11242	45	10	,	,	PUNCT
aiua-11242	45	11	patients	patient	NOUN
aiua-11242	45	12	were	be	AUX
aiua-11242	45	13	sequentially	sequentially	ADV
aiua-11242	45	14	assigned	assign	VERB
aiua-11242	45	15	to	to	ADP
aiua-11242	45	16	either	either	CCONJ
aiua-11242	45	17	enzalutamide	enzalutamide	ADJ
aiua-11242	45	18	or	or	CCONJ
aiua-11242	45	19	abiraterone	abiraterone	NOUN
aiua-11242	45	20	group	group	NOUN
aiua-11242	45	21	.	.	PUNCT
aiua-11242	46	1	castration	castration	NOUN
aiua-11242	46	2	resistance	resistance	NOUN
aiua-11242	46	3	was	be	AUX
aiua-11242	46	4	defined	define	VERB
aiua-11242	46	5	using	use	VERB
aiua-11242	46	6	the	the	DET
aiua-11242	46	7	european	european	PROPN
aiua-11242	46	8	association	association	PROPN
aiua-11242	46	9	of	of	ADP
aiua-11242	46	10	urology	urology	NOUN
aiua-11242	46	11	criteria	criterion	NOUN
aiua-11242	46	12	:	:	PUNCT
aiua-11242	46	13	1	1	X
aiua-11242	46	14	)	)	PUNCT
aiua-11242	46	15	three	three	NUM
aiua-11242	46	16	consecutives	consecutive	NOUN
aiua-11242	46	17	rises	rise	VERB
aiua-11242	46	18	in	in	ADP
aiua-11242	46	19	psa	psa	NOUN
aiua-11242	46	20	at	at	ADV
aiua-11242	46	21	least	least	ADV
aiua-11242	46	22	one	one	NUM
aiua-11242	46	23	week	week	NOUN
aiua-11242	46	24	apart	apart	ADV
aiua-11242	46	25	resulting	result	VERB
aiua-11242	46	26	in	in	ADP
aiua-11242	46	27	two	two	NUM
aiua-11242	46	28	50	50	NUM
aiua-11242	46	29	%	%	NOUN
aiua-11242	46	30	increases	increase	NOUN
aiua-11242	46	31	over	over	ADP
aiua-11242	46	32	the	the	DET
aiua-11242	46	33	nadir	nadir	NOUN
aiua-11242	46	34	,	,	PUNCT
aiua-11242	46	35	and	and	CCONJ
aiua-11242	46	36	a	a	DET
aiua-11242	46	37	psa	psa	NOUN
aiua-11242	46	38	>	>	X
aiua-11242	46	39	2	2	NUM
aiua-11242	46	40	ng	ng	PROPN
aiua-11242	46	41	/	/	SYM
aiua-11242	46	42	ml	ml	PROPN
aiua-11242	46	43	,	,	PUNCT
aiua-11242	46	44	or	or	CCONJ
aiua-11242	46	45	2	2	NUM
aiua-11242	46	46	)	)	PUNCT
aiua-11242	46	47	appearance	appearance	NOUN
aiua-11242	46	48	of	of	ADP
aiua-11242	46	49	new	new	ADJ
aiua-11242	46	50	lesions	lesion	NOUN
aiua-11242	46	51	(	(	PUNCT
aiua-11242	46	52	either	either	CCONJ
aiua-11242	46	53	two	two	NUM
aiua-11242	46	54	or	or	CCONJ
aiua-11242	46	55	more	more	ADJ
aiua-11242	46	56	new	new	ADJ
aiua-11242	46	57	bone	bone	NOUN
aiua-11242	46	58	lesions	lesion	NOUN
aiua-11242	46	59	or	or	CCONJ
aiua-11242	46	60	a	a	DET
aiua-11242	46	61	soft	soft	ADJ
aiua-11242	46	62	lesion	lesion	NOUN
aiua-11242	46	63	using	use	VERB
aiua-11242	46	64	response	response	NOUN
aiua-11242	46	65	evaluation	evaluation	NOUN
aiua-11242	46	66	criteria	criterion	NOUN
aiua-11242	46	67	in	in	ADP
aiua-11242	46	68	solid	solid	ADJ
aiua-11242	46	69	tumours	tumour	NOUN
aiua-11242	46	70	[	[	X
aiua-11242	46	71	recist	recist	NOUN
aiua-11242	46	72	)	)	PUNCT
aiua-11242	46	73	)	)	PUNCT
aiua-11242	46	74	,	,	PUNCT
aiua-11242	46	75	or	or	CCONJ
aiua-11242	46	76	3	3	X
aiua-11242	46	77	)	)	PUNCT
aiua-11242	46	78	clinical	clinical	ADJ
aiua-11242	46	79	deterioration	deterioration	NOUN
aiua-11242	46	80	.	.	PUNCT
aiua-11242	47	1	os	os	PROPN
aiua-11242	47	2	was	be	AUX
aiua-11242	47	3	measured	measure	VERB
aiua-11242	47	4	from	from	ADP
aiua-11242	47	5	the	the	DET
aiua-11242	47	6	day	day	NOUN
aiua-11242	47	7	the	the	DET
aiua-11242	47	8	crp	crp	NOUN
aiua-11242	47	9	and	and	CCONJ
aiua-11242	47	10	alb	alb	PROPN
aiua-11242	47	11	were	be	AUX
aiua-11242	47	12	collected	collect	VERB
aiua-11242	47	13	to	to	ADP
aiua-11242	47	14	death	death	NOUN
aiua-11242	47	15	from	from	ADP
aiua-11242	47	16	any	any	DET
aiua-11242	47	17	cause	cause	NOUN
aiua-11242	47	18	or	or	CCONJ
aiua-11242	47	19	the	the	DET
aiua-11242	47	20	final	final	ADJ
aiua-11242	47	21	date	date	NOUN
aiua-11242	47	22	of	of	ADP
aiua-11242	47	23	followup	followup	NOUN
aiua-11242	47	24	.	.	PUNCT
aiua-11242	48	1	pfs	pfs	PROPN
aiua-11242	48	2	was	be	AUX
aiua-11242	48	3	also	also	ADV
aiua-11242	48	4	measured	measure	VERB
aiua-11242	48	5	from	from	ADP
aiua-11242	48	6	the	the	DET
aiua-11242	48	7	day	day	NOUN
aiua-11242	48	8	the	the	DET
aiua-11242	48	9	crp	crp	NOUN
aiua-11242	48	10	and	and	CCONJ
aiua-11242	48	11	alb	alb	PROPN
aiua-11242	48	12	were	be	AUX
aiua-11242	48	13	collected	collect	VERB
aiua-11242	48	14	until	until	ADP
aiua-11242	48	15	one	one	NUM
aiua-11242	48	16	of	of	ADP
aiua-11242	48	17	the	the	DET
aiua-11242	48	18	above	above	ADV
aiua-11242	48	19	-	-	PUNCT
aiua-11242	48	20	mentioned	mention	VERB
aiua-11242	48	21	criteria	criterion	NOUN
aiua-11242	48	22	were	be	AUX
aiua-11242	48	23	met	meet	VERB
aiua-11242	48	24	or	or	CCONJ
aiua-11242	48	25	the	the	DET
aiua-11242	48	26	final	final	ADJ
aiua-11242	48	27	date	date	NOUN
aiua-11242	48	28	of	of	ADP
aiua-11242	48	29	follow	follow	NOUN
aiua-11242	48	30	-	-	PUNCT
aiua-11242	48	31	up	up	NOUN
aiua-11242	48	32	.	.	PUNCT
aiua-11242	49	1	comparisons	comparison	NOUN
aiua-11242	49	2	between	between	ADP
aiua-11242	49	3	groups	group	NOUN
aiua-11242	49	4	were	be	AUX
aiua-11242	49	5	performed	perform	VERB
aiua-11242	49	6	using	use	VERB
aiua-11242	49	7	the	the	DET
aiua-11242	49	8	chi	chi	ADJ
aiua-11242	49	9	-	-	PUNCT
aiua-11242	49	10	square	square	ADJ
aiua-11242	49	11	test	test	NOUN
aiua-11242	49	12	.	.	PUNCT
aiua-11242	50	1	car	car	NOUN
aiua-11242	50	2	was	be	AUX
aiua-11242	50	3	correlated	correlate	VERB
aiua-11242	50	4	with	with	ADP
aiua-11242	50	5	pfs	pfs	PROPN
aiua-11242	50	6	and	and	CCONJ
aiua-11242	50	7	os	os	NOUN
aiua-11242	50	8	.	.	PUNCT
aiua-11242	51	1	for	for	ADP
aiua-11242	51	2	that	that	PRON
aiua-11242	51	3	,	,	PUNCT
aiua-11242	51	4	samples	sample	NOUN
aiua-11242	51	5	were	be	AUX
aiua-11242	51	6	divided	divide	VERB
aiua-11242	51	7	in	in	ADP
aiua-11242	51	8	two	two	NUM
aiua-11242	51	9	groups	group	NOUN
aiua-11242	51	10	according	accord	VERB
aiua-11242	51	11	to	to	ADP
aiua-11242	51	12	the	the	DET
aiua-11242	51	13	optimal	optimal	ADJ
aiua-11242	51	14	cutoff	cutoff	NOUN
aiua-11242	51	15	point	point	NOUN
aiua-11242	51	16	found	find	VERB
aiua-11242	51	17	in	in	ADP
aiua-11242	51	18	a	a	DET
aiua-11242	51	19	roc	roc	PROPN
aiua-11242	51	20	curve	curve	NOUN
aiua-11242	51	21	.	.	PUNCT
aiua-11242	52	1	os	os	NOUN
aiua-11242	52	2	and	and	CCONJ
aiua-11242	52	3	pfs	pfs	PROPN
aiua-11242	52	4	curves	curve	NOUN
aiua-11242	52	5	were	be	AUX
aiua-11242	52	6	generated	generate	VERB
aiua-11242	52	7	using	use	VERB
aiua-11242	52	8	the	the	DET
aiua-11242	52	9	kaplan	kaplan	PROPN
aiua-11242	52	10	-	-	PUNCT
aiua-11242	52	11	meier	meier	PROPN
aiua-11242	52	12	method	method	NOUN
aiua-11242	52	13	,	,	PUNCT
aiua-11242	52	14	and	and	CCONJ
aiua-11242	52	15	differences	difference	NOUN
aiua-11242	52	16	between	between	ADP
aiua-11242	52	17	groups	group	NOUN
aiua-11242	52	18	were	be	AUX
aiua-11242	52	19	compared	compare	VERB
aiua-11242	52	20	using	use	VERB
aiua-11242	52	21	the	the	DET
aiua-11242	52	22	log	log	NOUN
aiua-11242	52	23	-	-	PUNCT
aiua-11242	52	24	rank	rank	NOUN
aiua-11242	52	25	test	test	NOUN
aiua-11242	52	26	.	.	PUNCT
aiua-11242	53	1	all	all	DET
aiua-11242	53	2	data	datum	NOUN
aiua-11242	53	3	were	be	AUX
aiua-11242	53	4	analysed	analyse	VERB
aiua-11242	53	5	using	use	VERB
aiua-11242	53	6	a	a	DET
aiua-11242	53	7	linear	linear	ADJ
aiua-11242	53	8	regression	regression	NOUN
aiua-11242	53	9	model	model	NOUN
aiua-11242	53	10	and	and	CCONJ
aiua-11242	53	11	kaplan	kaplan	PROPN
aiua-11242	53	12	-	-	PUNCT
aiua-11242	53	13	meier	meier	PROPN
aiua-11242	53	14	survival	survival	NOUN
aiua-11242	53	15	curves	curve	NOUN
aiua-11242	53	16	.	.	PUNCT
aiua-11242	54	1	the	the	DET
aiua-11242	54	2	statistical	statistical	ADJ
aiua-11242	54	3	hypothesis	hypothesis	NOUN
aiua-11242	54	4	tests	test	VERB
aiua-11242	54	5	with	with	ADP
aiua-11242	54	6	p	p	NOUN
aiua-11242	54	7	-	-	PUNCT
aiua-11242	54	8	value	value	NOUN
aiua-11242	54	9	<	<	X
aiua-11242	54	10	0.05	0.05	NUM
aiua-11242	54	11	were	be	AUX
aiua-11242	54	12	considered	consider	VERB
aiua-11242	54	13	significant	significant	ADJ
aiua-11242	54	14	.	.	PUNCT
aiua-11242	55	1	statistical	statistical	ADJ
aiua-11242	55	2	analyses	analysis	NOUN
aiua-11242	55	3	were	be	AUX
aiua-11242	55	4	performed	perform	VERB
aiua-11242	55	5	using	use	VERB
aiua-11242	55	6	spss	spss	PROPN
aiua-11242	55	7	software	software	PROPN
aiua-11242	55	8	ver	ver	NOUN
aiua-11242	55	9	.	.	PUNCT
aiua-11242	56	1	25.0	25.0	NUM
aiua-11242	56	2	(	(	PUNCT
aiua-11242	56	3	ibm	ibm	PROPN
aiua-11242	56	4	,	,	PUNCT
aiua-11242	56	5	armonk	armonk	PROPN
aiua-11242	56	6	,	,	PUNCT
aiua-11242	56	7	ny	ny	PROPN
aiua-11242	56	8	,	,	PUNCT
aiua-11242	56	9	usa	usa	PROPN
aiua-11242	56	10	)	)	PUNCT
aiua-11242	56	11	.	.	PUNCT
aiua-11242	56	12	results	result	VERB
aiua-11242	56	13	a	a	DET
aiua-11242	56	14	total	total	NOUN
aiua-11242	56	15	of	of	ADP
aiua-11242	56	16	200	200	NUM
aiua-11242	56	17	patients	patient	NOUN
aiua-11242	56	18	diagnosed	diagnose	VERB
aiua-11242	56	19	with	with	ADP
aiua-11242	56	20	mcrpc	mcrpc	NOUN
aiua-11242	56	21	were	be	AUX
aiua-11242	56	22	included	include	VERB
aiua-11242	56	23	,	,	PUNCT
aiua-11242	56	24	median	median	ADJ
aiua-11242	56	25	age	age	NOUN
aiua-11242	56	26	at	at	ADP
aiua-11242	56	27	inclusion	inclusion	NOUN
aiua-11242	56	28	being	be	AUX
aiua-11242	56	29	75.76	75.76	NUM
aiua-11242	56	30	±	±	NUM
aiua-11242	56	31	9.17	9.17	NUM
aiua-11242	56	32	years	year	NOUN
aiua-11242	56	33	old	old	ADJ
aiua-11242	56	34	.	.	PUNCT
aiua-11242	57	1	after	after	ADP
aiua-11242	57	2	a	a	DET
aiua-11242	57	3	median	median	ADJ
aiua-11242	57	4	follow	follow	NOUN
aiua-11242	57	5	-	-	PUNCT
aiua-11242	57	6	up	up	NOUN
aiua-11242	57	7	of	of	ADP
aiua-11242	57	8	23	23	NUM
aiua-11242	57	9	months	month	NOUN
aiua-11242	57	10	,	,	PUNCT
aiua-11242	57	11	72	72	NUM
aiua-11242	57	12	patients	patient	NOUN
aiua-11242	57	13	(	(	PUNCT
aiua-11242	57	14	36.1	36.1	NUM
aiua-11242	57	15	%	%	NOUN
aiua-11242	57	16	)	)	PUNCT
aiua-11242	57	17	had	have	AUX
aiua-11242	57	18	died	die	VERB
aiua-11242	57	19	.	.	PUNCT
aiua-11242	58	1	the	the	DET
aiua-11242	58	2	most	most	ADV
aiua-11242	58	3	prescribed	prescribed	ADJ
aiua-11242	58	4	treatment	treatment	NOUN
aiua-11242	58	5	was	be	AUX
aiua-11242	58	6	abiraterone	abiraterone	NOUN
aiua-11242	58	7	.	.	PUNCT
aiua-11242	59	1	table	table	NOUN
aiua-11242	59	2	1	1	NUM
aiua-11242	59	3	resumes	resume	VERB
aiua-11242	59	4	the	the	DET
aiua-11242	59	5	baseline	baseline	ADJ
aiua-11242	59	6	characteristics	characteristic	NOUN
aiua-11242	59	7	of	of	ADP
aiua-11242	59	8	the	the	DET
aiua-11242	59	9	population	population	NOUN
aiua-11242	59	10	.	.	PUNCT
aiua-11242	60	1	mean	mean	PROPN
aiua-11242	60	2	crp	crp	PROPN
aiua-11242	60	3	was	be	AUX
aiua-11242	60	4	2.30	2.30	NUM
aiua-11242	60	5	mg	mg	PROPN
aiua-11242	60	6	/	/	SYM
aiua-11242	60	7	dl	dl	PROPN
aiua-11242	60	8	(	(	PUNCT
aiua-11242	60	9	range	range	NOUN
aiua-11242	60	10	from	from	ADP
aiua-11242	60	11	0.02	0.02	NUM
aiua-11242	60	12	to	to	ADP
aiua-11242	60	13	24.08	24.08	NUM
aiua-11242	60	14	mg	mg	PROPN
aiua-11242	60	15	/	/	SYM
aiua-11242	60	16	dl	dl	PROPN
aiua-11242	60	17	)	)	PUNCT
aiua-11242	60	18	,	,	PUNCT
aiua-11242	60	19	mean	mean	VERB
aiua-11242	60	20	alb	alb	PROPN
aiua-11242	60	21	was	be	AUX
aiua-11242	60	22	3.99	3.99	NUM
aiua-11242	60	23	g	g	NOUN
aiua-11242	60	24	/	/	SYM
aiua-11242	60	25	dl	dl	PROPN
aiua-11242	60	26	(	(	PUNCT
aiua-11242	60	27	range	range	VERB
aiua-11242	60	28	from	from	ADP
aiua-11242	60	29	1.7	1.7	NUM
aiua-11242	60	30	to	to	PART
aiua-11242	60	31	5.5	5.5	NUM
aiua-11242	60	32	g	g	NOUN
aiua-11242	60	33	/	/	SYM
aiua-11242	60	34	dl	dl	NOUN
aiua-11242	60	35	)	)	PUNCT
aiua-11242	60	36	and	and	CCONJ
aiua-11242	60	37	mean	mean	ADJ
aiua-11242	60	38	car	car	NOUN
aiua-11242	60	39	was	be	AUX
aiua-11242	60	40	0.64	0.64	NUM
aiua-11242	60	41	.	.	PUNCT
aiua-11242	61	1	in	in	ADP
aiua-11242	61	2	the	the	DET
aiua-11242	61	3	present	present	ADJ
aiua-11242	61	4	study	study	NOUN
aiua-11242	61	5	,	,	PUNCT
aiua-11242	61	6	the	the	DET
aiua-11242	61	7	value	value	NOUN
aiua-11242	61	8	of	of	ADP
aiua-11242	61	9	0.22	0.22	NUM
aiua-11242	61	10	for	for	ADP
aiua-11242	61	11	car	car	NOUN
aiua-11242	61	12	was	be	AUX
aiua-11242	61	13	used	use	VERB
aiua-11242	61	14	as	as	ADP
aiua-11242	61	15	the	the	DET
aiua-11242	61	16	cut	cut	VERB
aiua-11242	61	17	-	-	PUNCT
aiua-11242	61	18	off	off	ADP
aiua-11242	61	19	value	value	NOUN
aiua-11242	61	20	.	.	PUNCT
aiua-11242	62	1	it	it	PRON
aiua-11242	62	2	provided	provide	VERB
aiua-11242	62	3	the	the	DET
aiua-11242	62	4	maximal	maximal	ADJ
aiua-11242	62	5	youden	youden	NOUN
aiua-11242	62	6	index	index	NOUN
aiua-11242	62	7	values	value	NOUN
aiua-11242	62	8	,	,	PUNCT
aiua-11242	62	9	with	with	ADP
aiua-11242	62	10	an	an	DET
aiua-11242	62	11	area	area	NOUN
aiua-11242	62	12	under	under	ADP
aiua-11242	62	13	the	the	DET
aiua-11242	62	14	curve	curve	NOUN
aiua-11242	62	15	(	(	PUNCT
aiua-11242	62	16	auc	auc	NOUN
aiua-11242	62	17	)	)	PUNCT
aiua-11242	62	18	of	of	ADP
aiua-11242	62	19	0.71	0.71	NUM
aiua-11242	62	20	(	(	PUNCT
aiua-11242	62	21	figure	figure	NOUN
aiua-11242	62	22	1	1	NUM
aiua-11242	62	23	)	)	PUNCT
aiua-11242	62	24	.	.	PUNCT
aiua-11242	63	1	car	car	NOUN
aiua-11242	63	2	showed	show	VERB
aiua-11242	63	3	an	an	DET
aiua-11242	63	4	inverse	inverse	NOUN
aiua-11242	63	5	and	and	CCONJ
aiua-11242	63	6	significant	significant	ADJ
aiua-11242	63	7	correlation	correlation	NOUN
aiua-11242	63	8	with	with	ADP
aiua-11242	63	9	table	table	NOUN
aiua-11242	63	10	1	1	NUM
aiua-11242	63	11	.	.	PUNCT
aiua-11242	63	12	patients	patient	NOUN
aiua-11242	63	13	’	'	PUNCT
aiua-11242	63	14	characteristics	characteristic	NOUN
aiua-11242	63	15	and	and	CCONJ
aiua-11242	63	16	comparison	comparison	NOUN
aiua-11242	63	17	between	between	ADP
aiua-11242	63	18	studied	study	VERB
aiua-11242	63	19	groups	group	NOUN
aiua-11242	63	20	.	.	PUNCT
aiua-11242	64	1	variables	variable	NOUN
aiua-11242	64	2	total	total	ADJ
aiua-11242	64	3	car	car	NOUN
aiua-11242	64	4	≤	≤	NOUN
aiua-11242	64	5	0.22	0.22	NUM
aiua-11242	64	6	car	car	NOUN
aiua-11242	64	7	>	>	X
aiua-11242	64	8	0.22	0.22	NUM
aiua-11242	64	9	p	p	NOUN
aiua-11242	64	10	value	value	NOUN
aiua-11242	64	11	n	n	PRON
aiua-11242	64	12	%	%	NOUN
aiua-11242	65	1	n	n	PRON
aiua-11242	65	2	%	%	NOUN
aiua-11242	66	1	n	n	CCONJ
aiua-11242	66	2	%	%	NOUN
aiua-11242	66	3	isup	isup	ADJ
aiua-11242	66	4	score	score	NOUN
aiua-11242	66	5	isup1	isup1	NOUN
aiua-11242	66	6	6.0	6.0	NUM
aiua-11242	66	7	%	%	NOUN
aiua-11242	66	8	5.6	5.6	NUM
aiua-11242	66	9	%	%	NOUN
aiua-11242	66	10	6.7	6.7	NUM
aiua-11242	66	11	%	%	NOUN
aiua-11242	66	12	n.s	n.s	PROPN
aiua-11242	66	13	.	.	PROPN
aiua-11242	66	14	isup2	isup2	NOUN
aiua-11242	67	1	20.2	20.2	NUM
aiua-11242	67	2	%	%	NOUN
aiua-11242	67	3	24.1	24.1	NUM
aiua-11242	67	4	%	%	NOUN
aiua-11242	67	5	13.3	13.3	NUM
aiua-11242	67	6	%	%	NOUN
aiua-11242	67	7	n.s	n.s	PROPN
aiua-11242	67	8	.	.	PUNCT
aiua-11242	67	9	isup3	isup3	PROPN
aiua-11242	67	10	34.5	34.5	NUM
aiua-11242	67	11	%	%	NOUN
aiua-11242	67	12	33.3	33.3	NUM
aiua-11242	67	13	%	%	NOUN
aiua-11242	67	14	36.7	36.7	NUM
aiua-11242	67	15	%	%	NOUN
aiua-11242	67	16	n.s	n.s	PROPN
aiua-11242	67	17	.	.	PUNCT
aiua-11242	67	18	isup4	isup4	NOUN
aiua-11242	68	1	17.9	17.9	NUM
aiua-11242	68	2	%	%	NOUN
aiua-11242	68	3	18.5	18.5	NUM
aiua-11242	68	4	%	%	NOUN
aiua-11242	68	5	16.7	16.7	NUM
aiua-11242	68	6	%	%	NOUN
aiua-11242	68	7	n.s	n.s	PROPN
aiua-11242	68	8	.	.	PROPN
aiua-11242	68	9	isup5	isup5	PROPN
aiua-11242	68	10	21.4	21.4	NUM
aiua-11242	68	11	%	%	NOUN
aiua-11242	68	12	18.5	18.5	NUM
aiua-11242	68	13	%	%	NOUN
aiua-11242	68	14	26.7	26.7	NUM
aiua-11242	68	15	%	%	NOUN
aiua-11242	68	16	n.s	n.s	PROPN
aiua-11242	68	17	.	.	PROPN
aiua-11242	68	18	disease	disease	PROPN
aiua-11242	68	19	burden	burden	VERB
aiua-11242	68	20	low	low	ADJ
aiua-11242	68	21	volume	volume	NOUN
aiua-11242	68	22	49.4	49.4	NUM
aiua-11242	68	23	%	%	NOUN
aiua-11242	68	24	52.5	52.5	NUM
aiua-11242	68	25	%	%	NOUN
aiua-11242	68	26	43.3	43.3	NUM
aiua-11242	68	27	%	%	NOUN
aiua-11242	68	28	n.s	n.s	PROPN
aiua-11242	68	29	.	.	PROPN
aiua-11242	68	30	high	high	PROPN
aiua-11242	68	31	volume	volume	NOUN
aiua-11242	68	32	50.6	50.6	NUM
aiua-11242	68	33	%	%	NOUN
aiua-11242	68	34	47.5	47.5	NUM
aiua-11242	68	35	%	%	NOUN
aiua-11242	68	36	56.7	56.7	NUM
aiua-11242	68	37	%	%	NOUN
aiua-11242	68	38	n.s	n.s	PROPN
aiua-11242	68	39	.	.	PROPN
aiua-11242	68	40	disease	disease	PROPN
aiua-11242	68	41	risk	risk	VERB
aiua-11242	68	42	low	low	ADJ
aiua-11242	68	43	risk	risk	NOUN
aiua-11242	68	44	64.1	64.1	NUM
aiua-11242	68	45	%	%	NOUN
aiua-11242	68	46	74.6	74.6	NUM
aiua-11242	68	47	%	%	NOUN
aiua-11242	68	48	45.5	45.5	NUM
aiua-11242	68	49	%	%	NOUN
aiua-11242	68	50	0.005	0.005	NUM
aiua-11242	68	51	high	high	ADJ
aiua-11242	68	52	risk	risk	NOUN
aiua-11242	68	53	35.9	35.9	NUM
aiua-11242	68	54	%	%	NOUN
aiua-11242	68	55	25.4	25.4	NUM
aiua-11242	68	56	%	%	NOUN
aiua-11242	68	57	54.5	54.5	NUM
aiua-11242	68	58	%	%	NOUN
aiua-11242	68	59	0.005	0.005	NUM
aiua-11242	68	60	local	local	ADJ
aiua-11242	68	61	treatment	treatment	NOUN
aiua-11242	68	62	(	(	PUNCT
aiua-11242	68	63	lt	lt	NOUN
aiua-11242	68	64	)	)	PUNCT
aiua-11242	68	65	with	with	ADP
aiua-11242	68	66	lt	lt	PRON
aiua-11242	68	67	67.0	67.0	NUM
aiua-11242	68	68	%	%	NOUN
aiua-11242	68	69	61.7	61.7	NUM
aiua-11242	68	70	%	%	NOUN
aiua-11242	68	71	75.7	75.7	NUM
aiua-11242	68	72	%	%	NOUN
aiua-11242	69	1	n.s	n.s	PROPN
aiua-11242	69	2	.	.	PROPN
aiua-11242	69	3	without	without	ADP
aiua-11242	69	4	lt	lt	DET
aiua-11242	69	5	33.0	33.0	NUM
aiua-11242	69	6	%	%	NOUN
aiua-11242	69	7	38.3	38.3	NUM
aiua-11242	69	8	%	%	NOUN
aiua-11242	69	9	24.3	24.3	NUM
aiua-11242	69	10	%	%	NOUN
aiua-11242	70	1	n.s	n.s	PROPN
aiua-11242	70	2	.	.	PROPN
aiua-11242	70	3	first	first	ADJ
aiua-11242	70	4	-	-	PUNCT
aiua-11242	70	5	line	line	NOUN
aiua-11242	70	6	treatment	treatment	NOUN
aiua-11242	70	7	for	for	ADP
aiua-11242	70	8	mcrpc	mcrpc	NOUN
aiua-11242	70	9	docetaxel	docetaxel	VERB
aiua-11242	70	10	23.5	23.5	NUM
aiua-11242	70	11	%	%	NOUN
aiua-11242	70	12	15.6	15.6	NUM
aiua-11242	70	13	%	%	NOUN
aiua-11242	70	14	36.8	36.8	NUM
aiua-11242	70	15	%	%	NOUN
aiua-11242	70	16	0.015	0.015	NUM
aiua-11242	70	17	abiraterone	abiraterone	NOUN
aiua-11242	70	18	46.1	46.1	NUM
aiua-11242	70	19	%	%	NOUN
aiua-11242	70	20	51.6	51.6	NUM
aiua-11242	70	21	%	%	NOUN
aiua-11242	70	22	36.8	36.8	NUM
aiua-11242	70	23	%	%	NOUN
aiua-11242	70	24	n.s	n.s	PROPN
aiua-11242	70	25	.	.	PROPN
aiua-11242	70	26	enzalutamide	enzalutamide	ADV
aiua-11242	70	27	30.4	30.4	NUM
aiua-11242	70	28	%	%	NOUN
aiua-11242	70	29	32.8	32.8	NUM
aiua-11242	70	30	%	%	NOUN
aiua-11242	70	31	26.3	26.3	NUM
aiua-11242	70	32	%	%	NOUN
aiua-11242	70	33	n.s	n.s	PROPN
aiua-11242	70	34	.	.	PROPN
aiua-11242	70	35	figure	figure	NOUN
aiua-11242	70	36	1	1	NUM
aiua-11242	70	37	.	.	PUNCT
aiua-11242	71	1	roc	roc	PROPN
aiua-11242	71	2	curve	curve	PROPN
aiua-11242	71	3	.	.	PUNCT
aiua-11242	72	1	archivio	archivio	NOUN
aiua-11242	72	2	italiano	italiano	PROPN
aiua-11242	72	3	di	di	PROPN
aiua-11242	72	4	urologia	urologia	PROPN
aiua-11242	72	5	e	e	PROPN
aiua-11242	72	6	andrologia	andrologia	NOUN
aiua-11242	72	7	2023	2023	NUM
aiua-11242	72	8	;	;	PUNCT
aiua-11242	72	9	95(3):11242	95(3):11242	NUM
aiua-11242	72	10	3	3	NUM
aiua-11242	72	11	car	car	NOUN
aiua-11242	72	12	as	as	ADP
aiua-11242	72	13	a	a	DET
aiua-11242	72	14	prognosis	prognosis	NOUN
aiua-11242	72	15	biomarker	biomarker	NOUN
aiua-11242	72	16	in	in	ADP
aiua-11242	72	17	mcrpc	mcrpc	PROPN
aiua-11242	72	18	both	both	CCONJ
aiua-11242	72	19	pfs	pfs	PROPN
aiua-11242	72	20	and	and	CCONJ
aiua-11242	72	21	os	os	INTJ
aiua-11242	72	22	(	(	PUNCT
aiua-11242	72	23	r	r	NOUN
aiua-11242	72	24	=	=	SYM
aiua-11242	72	25	-0.13	-0.13	NUM
aiua-11242	72	26	and	and	CCONJ
aiua-11242	72	27	r	r	NOUN
aiua-11242	72	28	=	=	SYM
aiua-11242	72	29	-0.24	-0.24	NOUN
aiua-11242	72	30	,	,	PUNCT
aiua-11242	72	31	p	p	NOUN
aiua-11242	72	32	=	=	X
aiua-11242	72	33	<	<	X
aiua-11242	72	34	0.05	0.05	NUM
aiua-11242	72	35	,	,	PUNCT
aiua-11242	72	36	respectively	respectively	ADV
aiua-11242	72	37	)	)	PUNCT
aiua-11242	72	38	.	.	PUNCT
aiua-11242	73	1	correlations	correlation	NOUN
aiua-11242	73	2	shown	show	VERB
aiua-11242	73	3	in	in	ADP
aiua-11242	73	4	figure	figure	NOUN
aiua-11242	73	5	2	2	NUM
aiua-11242	73	6	.	.	PUNCT
aiua-11242	73	7	using	use	VERB
aiua-11242	73	8	a	a	DET
aiua-11242	73	9	cut	cut	VERB
aiua-11242	73	10	-	-	PUNCT
aiua-11242	73	11	off	off	ADP
aiua-11242	73	12	value	value	NOUN
aiua-11242	73	13	of	of	ADP
aiua-11242	73	14	0.22	0.22	NUM
aiua-11242	73	15	,	,	PUNCT
aiua-11242	73	16	patients	patient	NOUN
aiua-11242	73	17	with	with	ADP
aiua-11242	73	18	a	a	DET
aiua-11242	73	19	car	car	NOUN
aiua-11242	73	20	≤	≤	NOUN
aiua-11242	73	21	0.22	0.22	NUM
aiua-11242	73	22	(	(	PUNCT
aiua-11242	73	23	63.2	63.2	NUM
aiua-11242	73	24	%	%	NOUN
aiua-11242	73	25	)	)	PUNCT
aiua-11242	73	26	showed	show	VERB
aiua-11242	73	27	longer	long	ADJ
aiua-11242	73	28	pfs	pfs	PROPN
aiua-11242	73	29	(	(	PUNCT
aiua-11242	73	30	15.92	15.92	NUM
aiua-11242	73	31	vs.	vs.	ADP
aiua-11242	73	32	9.46	9.46	NUM
aiua-11242	73	33	months	month	NOUN
aiua-11242	73	34	,	,	PUNCT
aiua-11242	73	35	p	p	NOUN
aiua-11242	73	36	=	=	X
aiua-11242	73	37	<	<	X
aiua-11242	73	38	0.05	0.05	NUM
aiua-11242	73	39	)	)	PUNCT
aiua-11242	73	40	and	and	CCONJ
aiua-11242	73	41	os	os	INTJ
aiua-11242	73	42	(	(	PUNCT
aiua-11242	73	43	25.72	25.72	NUM
aiua-11242	73	44	vs.	vs.	ADP
aiua-11242	73	45	15.79	15.79	NUM
aiua-11242	73	46	months	month	NOUN
aiua-11242	73	47	,	,	PUNCT
aiua-11242	73	48	p	p	NOUN
aiua-11242	73	49	=	=	X
aiua-11242	73	50	<	<	X
aiua-11242	73	51	0.05	0.05	NUM
aiua-11242	73	52	)	)	PUNCT
aiua-11242	73	53	.	.	PUNCT
aiua-11242	74	1	survival	survival	NOUN
aiua-11242	74	2	curves	curve	NOUN
aiua-11242	74	3	shown	show	VERB
aiua-11242	74	4	in	in	ADP
aiua-11242	74	5	figure	figure	NOUN
aiua-11242	74	6	3	3	NUM
aiua-11242	74	7	.	.	PUNCT
aiua-11242	75	1	when	when	SCONJ
aiua-11242	75	2	dividing	divide	VERB
aiua-11242	75	3	the	the	DET
aiua-11242	75	4	sample	sample	NOUN
aiua-11242	75	5	according	accord	VERB
aiua-11242	75	6	to	to	ADP
aiua-11242	75	7	when	when	SCONJ
aiua-11242	75	8	the	the	DET
aiua-11242	75	9	biochemical	biochemical	ADJ
aiua-11242	75	10	parameters	parameter	NOUN
aiua-11242	75	11	were	be	AUX
aiua-11242	75	12	collected	collect	VERB
aiua-11242	75	13	,	,	PUNCT
aiua-11242	75	14	the	the	DET
aiua-11242	75	15	os	os	NOUN
aiua-11242	75	16	of	of	ADP
aiua-11242	75	17	the	the	DET
aiua-11242	75	18	group	group	NOUN
aiua-11242	75	19	evaluated	evaluate	VERB
aiua-11242	75	20	at	at	ADP
aiua-11242	75	21	the	the	DET
aiua-11242	75	22	beginning	beginning	NOUN
aiua-11242	75	23	of	of	ADP
aiua-11242	75	24	systemic	systemic	ADJ
aiua-11242	75	25	treatment	treatment	NOUN
aiua-11242	75	26	was	be	AUX
aiua-11242	75	27	26.96	26.96	NUM
aiua-11242	75	28	vs	vs	ADP
aiua-11242	75	29	17.63	17.63	NUM
aiua-11242	75	30	months	month	NOUN
aiua-11242	75	31	,	,	PUNCT
aiua-11242	75	32	for	for	ADP
aiua-11242	75	33	a	a	DET
aiua-11242	75	34	car	car	NOUN
aiua-11242	75	35	≤	≤	NOUN
aiua-11242	75	36	0.22	0.22	NUM
aiua-11242	75	37	vs	vs	ADP
aiua-11242	75	38	>	>	X
aiua-11242	75	39	0.22	0.22	NUM
aiua-11242	75	40	,	,	PUNCT
aiua-11242	75	41	respectively	respectively	ADV
aiua-11242	75	42	(	(	PUNCT
aiua-11242	75	43	p	p	X
aiua-11242	75	44	<	<	X
aiua-11242	75	45	0.05	0.05	NUM
aiua-11242	75	46	)	)	PUNCT
aiua-11242	75	47	.	.	PUNCT
aiua-11242	76	1	in	in	ADP
aiua-11242	76	2	the	the	DET
aiua-11242	76	3	group	group	NOUN
aiua-11242	76	4	evaluated	evaluate	VERB
aiua-11242	76	5	during	during	ADP
aiua-11242	76	6	follow	follow	NOUN
aiua-11242	76	7	-	-	PUNCT
aiua-11242	76	8	up	up	NOUN
aiua-11242	76	9	,	,	PUNCT
aiua-11242	76	10	the	the	DET
aiua-11242	76	11	os	os	NOUN
aiua-11242	76	12	using	use	VERB
aiua-11242	76	13	the	the	DET
aiua-11242	76	14	same	same	ADJ
aiua-11242	76	15	cut	cut	NOUN
aiua-11242	76	16	-	-	PUNCT
aiua-11242	76	17	off	off	ADP
aiua-11242	76	18	point	point	NOUN
aiua-11242	76	19	was	be	AUX
aiua-11242	76	20	23.90	23.90	NUM
aiua-11242	76	21	vs	vs	ADP
aiua-11242	76	22	11.54	11.54	NUM
aiua-11242	76	23	months	month	NOUN
aiua-11242	76	24	,	,	PUNCT
aiua-11242	76	25	respectively	respectively	ADV
aiua-11242	76	26	(	(	PUNCT
aiua-11242	76	27	p	p	X
aiua-11242	76	28	<	<	X
aiua-11242	76	29	0.05	0.05	NUM
aiua-11242	76	30	)	)	PUNCT
aiua-11242	76	31	.	.	PUNCT
aiua-11242	77	1	survival	survival	NOUN
aiua-11242	77	2	curves	curve	NOUN
aiua-11242	77	3	below	below	ADV
aiua-11242	77	4	.	.	PUNCT
aiua-11242	78	1	dividing	divide	VERB
aiua-11242	78	2	the	the	DET
aiua-11242	78	3	sample	sample	NOUN
aiua-11242	78	4	according	accord	VERB
aiua-11242	78	5	to	to	ADP
aiua-11242	78	6	the	the	DET
aiua-11242	78	7	first	first	ADJ
aiua-11242	78	8	line	line	NOUN
aiua-11242	78	9	treatment	treatment	NOUN
aiua-11242	78	10	chosen	choose	VERB
aiua-11242	78	11	for	for	ADP
aiua-11242	78	12	mcrpc	mcrpc	NOUN
aiua-11242	78	13	,	,	PUNCT
aiua-11242	78	14	it	it	PRON
aiua-11242	78	15	was	be	AUX
aiua-11242	78	16	observed	observe	VERB
aiua-11242	78	17	an	an	DET
aiua-11242	78	18	os	os	NOUN
aiua-11242	78	19	of	of	ADP
aiua-11242	78	20	26.25	26.25	NUM
aiua-11242	78	21	vs	vs	ADP
aiua-11242	78	22	5.9	5.9	NUM
aiua-11242	78	23	months	month	NOUN
aiua-11242	78	24	(	(	PUNCT
aiua-11242	78	25	p	p	X
aiua-11242	78	26	<	<	X
aiua-11242	78	27	0.05	0.05	NUM
aiua-11242	78	28	)	)	PUNCT
aiua-11242	78	29	,	,	PUNCT
aiua-11242	78	30	27.71	27.71	NUM
aiua-11242	78	31	vs	vs	ADP
aiua-11242	78	32	22.57	22.57	NUM
aiua-11242	78	33	months	month	NOUN
aiua-11242	78	34	(	(	PUNCT
aiua-11242	78	35	p	p	X
aiua-11242	78	36	<	<	X
aiua-11242	78	37	0.05	0.05	NUM
aiua-11242	78	38	)	)	PUNCT
aiua-11242	78	39	and	and	CCONJ
aiua-11242	78	40	27.36	27.36	NUM
aiua-11242	78	41	vs	vs	ADP
aiua-11242	78	42	23.75	23.75	NUM
aiua-11242	78	43	months	month	NOUN
aiua-11242	78	44	(	(	PUNCT
aiua-11242	78	45	p	p	X
aiua-11242	78	46	=	=	PROPN
aiua-11242	78	47	n.s	n.s	PROPN
aiua-11242	78	48	.	.	PROPN
aiua-11242	78	49	)	)	PUNCT
aiua-11242	78	50	,	,	PUNCT
aiua-11242	78	51	for	for	ADP
aiua-11242	78	52	docetaxel	docetaxel	NOUN
aiua-11242	78	53	,	,	PUNCT
aiua-11242	78	54	abiraterone	abiraterone	NOUN
aiua-11242	78	55	and	and	CCONJ
aiua-11242	78	56	enzalutamide	enzalutamide	ADV
aiua-11242	78	57	,	,	PUNCT
aiua-11242	78	58	respectively	respectively	ADV
aiua-11242	78	59	.	.	PUNCT
aiua-11242	79	1	figure	figure	NOUN
aiua-11242	79	2	3	3	NUM
aiua-11242	79	3	.	.	PUNCT
aiua-11242	79	4	comparing	compare	VERB
aiua-11242	79	5	progression	progression	NOUN
aiua-11242	79	6	free	free	ADJ
aiua-11242	79	7	survival	survival	NOUN
aiua-11242	79	8	(	(	PUNCT
aiua-11242	79	9	pfs	pfs	PROPN
aiua-11242	79	10	)	)	PUNCT
aiua-11242	79	11	and	and	CCONJ
aiua-11242	79	12	overall	overall	ADJ
aiua-11242	79	13	survival	survival	NOUN
aiua-11242	79	14	(	(	PUNCT
aiua-11242	79	15	os	os	NOUN
aiua-11242	79	16	)	)	PUNCT
aiua-11242	79	17	between	between	ADP
aiua-11242	79	18	groups	group	NOUN
aiua-11242	79	19	according	accord	VERB
aiua-11242	79	20	to	to	ADP
aiua-11242	79	21	car	car	NOUN
aiua-11242	79	22	.	.	PUNCT
aiua-11242	80	1	figure	figure	NOUN
aiua-11242	80	2	2	2	NUM
aiua-11242	80	3	,	,	PUNCT
aiua-11242	80	4	.	.	PUNCT
aiua-11242	81	1	correlations	correlation	NOUN
aiua-11242	81	2	between	between	ADP
aiua-11242	81	3	car	car	NOUN
aiua-11242	81	4	and	and	CCONJ
aiua-11242	81	5	clinical	clinical	ADJ
aiua-11242	81	6	outcomes	outcome	NOUN
aiua-11242	81	7	.	.	PUNCT
aiua-11242	82	1	figure	figure	VERB
aiua-11242	82	2	4	4	NUM
aiua-11242	82	3	.	.	PUNCT
aiua-11242	82	4	comparing	compare	VERB
aiua-11242	82	5	overall	overall	ADJ
aiua-11242	82	6	survival	survival	NOUN
aiua-11242	82	7	(	(	PUNCT
aiua-11242	82	8	os	os	NOUN
aiua-11242	82	9	)	)	PUNCT
aiua-11242	82	10	between	between	ADP
aiua-11242	82	11	groups	group	NOUN
aiua-11242	82	12	at	at	ADP
aiua-11242	82	13	the	the	DET
aiua-11242	82	14	start	start	NOUN
aiua-11242	82	15	of	of	ADP
aiua-11242	82	16	systemic	systemic	ADJ
aiua-11242	82	17	treatment	treatment	NOUN
aiua-11242	82	18	and	and	CCONJ
aiua-11242	82	19	during	during	ADP
aiua-11242	82	20	follow	follow	NOUN
aiua-11242	82	21	-	-	PUNCT
aiua-11242	82	22	up	up	NOUN
aiua-11242	82	23	.	.	PUNCT
aiua-11242	83	1	archivio	archivio	NOUN
aiua-11242	83	2	italiano	italiano	PROPN
aiua-11242	83	3	di	di	X
aiua-11242	83	4	urologia	urologia	PROPN
aiua-11242	83	5	e	e	PROPN
aiua-11242	83	6	andrologia	andrologia	NOUN
aiua-11242	83	7	2023	2023	NUM
aiua-11242	83	8	;	;	PUNCT
aiua-11242	83	9	95(3):11242	95(3):11242	NUM
aiua-11242	83	10	j.	j.	PROPN
aiua-11242	83	11	lorigo	lorigo	PROPN
aiua-11242	83	12	,	,	PUNCT
aiua-11242	83	13	e.	e.	PROPN
aiua-11242	83	14	tavares	tavares	PROPN
aiua-11242	83	15	silva	silva	PROPN
aiua-11242	83	16	,	,	PUNCT
aiua-11242	83	17	j.	j.	PROPN
aiua-11242	83	18	pedroso	pedroso	PROPN
aiua-11242	83	19	lima	lima	PROPN
aiua-11242	83	20	,	,	PUNCT
aiua-11242	83	21	v.	v.	PROPN
aiua-11242	83	22	quaresma	quaresma	PROPN
aiua-11242	83	23	,	,	PUNCT
aiua-11242	83	24	r.	r.	PROPN
aiua-11242	83	25	pedrosa	pedrosa	PROPN
aiua-11242	83	26	,	,	PUNCT
aiua-11242	83	27	a.	a.	PROPN
aiua-11242	83	28	figueiredo	figueiredo	PROPN
aiua-11242	83	29	4	4	NUM
aiua-11242	83	30	discussion	discussion	NOUN
aiua-11242	83	31	in	in	ADP
aiua-11242	83	32	this	this	DET
aiua-11242	83	33	study	study	NOUN
aiua-11242	83	34	,	,	PUNCT
aiua-11242	83	35	we	we	PRON
aiua-11242	83	36	analysed	analyse	VERB
aiua-11242	83	37	the	the	DET
aiua-11242	83	38	prognostic	prognostic	ADJ
aiua-11242	83	39	value	value	NOUN
aiua-11242	83	40	of	of	ADP
aiua-11242	83	41	car	car	NOUN
aiua-11242	83	42	in	in	ADP
aiua-11242	83	43	178	178	NUM
aiua-11242	83	44	mcrpc	mcrpc	NOUN
aiua-11242	83	45	patients	patient	NOUN
aiua-11242	83	46	.	.	PUNCT
aiua-11242	84	1	we	we	PRON
aiua-11242	84	2	found	find	VERB
aiua-11242	84	3	car	car	NOUN
aiua-11242	84	4	to	to	PART
aiua-11242	84	5	be	be	AUX
aiua-11242	84	6	an	an	DET
aiua-11242	84	7	independent	independent	ADJ
aiua-11242	84	8	prognostic	prognostic	ADJ
aiua-11242	84	9	factor	factor	NOUN
aiua-11242	84	10	for	for	ADP
aiua-11242	84	11	patients	patient	NOUN
aiua-11242	84	12	with	with	ADP
aiua-11242	84	13	mcrpc	mcrpc	PROPN
aiua-11242	84	14	,	,	PUNCT
aiua-11242	84	15	either	either	CCONJ
aiua-11242	84	16	at	at	ADP
aiua-11242	84	17	diagnosis	diagnosis	NOUN
aiua-11242	84	18	and	and	CCONJ
aiua-11242	84	19	start	start	NOUN
aiua-11242	84	20	of	of	ADP
aiua-11242	84	21	systemic	systemic	ADJ
aiua-11242	84	22	treatment	treatment	NOUN
aiua-11242	84	23	and	and	CCONJ
aiua-11242	84	24	at	at	ADP
aiua-11242	84	25	any	any	DET
aiua-11242	84	26	point	point	NOUN
aiua-11242	84	27	during	during	ADP
aiua-11242	84	28	follow	follow	NOUN
aiua-11242	84	29	-	-	PUNCT
aiua-11242	84	30	up	up	NOUN
aiua-11242	84	31	.	.	PUNCT
aiua-11242	85	1	crp	crp	PROPN
aiua-11242	85	2	production	production	NOUN
aiua-11242	85	3	in	in	ADP
aiua-11242	85	4	the	the	DET
aiua-11242	85	5	liver	liver	NOUN
aiua-11242	85	6	is	be	AUX
aiua-11242	85	7	up	up	ADV
aiua-11242	85	8	-	-	PUNCT
aiua-11242	85	9	regulated	regulate	VERB
aiua-11242	85	10	by	by	ADP
aiua-11242	85	11	proinflammatory	proinflammatory	ADJ
aiua-11242	85	12	cytokines	cytokine	NOUN
aiua-11242	85	13	(	(	PUNCT
aiua-11242	85	14	e.g.	e.g.	ADV
aiua-11242	85	15	interleukin-6	interleukin-6	NUM
aiua-11242	85	16	[	[	X
aiua-11242	85	17	il-6	il-6	X
aiua-11242	85	18	]	]	PUNCT
aiua-11242	85	19	)	)	PUNCT
aiua-11242	85	20	(	(	PUNCT
aiua-11242	85	21	25	25	NUM
aiua-11242	85	22	)	)	PUNCT
aiua-11242	85	23	.	.	PUNCT
aiua-11242	86	1	increased	increase	VERB
aiua-11242	86	2	crp	crp	PROPN
aiua-11242	86	3	levels	level	NOUN
aiua-11242	86	4	have	have	AUX
aiua-11242	86	5	been	be	AUX
aiua-11242	86	6	reported	report	VERB
aiua-11242	86	7	in	in	ADP
aiua-11242	86	8	many	many	ADJ
aiua-11242	86	9	types	type	NOUN
aiua-11242	86	10	of	of	ADP
aiua-11242	86	11	malignancies	malignancy	NOUN
aiua-11242	86	12	(	(	PUNCT
aiua-11242	86	13	23	23	NUM
aiua-11242	86	14	)	)	PUNCT
aiua-11242	86	15	.	.	PUNCT
aiua-11242	87	1	cancer	cancer	NOUN
aiua-11242	87	2	cell	cell	NOUN
aiua-11242	87	3	proliferation	proliferation	NOUN
aiua-11242	87	4	,	,	PUNCT
aiua-11242	87	5	necrosis	necrosis	NOUN
aiua-11242	87	6	,	,	PUNCT
aiua-11242	87	7	invasion	invasion	NOUN
aiua-11242	87	8	,	,	PUNCT
aiua-11242	87	9	and	and	CCONJ
aiua-11242	87	10	hypoxia	hypoxia	NOUN
aiua-11242	87	11	trigger	trigger	NOUN
aiua-11242	87	12	immune	immune	ADJ
aiua-11242	87	13	responses	response	NOUN
aiua-11242	87	14	in	in	ADP
aiua-11242	87	15	the	the	DET
aiua-11242	87	16	tumour	tumour	NOUN
aiua-11242	87	17	microenvironment	microenvironment	NOUN
aiua-11242	87	18	that	that	PRON
aiua-11242	87	19	leads	lead	VERB
aiua-11242	87	20	to	to	ADP
aiua-11242	87	21	the	the	DET
aiua-11242	87	22	generation	generation	NOUN
aiua-11242	87	23	of	of	ADP
aiua-11242	87	24	various	various	ADJ
aiua-11242	87	25	proinflammatory	proinflammatory	ADJ
aiua-11242	87	26	factors	factor	NOUN
aiua-11242	87	27	(	(	PUNCT
aiua-11242	87	28	25	25	NUM
aiua-11242	87	29	,	,	PUNCT
aiua-11242	87	30	26	26	NUM
aiua-11242	87	31	)	)	PUNCT
aiua-11242	87	32	.	.	PUNCT
aiua-11242	88	1	two	two	NUM
aiua-11242	88	2	metaanalyses	metaanalyse	NOUN
aiua-11242	88	3	evaluated	evaluate	VERB
aiua-11242	88	4	the	the	DET
aiua-11242	88	5	role	role	NOUN
aiua-11242	88	6	of	of	ADP
aiua-11242	88	7	crp	crp	PROPN
aiua-11242	88	8	in	in	ADP
aiua-11242	88	9	kidney	kidney	NOUN
aiua-11242	88	10	,	,	PUNCT
aiua-11242	88	11	bladder	bladder	NOUN
aiua-11242	88	12	and	and	CCONJ
aiua-11242	88	13	prostate	prostate	NOUN
aiua-11242	88	14	cancers	cancer	NOUN
aiua-11242	88	15	and	and	CCONJ
aiua-11242	88	16	found	find	VERB
aiua-11242	88	17	a	a	DET
aiua-11242	88	18	potential	potential	ADJ
aiua-11242	88	19	prognostic	prognostic	ADJ
aiua-11242	88	20	value	value	NOUN
aiua-11242	88	21	in	in	ADP
aiua-11242	88	22	all	all	DET
aiua-11242	88	23	three	three	NUM
aiua-11242	88	24	malignancies	malignancy	NOUN
aiua-11242	88	25	(	(	PUNCT
aiua-11242	88	26	24	24	NUM
aiua-11242	88	27	,	,	PUNCT
aiua-11242	88	28	26	26	NUM
aiua-11242	88	29	)	)	PUNCT
aiua-11242	88	30	.	.	PUNCT
aiua-11242	89	1	despite	despite	SCONJ
aiua-11242	89	2	not	not	PART
aiua-11242	89	3	being	be	AUX
aiua-11242	89	4	a	a	DET
aiua-11242	89	5	perfect	perfect	ADJ
aiua-11242	89	6	marker	marker	NOUN
aiua-11242	89	7	of	of	ADP
aiua-11242	89	8	nutritional	nutritional	ADJ
aiua-11242	89	9	status	status	NOUN
aiua-11242	89	10	,	,	PUNCT
aiua-11242	89	11	because	because	SCONJ
aiua-11242	89	12	of	of	ADP
aiua-11242	89	13	its	its	PRON
aiua-11242	89	14	long	long	ADJ
aiua-11242	89	15	half	half	ADJ
aiua-11242	89	16	-	-	PUNCT
aiua-11242	89	17	life	life	NOUN
aiua-11242	89	18	and	and	CCONJ
aiua-11242	89	19	susceptibility	susceptibility	NOUN
aiua-11242	89	20	to	to	ADP
aiua-11242	89	21	other	other	ADJ
aiua-11242	89	22	systemic	systemic	ADJ
aiua-11242	89	23	factors	factor	NOUN
aiua-11242	89	24	,	,	PUNCT
aiua-11242	89	25	albumin	albumin	NOUN
aiua-11242	89	26	is	be	AUX
aiua-11242	89	27	well	well	ADV
aiua-11242	89	28	correlated	correlate	VERB
aiua-11242	89	29	with	with	ADP
aiua-11242	89	30	nutrition	nutrition	NOUN
aiua-11242	89	31	status	status	NOUN
aiua-11242	89	32	(	(	PUNCT
aiua-11242	89	33	25	25	NUM
aiua-11242	89	34	)	)	PUNCT
aiua-11242	89	35	.	.	PUNCT
aiua-11242	90	1	low	low	ADJ
aiua-11242	90	2	serum	serum	NOUN
aiua-11242	90	3	albumin	albumin	ADJ
aiua-11242	90	4	levels	level	NOUN
aiua-11242	90	5	are	be	AUX
aiua-11242	90	6	caused	cause	VERB
aiua-11242	90	7	by	by	ADP
aiua-11242	90	8	low	low	ADJ
aiua-11242	90	9	nutrient	nutrient	NOUN
aiua-11242	90	10	intakes	intake	NOUN
aiua-11242	90	11	and	and	CCONJ
aiua-11242	90	12	tumour	tumour	NOUN
aiua-11242	90	13	overconsumption	overconsumption	NOUN
aiua-11242	90	14	(	(	PUNCT
aiua-11242	90	15	26	26	NUM
aiua-11242	90	16	)	)	PUNCT
aiua-11242	90	17	.	.	PUNCT
aiua-11242	91	1	protein	protein	NOUN
aiua-11242	91	2	malnutrition	malnutrition	NOUN
aiua-11242	91	3	can	can	AUX
aiua-11242	91	4	lead	lead	VERB
aiua-11242	91	5	to	to	ADP
aiua-11242	91	6	oedema	oedema	PROPN
aiua-11242	91	7	,	,	PUNCT
aiua-11242	91	8	impaired	impaired	ADJ
aiua-11242	91	9	organ	organ	NOUN
aiua-11242	91	10	function	function	NOUN
aiua-11242	91	11	and	and	CCONJ
aiua-11242	91	12	immunosuppression	immunosuppression	NOUN
aiua-11242	91	13	.	.	PUNCT
aiua-11242	92	1	moreover	moreover	ADV
aiua-11242	92	2	,	,	PUNCT
aiua-11242	92	3	hypoalbuminemia	hypoalbuminemia	ADV
aiua-11242	92	4	is	be	AUX
aiua-11242	92	5	associated	associate	VERB
aiua-11242	92	6	with	with	ADP
aiua-11242	92	7	higher	high	ADJ
aiua-11242	92	8	mortality	mortality	NOUN
aiua-11242	92	9	in	in	ADP
aiua-11242	92	10	cancer	cancer	NOUN
aiua-11242	92	11	patients	patient	NOUN
aiua-11242	92	12	(	(	PUNCT
aiua-11242	92	13	23	23	NUM
aiua-11242	92	14	,	,	PUNCT
aiua-11242	92	15	25	25	NUM
aiua-11242	92	16	,	,	PUNCT
aiua-11242	92	17	26	26	NUM
aiua-11242	92	18	)	)	PUNCT
aiua-11242	92	19	.	.	PUNCT
aiua-11242	93	1	recently	recently	ADV
aiua-11242	93	2	,	,	PUNCT
aiua-11242	93	3	several	several	ADJ
aiua-11242	93	4	studies	study	NOUN
aiua-11242	93	5	have	have	AUX
aiua-11242	93	6	reported	report	VERB
aiua-11242	93	7	the	the	DET
aiua-11242	93	8	relation	relation	NOUN
aiua-11242	93	9	between	between	ADP
aiua-11242	93	10	high	high	ADJ
aiua-11242	93	11	car	car	NOUN
aiua-11242	93	12	and	and	CCONJ
aiua-11242	93	13	poor	poor	ADJ
aiua-11242	93	14	prognosis	prognosis	NOUN
aiua-11242	93	15	in	in	ADP
aiua-11242	93	16	cancer	cancer	NOUN
aiua-11242	93	17	patients	patient	NOUN
aiua-11242	93	18	(	(	PUNCT
aiua-11242	93	19	20	20	NUM
aiua-11242	93	20	-	-	SYM
aiua-11242	93	21	22	22	NUM
aiua-11242	93	22	)	)	PUNCT
aiua-11242	93	23	.	.	PUNCT
aiua-11242	94	1	accordingly	accordingly	ADV
aiua-11242	94	2	,	,	PUNCT
aiua-11242	94	3	we	we	PRON
aiua-11242	94	4	found	find	VERB
aiua-11242	94	5	a	a	DET
aiua-11242	94	6	mean	mean	ADJ
aiua-11242	94	7	crp	crp	NOUN
aiua-11242	94	8	and	and	CCONJ
aiua-11242	94	9	alb	alb	PROPN
aiua-11242	94	10	,	,	PUNCT
aiua-11242	94	11	respectively	respectively	ADV
aiua-11242	94	12	,	,	PUNCT
aiua-11242	94	13	above	above	ADP
aiua-11242	94	14	(	(	PUNCT
aiua-11242	94	15	2.30	2.30	NUM
aiua-11242	94	16	mg	mg	PROPN
aiua-11242	94	17	/	/	SYM
aiua-11242	94	18	dl	dl	PROPN
aiua-11242	94	19	)	)	PUNCT
aiua-11242	94	20	and	and	CCONJ
aiua-11242	94	21	below	below	ADV
aiua-11242	94	22	(	(	PUNCT
aiua-11242	94	23	3.99	3.99	NUM
aiua-11242	94	24	g	g	NOUN
aiua-11242	94	25	/	/	SYM
aiua-11242	94	26	dl	dl	NOUN
aiua-11242	94	27	)	)	PUNCT
aiua-11242	94	28	normal	normal	ADJ
aiua-11242	94	29	range	range	NOUN
aiua-11242	94	30	values	value	NOUN
aiua-11242	94	31	.	.	PUNCT
aiua-11242	95	1	in	in	ADP
aiua-11242	95	2	this	this	DET
aiua-11242	95	3	study	study	NOUN
aiua-11242	95	4	,	,	PUNCT
aiua-11242	95	5	we	we	PRON
aiua-11242	95	6	used	use	VERB
aiua-11242	95	7	the	the	DET
aiua-11242	95	8	roc	roc	PROPN
aiua-11242	95	9	analysis	analysis	NOUN
aiua-11242	95	10	to	to	PART
aiua-11242	95	11	yield	yield	VERB
aiua-11242	95	12	a	a	DET
aiua-11242	95	13	car	car	NOUN
aiua-11242	95	14	0.22	0.22	NUM
aiua-11242	95	15	cut	cut	VERB
aiua-11242	95	16	-	-	PUNCT
aiua-11242	95	17	off	off	ADP
aiua-11242	95	18	value	value	NOUN
aiua-11242	95	19	for	for	ADP
aiua-11242	95	20	predicting	predict	VERB
aiua-11242	95	21	pfs	pfs	PROPN
aiua-11242	95	22	and	and	CCONJ
aiua-11242	95	23	os	os	NOUN
aiua-11242	95	24	in	in	ADP
aiua-11242	95	25	mcrpc	mcrpc	PROPN
aiua-11242	95	26	and	and	CCONJ
aiua-11242	95	27	we	we	PRON
aiua-11242	95	28	were	be	AUX
aiua-11242	95	29	able	able	ADJ
aiua-11242	95	30	to	to	PART
aiua-11242	95	31	find	find	VERB
aiua-11242	95	32	a	a	DET
aiua-11242	95	33	significant	significant	ADJ
aiua-11242	95	34	difference	difference	NOUN
aiua-11242	95	35	between	between	ADP
aiua-11242	95	36	patients	patient	NOUN
aiua-11242	95	37	with	with	ADP
aiua-11242	95	38	a	a	DET
aiua-11242	95	39	car	car	NOUN
aiua-11242	95	40	≤	≤	NOUN
aiua-11242	95	41	0.22	0.22	NUM
aiua-11242	95	42	or	or	CCONJ
aiua-11242	95	43	>	>	ADP
aiua-11242	95	44	0.22	0.22	NUM
aiua-11242	95	45	.	.	PUNCT
aiua-11242	96	1	taking	take	VERB
aiua-11242	96	2	advantage	advantage	NOUN
aiua-11242	96	3	of	of	ADP
aiua-11242	96	4	the	the	DET
aiua-11242	96	5	study	study	NOUN
aiua-11242	96	6	design	design	NOUN
aiua-11242	96	7	,	,	PUNCT
aiua-11242	96	8	we	we	PRON
aiua-11242	96	9	tried	try	VERB
aiua-11242	96	10	to	to	PART
aiua-11242	96	11	find	find	VERB
aiua-11242	96	12	if	if	SCONJ
aiua-11242	96	13	the	the	DET
aiua-11242	96	14	ratio	ratio	NOUN
aiua-11242	96	15	was	be	AUX
aiua-11242	96	16	useful	useful	ADJ
aiua-11242	96	17	at	at	ADP
aiua-11242	96	18	the	the	DET
aiua-11242	96	19	start	start	NOUN
aiua-11242	96	20	of	of	ADP
aiua-11242	96	21	systemic	systemic	ADJ
aiua-11242	96	22	treatment	treatment	NOUN
aiua-11242	96	23	and	and	CCONJ
aiua-11242	96	24	during	during	ADP
aiua-11242	96	25	follow	follow	NOUN
aiua-11242	96	26	-	-	PUNCT
aiua-11242	96	27	up	up	NOUN
aiua-11242	96	28	.	.	PUNCT
aiua-11242	97	1	we	we	PRON
aiua-11242	97	2	found	find	VERB
aiua-11242	97	3	a	a	DET
aiua-11242	97	4	significant	significant	ADJ
aiua-11242	97	5	correlation	correlation	NOUN
aiua-11242	97	6	irrespectively	irrespectively	ADV
aiua-11242	97	7	of	of	ADP
aiua-11242	97	8	the	the	DET
aiua-11242	97	9	analysis	analysis	NOUN
aiua-11242	97	10	timing	timing	NOUN
aiua-11242	97	11	.	.	PUNCT
aiua-11242	98	1	these	these	DET
aiua-11242	98	2	findings	finding	NOUN
aiua-11242	98	3	are	be	AUX
aiua-11242	98	4	in	in	ADP
aiua-11242	98	5	line	line	NOUN
aiua-11242	98	6	with	with	ADP
aiua-11242	98	7	previous	previous	ADJ
aiua-11242	98	8	studies	study	NOUN
aiua-11242	98	9	(	(	PUNCT
aiua-11242	98	10	23	23	NUM
aiua-11242	98	11	,	,	PUNCT
aiua-11242	98	12	25	25	NUM
aiua-11242	98	13	,	,	PUNCT
aiua-11242	98	14	26	26	NUM
aiua-11242	98	15	)	)	PUNCT
aiua-11242	98	16	.	.	PUNCT
aiua-11242	99	1	however	however	ADV
aiua-11242	99	2	,	,	PUNCT
aiua-11242	99	3	all	all	DET
aiua-11242	99	4	those	those	DET
aiua-11242	99	5	studies	study	NOUN
aiua-11242	99	6	have	have	AUX
aiua-11242	99	7	only	only	ADV
aiua-11242	99	8	evaluated	evaluate	VERB
aiua-11242	99	9	patients	patient	NOUN
aiua-11242	99	10	in	in	ADP
aiua-11242	99	11	the	the	DET
aiua-11242	99	12	beginning	beginning	NOUN
aiua-11242	99	13	of	of	ADP
aiua-11242	99	14	systemic	systemic	ADJ
aiua-11242	99	15	treatment	treatment	NOUN
aiua-11242	99	16	.	.	PUNCT
aiua-11242	100	1	although	although	SCONJ
aiua-11242	100	2	not	not	PART
aiua-11242	100	3	surprising	surprising	ADJ
aiua-11242	100	4	,	,	PUNCT
aiua-11242	100	5	this	this	DET
aiua-11242	100	6	study	study	NOUN
aiua-11242	100	7	proves	prove	VERB
aiua-11242	100	8	the	the	DET
aiua-11242	100	9	usefulness	usefulness	NOUN
aiua-11242	100	10	of	of	ADP
aiua-11242	100	11	car	car	NOUN
aiua-11242	100	12	predicting	predict	VERB
aiua-11242	100	13	outcomes	outcome	NOUN
aiua-11242	100	14	during	during	ADP
aiua-11242	100	15	the	the	DET
aiua-11242	100	16	oncological	oncological	ADJ
aiua-11242	100	17	follow	follow	NOUN
aiua-11242	100	18	-	-	PUNCT
aiua-11242	100	19	up	up	NOUN
aiua-11242	100	20	.	.	PUNCT
aiua-11242	101	1	the	the	DET
aiua-11242	101	2	number	number	NOUN
aiua-11242	101	3	of	of	ADP
aiua-11242	101	4	drugs	drug	NOUN
aiua-11242	101	5	approved	approve	VERB
aiua-11242	101	6	for	for	ADP
aiua-11242	101	7	treatment	treatment	NOUN
aiua-11242	101	8	of	of	ADP
aiua-11242	101	9	mcrpc	mcrpc	NOUN
aiua-11242	101	10	is	be	AUX
aiua-11242	101	11	vast	vast	ADJ
aiua-11242	101	12	(	(	PUNCT
aiua-11242	101	13	27	27	NUM
aiua-11242	101	14	-	-	SYM
aiua-11242	101	15	30	30	NUM
aiua-11242	101	16	)	)	PUNCT
aiua-11242	101	17	.	.	PUNCT
aiua-11242	102	1	in	in	ADP
aiua-11242	102	2	our	our	PRON
aiua-11242	102	3	study	study	NOUN
aiua-11242	102	4	,	,	PUNCT
aiua-11242	102	5	27	27	NUM
aiua-11242	102	6	%	%	NOUN
aiua-11242	102	7	of	of	ADP
aiua-11242	102	8	the	the	DET
aiua-11242	102	9	patients	patient	NOUN
aiua-11242	102	10	received	receive	VERB
aiua-11242	102	11	docetaxel	docetaxel	NOUN
aiua-11242	102	12	,	,	PUNCT
aiua-11242	102	13	41.6	41.6	NUM
aiua-11242	102	14	%	%	NOUN
aiua-11242	102	15	abiraterone	abiraterone	NOUN
aiua-11242	102	16	and	and	CCONJ
aiua-11242	102	17	31.5	31.5	NUM
aiua-11242	102	18	%	%	NOUN
aiua-11242	102	19	enzalutamide	enzalutamide	NOUN
aiua-11242	102	20	.	.	PUNCT
aiua-11242	103	1	we	we	PRON
aiua-11242	103	2	observed	observe	VERB
aiua-11242	103	3	a	a	DET
aiua-11242	103	4	significantly	significantly	ADV
aiua-11242	103	5	higher	high	ADJ
aiua-11242	103	6	proportion	proportion	NOUN
aiua-11242	103	7	of	of	ADP
aiua-11242	103	8	patients	patient	NOUN
aiua-11242	103	9	with	with	ADP
aiua-11242	103	10	car	car	NOUN
aiua-11242	103	11	>	>	X
aiua-11242	103	12	0.22	0.22	NUM
aiua-11242	103	13	receiving	receive	VERB
aiua-11242	103	14	docetaxel	docetaxel	NOUN
aiua-11242	103	15	vs	vs	ADP
aiua-11242	103	16	nha	nha	NOUN
aiua-11242	103	17	.	.	PUNCT
aiua-11242	104	1	this	this	PRON
aiua-11242	104	2	can	can	AUX
aiua-11242	104	3	be	be	AUX
aiua-11242	104	4	due	due	ADJ
aiua-11242	104	5	to	to	ADP
aiua-11242	104	6	the	the	DET
aiua-11242	104	7	higher	high	ADJ
aiua-11242	104	8	disease	disease	NOUN
aiua-11242	104	9	stress	stress	NOUN
aiua-11242	104	10	associated	associate	VERB
aiua-11242	104	11	with	with	ADP
aiua-11242	104	12	the	the	DET
aiua-11242	104	13	poor	poor	ADJ
aiua-11242	104	14	risk	risk	NOUN
aiua-11242	104	15	factors	factor	NOUN
aiua-11242	104	16	present	present	ADJ
aiua-11242	104	17	in	in	ADP
aiua-11242	104	18	these	these	DET
aiua-11242	104	19	sub	sub	NOUN
aiua-11242	104	20	-	-	NOUN
aiua-11242	104	21	group	group	NOUN
aiua-11242	104	22	.	.	PUNCT
aiua-11242	105	1	because	because	SCONJ
aiua-11242	105	2	docetaxel	docetaxel	PROPN
aiua-11242	105	3	was	be	AUX
aiua-11242	105	4	prescribed	prescribe	VERB
aiua-11242	105	5	in	in	ADP
aiua-11242	105	6	patients	patient	NOUN
aiua-11242	105	7	with	with	ADP
aiua-11242	105	8	more	more	ADV
aiua-11242	105	9	aggressive	aggressive	ADJ
aiua-11242	105	10	disease	disease	NOUN
aiua-11242	105	11	,	,	PUNCT
aiua-11242	105	12	their	their	PRON
aiua-11242	105	13	os	os	NOUN
aiua-11242	105	14	were	be	AUX
aiua-11242	105	15	also	also	ADV
aiua-11242	105	16	lower	low	ADJ
aiua-11242	105	17	.	.	PUNCT
aiua-11242	106	1	however	however	ADV
aiua-11242	106	2	,	,	PUNCT
aiua-11242	106	3	car	car	NOUN
aiua-11242	106	4	was	be	AUX
aiua-11242	106	5	still	still	ADV
aiua-11242	106	6	able	able	ADJ
aiua-11242	106	7	to	to	PART
aiua-11242	106	8	differentiate	differentiate	VERB
aiua-11242	106	9	patients	patient	NOUN
aiua-11242	106	10	receiving	receive	VERB
aiua-11242	106	11	docetaxel	docetaxel	NOUN
aiua-11242	106	12	according	accord	VERB
aiua-11242	106	13	to	to	ADP
aiua-11242	106	14	their	their	PRON
aiua-11242	106	15	prognosis	prognosis	NOUN
aiua-11242	106	16	.	.	PUNCT
aiua-11242	107	1	the	the	DET
aiua-11242	107	2	groups	group	NOUN
aiua-11242	107	3	receiving	receive	VERB
aiua-11242	107	4	abiraterone	abiraterone	NOUN
aiua-11242	107	5	and	and	CCONJ
aiua-11242	107	6	enzalutamide	enzalutamide	NOUN
aiua-11242	107	7	were	be	AUX
aiua-11242	107	8	more	more	ADV
aiua-11242	107	9	homogenous	homogenous	ADJ
aiua-11242	107	10	.	.	PUNCT
aiua-11242	108	1	when	when	SCONJ
aiua-11242	108	2	grouping	group	VERB
aiua-11242	108	3	the	the	DET
aiua-11242	108	4	sample	sample	NOUN
aiua-11242	108	5	by	by	ADP
aiua-11242	108	6	treatment	treatment	NOUN
aiua-11242	108	7	type	type	NOUN
aiua-11242	108	8	,	,	PUNCT
aiua-11242	108	9	we	we	PRON
aiua-11242	108	10	found	find	VERB
aiua-11242	108	11	longer	long	ADJ
aiua-11242	108	12	os	os	NOUN
aiua-11242	108	13	for	for	ADP
aiua-11242	108	14	patients	patient	NOUN
aiua-11242	108	15	with	with	ADP
aiua-11242	108	16	car	car	NOUN
aiua-11242	108	17	≤	≤	NOUN
aiua-11242	108	18	0.22	0.22	NUM
aiua-11242	108	19	taking	take	VERB
aiua-11242	108	20	abiraterone	abiraterone	NOUN
aiua-11242	108	21	,	,	PUNCT
aiua-11242	108	22	however	however	ADV
aiua-11242	108	23	,	,	PUNCT
aiua-11242	108	24	patients	patient	NOUN
aiua-11242	108	25	on	on	ADP
aiua-11242	108	26	enzalutamide	enzalutamide	ADP
aiua-11242	108	27	didn´t	didn´t	NOUN
aiua-11242	108	28	showed	show	VERB
aiua-11242	108	29	a	a	DET
aiua-11242	108	30	significant	significant	ADJ
aiua-11242	108	31	difference	difference	NOUN
aiua-11242	108	32	in	in	ADP
aiua-11242	108	33	os	os	NOUN
aiua-11242	108	34	,	,	PUNCT
aiua-11242	108	35	car	car	NOUN
aiua-11242	108	36	(	(	PUNCT
aiua-11242	108	37	p	p	X
aiua-11242	108	38	=	=	NOUN
aiua-11242	108	39	0.12	0.12	NUM
aiua-11242	108	40	)	)	PUNCT
aiua-11242	108	41	,	,	PUNCT
aiua-11242	108	42	with	with	ADP
aiua-11242	108	43	patients	patient	NOUN
aiua-11242	108	44	showing	show	VERB
aiua-11242	108	45	an	an	DET
aiua-11242	108	46	os	os	NOUN
aiua-11242	108	47	of	of	ADP
aiua-11242	108	48	27.36	27.36	NUM
aiua-11242	108	49	and	and	CCONJ
aiua-11242	108	50	23.75	23.75	NUM
aiua-11242	108	51	months	month	NOUN
aiua-11242	108	52	,	,	PUNCT
aiua-11242	108	53	for	for	ADP
aiua-11242	108	54	a	a	DET
aiua-11242	108	55	car	car	NOUN
aiua-11242	108	56	≤	≤	NOUN
aiua-11242	108	57	0.22	0.22	NUM
aiua-11242	108	58	vs	vs	ADP
aiua-11242	108	59	>	>	X
aiua-11242	108	60	0.22	0.22	NUM
aiua-11242	108	61	,	,	PUNCT
aiua-11242	108	62	respectively	respectively	ADV
aiua-11242	108	63	.	.	PUNCT
aiua-11242	109	1	we	we	PRON
aiua-11242	109	2	attribute	attribute	VERB
aiua-11242	109	3	this	this	DET
aiua-11242	109	4	lack	lack	NOUN
aiua-11242	109	5	of	of	ADP
aiua-11242	109	6	significance	significance	NOUN
aiua-11242	109	7	to	to	ADP
aiua-11242	109	8	the	the	DET
aiua-11242	109	9	small	small	ADJ
aiua-11242	109	10	sample	sample	NOUN
aiua-11242	109	11	size	size	NOUN
aiua-11242	109	12	.	.	PUNCT
aiua-11242	110	1	it	it	PRON
aiua-11242	110	2	should	should	AUX
aiua-11242	110	3	be	be	AUX
aiua-11242	110	4	noted	note	VERB
aiua-11242	110	5	that	that	SCONJ
aiua-11242	110	6	the	the	DET
aiua-11242	110	7	current	current	ADJ
aiua-11242	110	8	study	study	NOUN
aiua-11242	110	9	has	have	VERB
aiua-11242	110	10	limitations	limitation	NOUN
aiua-11242	110	11	,	,	PUNCT
aiua-11242	110	12	including	include	VERB
aiua-11242	110	13	its	its	PRON
aiua-11242	110	14	retrospective	retrospective	ADJ
aiua-11242	110	15	nature	nature	NOUN
aiua-11242	110	16	and	and	CCONJ
aiua-11242	110	17	a	a	DET
aiua-11242	110	18	relatively	relatively	ADV
aiua-11242	110	19	small	small	ADJ
aiua-11242	110	20	sample	sample	NOUN
aiua-11242	110	21	size	size	NOUN
aiua-11242	110	22	,	,	PUNCT
aiua-11242	110	23	which	which	PRON
aiua-11242	110	24	might	might	AUX
aiua-11242	110	25	have	have	AUX
aiua-11242	110	26	caused	cause	VERB
aiua-11242	110	27	selection	selection	NOUN
aiua-11242	110	28	bias	bias	NOUN
aiua-11242	110	29	.	.	PUNCT
aiua-11242	111	1	large	large	ADJ
aiua-11242	111	2	-	-	PUNCT
aiua-11242	111	3	scale	scale	NOUN
aiua-11242	111	4	and	and	CCONJ
aiua-11242	111	5	prospective	prospective	ADJ
aiua-11242	111	6	studies	study	NOUN
aiua-11242	111	7	are	be	AUX
aiua-11242	111	8	further	far	ADV
aiua-11242	111	9	warranted	warrant	VERB
aiua-11242	111	10	to	to	PART
aiua-11242	111	11	confirm	confirm	VERB
aiua-11242	111	12	our	our	PRON
aiua-11242	111	13	preliminary	preliminary	ADJ
aiua-11242	111	14	findings	finding	NOUN
aiua-11242	111	15	.	.	PUNCT
aiua-11242	112	1	conclusions	conclusion	NOUN
aiua-11242	112	2	in	in	ADP
aiua-11242	112	3	conclusion	conclusion	NOUN
aiua-11242	112	4	,	,	PUNCT
aiua-11242	112	5	according	accord	VERB
aiua-11242	112	6	to	to	ADP
aiua-11242	112	7	this	this	DET
aiua-11242	112	8	study	study	NOUN
aiua-11242	112	9	,	,	PUNCT
aiua-11242	112	10	higher	high	ADJ
aiua-11242	112	11	values	value	NOUN
aiua-11242	112	12	of	of	ADP
aiua-11242	112	13	car	car	NOUN
aiua-11242	112	14	are	be	AUX
aiua-11242	112	15	associated	associate	VERB
aiua-11242	112	16	with	with	ADP
aiua-11242	112	17	lower	low	ADJ
aiua-11242	112	18	pfs	pfs	PROPN
aiua-11242	112	19	and	and	CCONJ
aiua-11242	112	20	os	os	NOUN
aiua-11242	112	21	in	in	ADP
aiua-11242	112	22	mcrpc	mcrpc	PROPN
aiua-11242	112	23	patients	patient	NOUN
aiua-11242	112	24	.	.	PUNCT
aiua-11242	113	1	these	these	DET
aiua-11242	113	2	results	result	NOUN
aiua-11242	113	3	suggest	suggest	VERB
aiua-11242	113	4	that	that	SCONJ
aiua-11242	113	5	car	car	NOUN
aiua-11242	113	6	is	be	AUX
aiua-11242	113	7	a	a	DET
aiua-11242	113	8	good	good	ADJ
aiua-11242	113	9	prognosis	prognosis	NOUN
aiua-11242	113	10	biomarker	biomarker	NOUN
aiua-11242	113	11	,	,	PUNCT
aiua-11242	113	12	irrespective	irrespective	ADV
aiua-11242	113	13	of	of	ADP
aiua-11242	113	14	the	the	DET
aiua-11242	113	15	moment	moment	NOUN
aiua-11242	113	16	of	of	ADP
aiua-11242	113	17	evaluation	evaluation	NOUN
aiua-11242	113	18	and	and	CCONJ
aiua-11242	113	19	chosen	choose	VERB
aiua-11242	113	20	treatment	treatment	NOUN
aiua-11242	113	21	option	option	NOUN
aiua-11242	113	22	.	.	PUNCT
aiua-11242	114	1	references	reference	NOUN
aiua-11242	114	2	1	1	NUM
aiua-11242	114	3	.	.	PUNCT
aiua-11242	114	4	prostate	prostate	NOUN
aiua-11242	114	5	cancer	cancer	NOUN
aiua-11242	114	6	statistics	statistic	NOUN
aiua-11242	115	1	[	[	X
aiua-11242	115	2	internet	internet	NOUN
aiua-11242	115	3	]	]	PUNCT
aiua-11242	115	4	.	.	PUNCT
aiua-11242	116	1	cancer.net	cancer.net	NOUN
aiua-11242	116	2	.	.	PUNCT
aiua-11242	116	3	2012	2012	NUM
aiua-11242	116	4	[	[	X
aiua-11242	116	5	cited	cite	VERB
aiua-11242	116	6	2022	2022	NUM
aiua-11242	116	7	nov	nov	PROPN
aiua-11242	116	8	12	12	NUM
aiua-11242	116	9	]	]	PUNCT
aiua-11242	116	10	.	.	PUNCT
aiua-11242	117	1	available	available	ADJ
aiua-11242	117	2	from	from	ADP
aiua-11242	117	3	:	:	PUNCT
aiua-11242	117	4	https://www.cancer.net/cancertypes/prostate-cancer/statistics	https://www.cancer.net/cancertypes/prostate-cancer/statistic	NOUN
aiua-11242	117	5	.	.	PUNCT
aiua-11242	118	1	2	2	X
aiua-11242	118	2	.	.	X
aiua-11242	118	3	key	key	ADJ
aiua-11242	118	4	statistics	statistic	NOUN
aiua-11242	118	5	for	for	ADP
aiua-11242	118	6	prostate	prostate	NOUN
aiua-11242	118	7	cancer	cancer	NOUN
aiua-11242	118	8	|	|	NOUN
aiua-11242	118	9	prostate	prostate	NOUN
aiua-11242	118	10	cancer	cancer	NOUN
aiua-11242	118	11	facts	fact	NOUN
aiua-11242	118	12	[	[	X
aiua-11242	118	13	internet	internet	NOUN
aiua-11242	118	14	]	]	PUNCT
aiua-11242	118	15	.	.	PUNCT
aiua-11242	119	1	cancer.org	cancer.org	X
aiua-11242	119	2	.	.	PUNCT
aiua-11242	119	3	2022	2022	NUM
aiua-11242	120	1	[	[	X
aiua-11242	120	2	cited	cite	VERB
aiua-11242	120	3	2022	2022	NUM
aiua-11242	120	4	nov	nov	PROPN
aiua-11242	120	5	12	12	NUM
aiua-11242	120	6	]	]	PUNCT
aiua-11242	120	7	.	.	PUNCT
aiua-11242	121	1	available	available	ADJ
aiua-11242	121	2	from	from	ADP
aiua-11242	121	3	:	:	PUNCT
aiua-11242	121	4	https://www	https://www	PROPN
aiua-11242	121	5	.	.	PROPN
aiua-11242	122	1	cancer.org/cancer/prostate-cancer/about/key-statistics.html	cancer.org/cancer/prostate-cancer/about/key-statistics.html	PROPN
aiua-11242	122	2	3	3	PROPN
aiua-11242	122	3	.	.	PUNCT
aiua-11242	122	4	wein	wein	PROPN
aiua-11242	122	5	aj	aj	PROPN
aiua-11242	122	6	,	,	PUNCT
aiua-11242	122	7	kavoussi	kavoussi	PROPN
aiua-11242	122	8	lr	lr	PROPN
aiua-11242	122	9	,	,	PUNCT
aiua-11242	122	10	partin	partin	PROPN
aiua-11242	122	11	aw	aw	INTJ
aiua-11242	122	12	,	,	PUNCT
aiua-11242	122	13	peters	peters	PROPN
aiua-11242	122	14	ca	can	AUX
aiua-11242	122	15	.	.	PUNCT
aiua-11242	123	1	campbell	campbell	PROPN
aiua-11242	123	2	-	-	PUNCT
aiua-11242	123	3	walsh	walsh	PROPN
aiua-11242	123	4	urology	urology	NOUN
aiua-11242	123	5	.	.	PUNCT
aiua-11242	124	1	philadelphia	philadelphia	PROPN
aiua-11242	124	2	,	,	PUNCT
aiua-11242	124	3	pa	pa	PROPN
aiua-11242	124	4	:	:	PUNCT
aiua-11242	124	5	elsevier	elsevier	NOUN
aiua-11242	124	6	;	;	PUNCT
aiua-11242	124	7	2016	2016	NUM
aiua-11242	124	8	.	.	PUNCT
aiua-11242	125	1	4	4	X
aiua-11242	125	2	.	.	X
aiua-11242	125	3	epstein	epstein	PROPN
aiua-11242	125	4	mm	mm	PROPN
aiua-11242	125	5	,	,	PUNCT
aiua-11242	125	6	edgren	edgren	PROPN
aiua-11242	125	7	g	g	PROPN
aiua-11242	125	8	,	,	PUNCT
aiua-11242	125	9	rider	rider	NOUN
aiua-11242	125	10	jr	jr	PROPN
aiua-11242	125	11	,	,	PUNCT
aiua-11242	125	12	et	et	PROPN
aiua-11242	125	13	al	al	PROPN
aiua-11242	125	14	.	.	PUNCT
aiua-11242	126	1	temporal	temporal	ADJ
aiua-11242	126	2	trends	trend	NOUN
aiua-11242	126	3	in	in	ADP
aiua-11242	126	4	cause	cause	NOUN
aiua-11242	126	5	of	of	ADP
aiua-11242	126	6	death	death	NOUN
aiua-11242	126	7	among	among	ADP
aiua-11242	126	8	swedish	swedish	ADJ
aiua-11242	126	9	and	and	CCONJ
aiua-11242	126	10	us	we	PRON
aiua-11242	126	11	men	man	NOUN
aiua-11242	126	12	with	with	ADP
aiua-11242	126	13	prostate	prostate	NOUN
aiua-11242	126	14	cancer	cancer	NOUN
aiua-11242	126	15	.	.	PUNCT
aiua-11242	127	1	j	j	PROPN
aiua-11242	127	2	natl	natl	PROPN
aiua-11242	127	3	cancer	cancer	PROPN
aiua-11242	127	4	inst	inst	PROPN
aiua-11242	127	5	.	.	PUNCT
aiua-11242	127	6	2012	2012	NUM
aiua-11242	127	7	;	;	PUNCT
aiua-11242	127	8	104:1335	104:1335	NUM
aiua-11242	127	9	-	-	SYM
aiua-11242	127	10	42	42	NUM
aiua-11242	127	11	.	.	PUNCT
aiua-11242	128	1	5	5	NUM
aiua-11242	128	2	.	.	X
aiua-11242	128	3	huggins	huggins	PROPN
aiua-11242	128	4	c	c	PROPN
aiua-11242	128	5	,	,	PUNCT
aiua-11242	128	6	hodges	hodges	PROPN
aiua-11242	128	7	cv	cv	PROPN
aiua-11242	128	8	.	.	PROPN
aiua-11242	128	9	studies	study	NOUN
aiua-11242	128	10	on	on	ADP
aiua-11242	128	11	prostatic	prostatic	ADJ
aiua-11242	128	12	cancer	cancer	NOUN
aiua-11242	128	13	:	:	PUNCT
aiua-11242	128	14	i.	i.	NOUN
aiua-11242	128	15	the	the	DET
aiua-11242	128	16	effect	effect	NOUN
aiua-11242	128	17	of	of	ADP
aiua-11242	128	18	castration	castration	NOUN
aiua-11242	128	19	,	,	PUNCT
aiua-11242	128	20	of	of	ADP
aiua-11242	128	21	estrogen	estrogen	NOUN
aiua-11242	128	22	and	and	CCONJ
aiua-11242	128	23	of	of	ADP
aiua-11242	128	24	androgen	androgen	NOUN
aiua-11242	128	25	injection	injection	NOUN
aiua-11242	128	26	on	on	ADP
aiua-11242	128	27	serum	serum	NOUN
aiua-11242	128	28	phosphatases	phosphatase	NOUN
aiua-11242	128	29	in	in	ADP
aiua-11242	128	30	metastatic	metastatic	ADJ
aiua-11242	128	31	carcinoma	carcinoma	NOUN
aiua-11242	128	32	of	of	ADP
aiua-11242	128	33	the	the	DET
aiua-11242	128	34	prostate	prostate	NOUN
aiua-11242	128	35	.	.	PUNCT
aiua-11242	129	1	j	j	PROPN
aiua-11242	129	2	urol	urol	PROPN
aiua-11242	129	3	.	.	PUNCT
aiua-11242	129	4	2002	2002	NUM
aiua-11242	129	5	;	;	PUNCT
aiua-11242	129	6	168:9	168:9	NUM
aiua-11242	129	7	-	-	SYM
aiua-11242	129	8	12	12	NUM
aiua-11242	129	9	.	.	PUNCT
aiua-11242	130	1	6	6	NUM
aiua-11242	130	2	.	.	X
aiua-11242	130	3	teo	teo	PROPN
aiua-11242	130	4	my	my	PROPN
aiua-11242	130	5	,	,	PUNCT
aiua-11242	130	6	scher	scher	PROPN
aiua-11242	130	7	hi	hi	PROPN
aiua-11242	130	8	.	.	PROPN
aiua-11242	130	9	chaarted	chaarte	VERB
aiua-11242	130	10	/	/	SYM
aiua-11242	130	11	getug	getug	PROPN
aiua-11242	130	12	12	12	NUM
aiua-11242	130	13	—	—	PUNCT
aiua-11242	130	14	docetaxel	docetaxel	NOUN
aiua-11242	130	15	in	in	ADP
aiua-11242	130	16	noncastrate	noncastrate	ADJ
aiua-11242	130	17	prostate	prostate	NOUN
aiua-11242	130	18	cancers	cancer	NOUN
aiua-11242	130	19	.	.	PUNCT
aiua-11242	131	1	nat	nat	PROPN
aiua-11242	131	2	rev	rev	VERB
aiua-11242	131	3	clin	clin	PROPN
aiua-11242	131	4	oncol	oncol	PROPN
aiua-11242	131	5	.	.	PUNCT
aiua-11242	132	1	2015	2015	NUM
aiua-11242	132	2	;	;	PUNCT
aiua-11242	132	3	12:687	12:687	NUM
aiua-11242	132	4	-	-	SYM
aiua-11242	132	5	8	8	NUM
aiua-11242	132	6	.	.	NOUN
aiua-11242	133	1	7	7	NUM
aiua-11242	133	2	.	.	X
aiua-11242	133	3	james	james	PROPN
aiua-11242	133	4	n	n	CCONJ
aiua-11242	133	5	,	,	PUNCT
aiua-11242	133	6	woods	woods	PROPN
aiua-11242	133	7	b	b	NOUN
aiua-11242	133	8	,	,	PUNCT
aiua-11242	133	9	sideris	sideris	NOUN
aiua-11242	133	10	e	e	NOUN
aiua-11242	133	11	,	,	PUNCT
aiua-11242	133	12	et	et	PROPN
aiua-11242	133	13	al	al	PROPN
aiua-11242	133	14	.	.	PROPN
aiua-11242	133	15	addition	addition	NOUN
aiua-11242	133	16	of	of	ADP
aiua-11242	133	17	docetaxel	docetaxel	PROPN
aiua-11242	133	18	to	to	PART
aiua-11242	133	19	firstline	firstline	VERB
aiua-11242	133	20	long	long	ADJ
aiua-11242	133	21	-	-	PUNCT
aiua-11242	133	22	term	term	NOUN
aiua-11242	133	23	hormone	hormone	NOUN
aiua-11242	133	24	therapy	therapy	NOUN
aiua-11242	133	25	in	in	ADP
aiua-11242	133	26	prostate	prostate	NOUN
aiua-11242	133	27	cancer	cancer	NOUN
aiua-11242	133	28	(	(	PUNCT
aiua-11242	133	29	stampede	stampede	NOUN
aiua-11242	133	30	):	):	PUNCT
aiua-11242	133	31	long	long	ADJ
aiua-11242	133	32	-	-	PUNCT
aiua-11242	133	33	term	term	NOUN
aiua-11242	133	34	survival	survival	NOUN
aiua-11242	133	35	,	,	PUNCT
aiua-11242	133	36	quality	quality	NOUN
aiua-11242	133	37	-	-	PUNCT
aiua-11242	133	38	adjusted	adjust	VERB
aiua-11242	133	39	survival	survival	NOUN
aiua-11242	133	40	,	,	PUNCT
aiua-11242	133	41	and	and	CCONJ
aiua-11242	133	42	cost	cost	NOUN
aiua-11242	133	43	-	-	PUNCT
aiua-11242	133	44	effectiveness	effectiveness	NOUN
aiua-11242	133	45	analysis	analysis	NOUN
aiua-11242	133	46	.	.	PUNCT
aiua-11242	134	1	j	j	PROPN
aiua-11242	134	2	clin	clin	PROPN
aiua-11242	134	3	oncol	oncol	PROPN
aiua-11242	134	4	.	.	PUNCT
aiua-11242	135	1	2018	2018	NUM
aiua-11242	136	1	;	;	PUNCT
aiua-11242	136	2	36(6	36(6	NUM
aiua-11242	136	3	suppl):162	suppl):162	PROPN
aiua-11242	136	4	-	-	PUNCT
aiua-11242	136	5	2	2	NUM
aiua-11242	136	6	.	.	NOUN
aiua-11242	136	7	8	8	NUM
aiua-11242	136	8	.	.	PUNCT
aiua-11242	137	1	sharma	sharma	PROPN
aiua-11242	137	2	a.	a.	PROPN
aiua-11242	137	3	a	a	DET
aiua-11242	137	4	game	game	NOUN
aiua-11242	137	5	changing	change	VERB
aiua-11242	137	6	latitude	latitude	NOUN
aiua-11242	137	7	:	:	PUNCT
aiua-11242	137	8	role	role	NOUN
aiua-11242	137	9	of	of	ADP
aiua-11242	137	10	abiraterone	abiraterone	NOUN
aiua-11242	137	11	plus	plus	CCONJ
aiua-11242	137	12	prednisolone	prednisolone	PROPN
aiua-11242	137	13	in	in	ADP
aiua-11242	137	14	metastatic	metastatic	ADJ
aiua-11242	137	15	hormone	hormone	NOUN
aiua-11242	137	16	-	-	PUNCT
aiua-11242	137	17	sensitive	sensitive	ADJ
aiua-11242	137	18	prostate	prostate	NOUN
aiua-11242	137	19	cancer	cancer	NOUN
aiua-11242	137	20	.	.	PUNCT
aiua-11242	138	1	indian	indian	PROPN
aiua-11242	138	2	j	j	PROPN
aiua-11242	138	3	urol	urol	PROPN
aiua-11242	138	4	.	.	PROPN
aiua-11242	138	5	2017	2017	NUM
aiua-11242	138	6	;	;	PUNCT
aiua-11242	138	7	33:333	33:333	NUM
aiua-11242	138	8	.	.	NOUN
aiua-11242	139	1	9	9	NUM
aiua-11242	139	2	.	.	X
aiua-11242	140	1	davis	davis	PROPN
aiua-11242	140	2	i	i	PROPN
aiua-11242	140	3	d	d	PROPN
aiua-11242	140	4	,	,	PUNCT
aiua-11242	140	5	stockler	stockler	PROPN
aiua-11242	140	6	mr	mr	PROPN
aiua-11242	140	7	,	,	PUNCT
aiua-11242	140	8	martin	martin	PROPN
aiua-11242	140	9	a	a	PROPN
aiua-11242	140	10	,	,	PUNCT
aiua-11242	140	11	et	et	PROPN
aiua-11242	140	12	al	al	PROPN
aiua-11242	140	13	.	.	PROPN
aiua-11242	140	14	randomised	randomise	VERB
aiua-11242	140	15	phase	phase	NOUN
aiua-11242	140	16	3	3	NUM
aiua-11242	140	17	trial	trial	NOUN
aiua-11242	140	18	of	of	ADP
aiua-11242	140	19	enzalutamide	enzalutamide	NOUN
aiua-11242	140	20	in	in	ADP
aiua-11242	140	21	first	first	ADJ
aiua-11242	140	22	line	line	NOUN
aiua-11242	140	23	androgen	androgen	NOUN
aiua-11242	140	24	deprivation	deprivation	NOUN
aiua-11242	140	25	therapy	therapy	NOUN
aiua-11242	140	26	for	for	ADP
aiua-11242	140	27	metastatic	metastatic	ADJ
aiua-11242	140	28	prostate	prostate	NOUN
aiua-11242	140	29	cancer	cancer	NOUN
aiua-11242	140	30	:	:	PUNCT
aiua-11242	140	31	enzamet	enzamet	NOUN
aiua-11242	140	32	(	(	PUNCT
aiua-11242	140	33	anzup	anzup	NOUN
aiua-11242	140	34	1304	1304	NUM
aiua-11242	140	35	)	)	PUNCT
aiua-11242	140	36	.	.	PUNCT
aiua-11242	141	1	annal	annal	ADJ
aiua-11242	141	2	oncol	oncol	PROPN
aiua-11242	141	3	.	.	PUNCT
aiua-11242	142	1	2014	2014	NUM
aiua-11242	142	2	;	;	PUNCT
aiua-11242	142	3	25	25	NUM
aiua-11242	142	4	:	:	PUNCT
aiua-11242	142	5	iv278	iv278	PROPN
aiua-11242	142	6	.	.	PUNCT
aiua-11242	143	1	10	10	NUM
aiua-11242	143	2	.	.	PUNCT
aiua-11242	144	1	chi	chi	PROPN
aiua-11242	144	2	kn	kn	PROPN
aiua-11242	144	3	,	,	PUNCT
aiua-11242	144	4	chowdhury	chowdhury	PROPN
aiua-11242	144	5	s	s	PART
aiua-11242	144	6	,	,	PUNCT
aiua-11242	144	7	radziszewski	radziszewski	VERB
aiua-11242	144	8	p	p	NOUN
aiua-11242	144	9	,	,	PUNCT
aiua-11242	144	10	et	et	PROPN
aiua-11242	144	11	al	al	PROPN
aiua-11242	144	12	.	.	PROPN
aiua-11242	144	13	titan	titan	PROPN
aiua-11242	144	14	:	:	PUNCT
aiua-11242	144	15	a	a	DET
aiua-11242	144	16	randomized	randomized	ADJ
aiua-11242	144	17	,	,	PUNCT
aiua-11242	144	18	double	double	ADJ
aiua-11242	144	19	-	-	PUNCT
aiua-11242	144	20	blind	blind	ADJ
aiua-11242	144	21	,	,	PUNCT
aiua-11242	144	22	placebo	placebo	NOUN
aiua-11242	144	23	-	-	PUNCT
aiua-11242	144	24	controlled	control	VERB
aiua-11242	144	25	,	,	PUNCT
aiua-11242	144	26	phase	phase	NOUN
aiua-11242	144	27	3	3	NUM
aiua-11242	144	28	trial	trial	NOUN
aiua-11242	144	29	of	of	ADP
aiua-11242	144	30	apalutamide	apalutamide	ADJ
aiua-11242	144	31	(	(	PUNCT
aiua-11242	144	32	arn-509	arn-509	ADJ
aiua-11242	144	33	)	)	PUNCT
aiua-11242	144	34	plus	plus	CCONJ
aiua-11242	144	35	androgen	androgen	NOUN
aiua-11242	144	36	deprivation	deprivation	NOUN
aiua-11242	144	37	therapy	therapy	NOUN
aiua-11242	144	38	(	(	PUNCT
aiua-11242	144	39	adt	adt	NOUN
aiua-11242	144	40	)	)	PUNCT
aiua-11242	144	41	in	in	ADP
aiua-11242	144	42	metastatic	metastatic	ADJ
aiua-11242	144	43	hormone	hormone	NOUN
aiua-11242	144	44	-	-	PUNCT
aiua-11242	144	45	sensitive	sensitive	ADJ
aiua-11242	144	46	prostate	prostate	NOUN
aiua-11242	144	47	cancer	cancer	NOUN
aiua-11242	144	48	(	(	PUNCT
aiua-11242	144	49	mhspc	mhspc	PROPN
aiua-11242	144	50	)	)	PUNCT
aiua-11242	144	51	.	.	PUNCT
aiua-11242	145	1	annal	annal	ADJ
aiua-11242	145	2	oncol	oncol	NOUN
aiua-11242	145	3	.	.	PUNCT
aiua-11242	146	1	2016	2016	NUM
aiua-11242	146	2	;	;	PUNCT
aiua-11242	146	3	27	27	NUM
aiua-11242	146	4	:	:	PUNCT
aiua-11242	146	5	vi265	vi265	NOUN
aiua-11242	146	6	.	.	PUNCT
aiua-11242	147	1	11	11	NUM
aiua-11242	147	2	.	.	PUNCT
aiua-11242	148	1	tombal	tombal	PROPN
aiua-11242	148	2	b	b	PROPN
aiua-11242	148	3	,	,	PUNCT
aiua-11242	148	4	saad	saad	PROPN
aiua-11242	148	5	f	f	PROPN
aiua-11242	148	6	,	,	PUNCT
aiua-11242	148	7	hussain	hussain	PROPN
aiua-11242	148	8	m	m	PROPN
aiua-11242	148	9	,	,	PUNCT
aiua-11242	149	1	et	et	PROPN
aiua-11242	149	2	al	al	PROPN
aiua-11242	149	3	.	.	PUNCT
aiua-11242	149	4	arasens	arasens	PROPN
aiua-11242	149	5	:	:	PUNCT
aiua-11242	149	6	a	a	DET
aiua-11242	149	7	phase	phase	NOUN
aiua-11242	149	8	3	3	NUM
aiua-11242	149	9	trial	trial	NOUN
aiua-11242	149	10	of	of	ADP
aiua-11242	149	11	darolutamide	darolutamide	NOUN
aiua-11242	149	12	in	in	ADP
aiua-11242	149	13	males	male	NOUN
aiua-11242	149	14	with	with	ADP
aiua-11242	149	15	metastatic	metastatic	ADJ
aiua-11242	149	16	hormone	hormone	NOUN
aiua-11242	149	17	-	-	PUNCT
aiua-11242	149	18	sensitive	sensitive	ADJ
aiua-11242	149	19	prostate	prostate	NOUN
aiua-11242	149	20	cancer	cancer	NOUN
aiua-11242	149	21	(	(	PUNCT
aiua-11242	149	22	mhspc	mhspc	PROPN
aiua-11242	149	23	)	)	PUNCT
aiua-11242	149	24	.	.	PUNCT
aiua-11242	150	1	annal	annal	ADJ
aiua-11242	150	2	oncol	oncol	PROPN
aiua-11242	150	3	.	.	PUNCT
aiua-11242	151	1	2017	2017	NUM
aiua-11242	151	2	;	;	PUNCT
aiua-11242	151	3	28	28	NUM
aiua-11242	151	4	:	:	PUNCT
aiua-11242	151	5	v291	v291	PROPN
aiua-11242	151	6	-	-	PUNCT
aiua-11242	151	7	2	2	NUM
aiua-11242	151	8	.	.	NUM
aiua-11242	151	9	12	12	NUM
aiua-11242	151	10	.	.	PUNCT
aiua-11242	152	1	aly	aly	PROPN
aiua-11242	152	2	m	m	PROPN
aiua-11242	152	3	,	,	PUNCT
aiua-11242	152	4	leval	leval	NOUN
aiua-11242	152	5	a	a	NOUN
aiua-11242	152	6	,	,	PUNCT
aiua-11242	152	7	schain	schain	NOUN
aiua-11242	152	8	f	f	PROPN
aiua-11242	152	9	,	,	PUNCT
aiua-11242	152	10	et	et	PROPN
aiua-11242	152	11	al	al	PROPN
aiua-11242	152	12	.	.	PROPN
aiua-11242	152	13	survival	survival	PROPN
aiua-11242	152	14	in	in	ADP
aiua-11242	152	15	patients	patient	NOUN
aiua-11242	152	16	diagnosed	diagnose	VERB
aiua-11242	152	17	with	with	ADP
aiua-11242	152	18	castration	castration	NOUN
aiua-11242	152	19	-	-	PUNCT
aiua-11242	152	20	resistant	resistant	ADJ
aiua-11242	152	21	prostate	prostate	NOUN
aiua-11242	152	22	cancer	cancer	NOUN
aiua-11242	152	23	:	:	PUNCT
aiua-11242	152	24	a	a	DET
aiua-11242	152	25	population	population	NOUN
aiua-11242	152	26	-	-	PUNCT
aiua-11242	152	27	based	base	VERB
aiua-11242	152	28	observational	observational	ADJ
aiua-11242	152	29	study	study	NOUN
aiua-11242	152	30	in	in	ADP
aiua-11242	152	31	sweden	sweden	PROPN
aiua-11242	152	32	.	.	PUNCT
aiua-11242	153	1	scand	scand	PROPN
aiua-11242	153	2	j	j	PROPN
aiua-11242	153	3	urol	urol	PROPN
aiua-11242	153	4	.	.	PUNCT
aiua-11242	154	1	2020	2020	NUM
aiua-11242	154	2	;	;	PUNCT
aiua-11242	154	3	54:115	54:115	NUM
aiua-11242	154	4	-	-	SYM
aiua-11242	154	5	21	21	NUM
aiua-11242	154	6	.	.	PUNCT
aiua-11242	154	7	13	13	NUM
aiua-11242	154	8	.	.	PUNCT
aiua-11242	155	1	capoun	capoun	PROPN
aiua-11242	155	2	o	o	PROPN
aiua-11242	155	3	,	,	PUNCT
aiua-11242	155	4	mikulová	mikulová	X
aiua-11242	155	5	v	v	NOUN
aiua-11242	155	6	,	,	PUNCT
aiua-11242	155	7	jancíková	jancíková	PROPN
aiua-11242	155	8	m	m	PROPN
aiua-11242	155	9	,	,	PUNCT
aiua-11242	155	10	et	et	PROPN
aiua-11242	155	11	al	al	PROPN
aiua-11242	155	12	.	.	PUNCT
aiua-11242	156	1	prognosis	prognosis	NOUN
aiua-11242	156	2	of	of	ADP
aiua-11242	156	3	castration	castration	NOUN
aiua-11242	156	4	-	-	PUNCT
aiua-11242	156	5	resistant	resistant	ADJ
aiua-11242	156	6	prostate	prostate	NOUN
aiua-11242	156	7	cancer	cancer	NOUN
aiua-11242	156	8	patients	patient	NOUN
aiua-11242	156	9	use	use	VERB
aiua-11242	156	10	of	of	ADP
aiua-11242	156	11	the	the	DET
aiua-11242	156	12	adnatest	adnate	ADJ
aiua-11242	156	13	®	®	NOUN
aiua-11242	156	14	system	system	NOUN
aiua-11242	156	15	for	for	ADP
aiua-11242	156	16	detection	detection	NOUN
aiua-11242	156	17	of	of	ADP
aiua-11242	156	18	circulating	circulate	VERB
aiua-11242	156	19	tumor	tumor	NOUN
aiua-11242	156	20	cells	cell	NOUN
aiua-11242	156	21	.	.	PUNCT
aiua-11242	157	1	anticancer	anticancer	NOUN
aiua-11242	157	2	research	research	NOUN
aiua-11242	157	3	.	.	PUNCT
aiua-11242	158	1	2016	2016	NUM
aiua-11242	158	2	;	;	PUNCT
aiua-11242	158	3	36:2019	36:2019	NUM
aiua-11242	158	4	-	-	SYM
aiua-11242	158	5	26	26	NUM
aiua-11242	158	6	.	.	PUNCT
aiua-11242	159	1	14	14	NUM
aiua-11242	159	2	.	.	PUNCT
aiua-11242	160	1	kasymjanova	kasymjanova	PROPN
aiua-11242	160	2	g	g	PROPN
aiua-11242	160	3	,	,	PUNCT
aiua-11242	160	4	macdonald	macdonald	PROPN
aiua-11242	160	5	n	n	CCONJ
aiua-11242	160	6	,	,	PUNCT
aiua-11242	160	7	agulnik	agulnik	X
aiua-11242	160	8	js	js	PROPN
aiua-11242	160	9	,	,	PUNCT
aiua-11242	160	10	et	et	PROPN
aiua-11242	160	11	al	al	PROPN
aiua-11242	160	12	.	.	PUNCT
aiua-11242	161	1	the	the	DET
aiua-11242	161	2	predictive	predictive	ADJ
aiua-11242	161	3	archivio	archivio	NOUN
aiua-11242	161	4	italiano	italiano	NOUN
aiua-11242	161	5	di	di	X
aiua-11242	161	6	urologia	urologia	PROPN
aiua-11242	161	7	e	e	PROPN
aiua-11242	161	8	andrologia	andrologia	NOUN
aiua-11242	161	9	2023	2023	NUM
aiua-11242	161	10	;	;	PUNCT
aiua-11242	161	11	95(3):11242	95(3):11242	NUM
aiua-11242	161	12	5	5	NUM
aiua-11242	161	13	car	car	NOUN
aiua-11242	161	14	as	as	ADP
aiua-11242	161	15	a	a	DET
aiua-11242	161	16	prognosis	prognosis	NOUN
aiua-11242	161	17	biomarker	biomarker	NOUN
aiua-11242	161	18	in	in	ADP
aiua-11242	161	19	mcrpc	mcrpc	NOUN
aiua-11242	161	20	value	value	NOUN
aiua-11242	161	21	of	of	ADP
aiua-11242	161	22	pre	pre	ADJ
aiua-11242	161	23	-	-	ADJ
aiua-11242	161	24	treatment	treatment	ADJ
aiua-11242	161	25	inflammatory	inflammatory	ADJ
aiua-11242	161	26	markers	marker	NOUN
aiua-11242	161	27	in	in	ADP
aiua-11242	161	28	advanced	advanced	ADJ
aiua-11242	161	29	nonsmall	nonsmall	ADJ
aiua-11242	161	30	-	-	PUNCT
aiua-11242	161	31	cell	cell	NOUN
aiua-11242	161	32	lung	lung	NOUN
aiua-11242	161	33	cancer	cancer	NOUN
aiua-11242	161	34	.	.	PUNCT
aiua-11242	162	1	cur	cur	VERB
aiua-11242	162	2	oncol	oncol	ADJ
aiua-11242	162	3	2010	2010	NUM
aiua-11242	162	4	;	;	PUNCT
aiua-11242	162	5	17:52	17:52	NUM
aiua-11242	162	6	-	-	SYM
aiua-11242	162	7	8	8	NUM
aiua-11242	162	8	.	.	NOUN
aiua-11242	162	9	15	15	NUM
aiua-11242	162	10	.	.	PUNCT
aiua-11242	163	1	wang	wang	PROPN
aiua-11242	163	2	d	d	PROPN
aiua-11242	163	3	,	,	PUNCT
aiua-11242	163	4	luo	luo	PROPN
aiua-11242	163	5	h	h	PROPN
aiua-11242	163	6	,	,	PUNCT
aiua-11242	163	7	qiu	qiu	PROPN
aiua-11242	163	8	m	m	PROPN
aiua-11242	163	9	,	,	PUNCT
aiua-11242	163	10	et	et	PROPN
aiua-11242	163	11	al	al	PROPN
aiua-11242	163	12	.	.	PROPN
aiua-11242	163	13	comparison	comparison	NOUN
aiua-11242	163	14	of	of	ADP
aiua-11242	163	15	the	the	DET
aiua-11242	163	16	prognostic	prognostic	ADJ
aiua-11242	163	17	values	value	NOUN
aiua-11242	163	18	of	of	ADP
aiua-11242	163	19	various	various	ADJ
aiua-11242	163	20	inflammation	inflammation	NOUN
aiua-11242	163	21	based	base	VERB
aiua-11242	163	22	factors	factor	NOUN
aiua-11242	163	23	in	in	ADP
aiua-11242	163	24	patients	patient	NOUN
aiua-11242	163	25	with	with	ADP
aiua-11242	163	26	pancreatic	pancreatic	ADJ
aiua-11242	163	27	cancer	cancer	NOUN
aiua-11242	163	28	.	.	PUNCT
aiua-11242	164	1	med	med	PROPN
aiua-11242	164	2	oncol	oncol	ADJ
aiua-11242	164	3	.	.	PUNCT
aiua-11242	165	1	2012	2012	NUM
aiua-11242	165	2	;	;	PUNCT
aiua-11242	165	3	29:3092	29:3092	PROPN
aiua-11242	165	4	-	-	SYM
aiua-11242	165	5	100	100	NUM
aiua-11242	165	6	.	.	PUNCT
aiua-11242	166	1	16	16	NUM
aiua-11242	166	2	.	.	PUNCT
aiua-11242	166	3	buzby	buzby	NOUN
aiua-11242	166	4	gp	gp	PROPN
aiua-11242	166	5	,	,	PUNCT
aiua-11242	166	6	mullen	mullen	PROPN
aiua-11242	166	7	jl	jl	PROPN
aiua-11242	166	8	,	,	PUNCT
aiua-11242	166	9	matthews	matthews	PROPN
aiua-11242	166	10	dc	dc	PROPN
aiua-11242	166	11	,	,	PUNCT
aiua-11242	166	12	et	et	PROPN
aiua-11242	166	13	al	al	PROPN
aiua-11242	166	14	.	.	PROPN
aiua-11242	167	1	prognostic	prognostic	ADJ
aiua-11242	167	2	nutritional	nutritional	ADJ
aiua-11242	167	3	index	index	NOUN
aiua-11242	167	4	in	in	ADP
aiua-11242	167	5	gastrointestinal	gastrointestinal	ADJ
aiua-11242	167	6	surgery	surgery	NOUN
aiua-11242	167	7	.	.	PUNCT
aiua-11242	168	1	am	be	AUX
aiua-11242	168	2	j	j	PROPN
aiua-11242	168	3	surg	surg	NOUN
aiua-11242	168	4	1980	1980	NUM
aiua-11242	168	5	;	;	PUNCT
aiua-11242	168	6	139:160	139:160	PROPN
aiua-11242	168	7	-	-	SYM
aiua-11242	168	8	7	7	NUM
aiua-11242	168	9	.	.	NUM
aiua-11242	168	10	17	17	NUM
aiua-11242	168	11	.	.	PUNCT
aiua-11242	169	1	sugimoto	sugimoto	PROPN
aiua-11242	169	2	a	a	PROPN
aiua-11242	169	3	,	,	PUNCT
aiua-11242	169	4	toyokawa	toyokawa	PROPN
aiua-11242	169	5	t	t	PROPN
aiua-11242	169	6	,	,	PUNCT
aiua-11242	169	7	miki	miki	PROPN
aiua-11242	169	8	y	y	PROPN
aiua-11242	169	9	,	,	PUNCT
aiua-11242	169	10	et	et	PROPN
aiua-11242	169	11	al	al	PROPN
aiua-11242	169	12	.	.	PROPN
aiua-11242	169	13	preoperative	preoperative	PROPN
aiua-11242	169	14	c	c	ADJ
aiua-11242	169	15	-	-	ADJ
aiua-11242	169	16	reactive	reactive	ADJ
aiua-11242	169	17	protein	protein	NOUN
aiua-11242	169	18	to	to	ADP
aiua-11242	169	19	albumin	albumin	ADJ
aiua-11242	169	20	ratio	ratio	NOUN
aiua-11242	169	21	predicts	predict	VERB
aiua-11242	169	22	anastomotic	anastomotic	ADJ
aiua-11242	169	23	leakage	leakage	NOUN
aiua-11242	169	24	after	after	ADP
aiua-11242	169	25	esophagectomy	esophagectomy	NOUN
aiua-11242	169	26	for	for	ADP
aiua-11242	169	27	thoracic	thoracic	NOUN
aiua-11242	169	28	esophageal	esophageal	ADJ
aiua-11242	169	29	cancer	cancer	NOUN
aiua-11242	169	30	:	:	PUNCT
aiua-11242	169	31	a	a	DET
aiua-11242	169	32	single	single	ADJ
aiua-11242	169	33	-	-	PUNCT
aiua-11242	169	34	center	center	NOUN
aiua-11242	169	35	retrospective	retrospective	ADJ
aiua-11242	169	36	cohort	cohort	NOUN
aiua-11242	169	37	study	study	NOUN
aiua-11242	169	38	.	.	PUNCT
aiua-11242	170	1	bmc	bmc	ADJ
aiua-11242	170	2	surg	surg	PROPN
aiua-11242	170	3	.	.	PUNCT
aiua-11242	171	1	2021	2021	NUM
aiua-11242	171	2	;	;	PUNCT
aiua-11242	171	3	21:348	21:348	NUM
aiua-11242	171	4	18	18	NUM
aiua-11242	171	5	.	.	PUNCT
aiua-11242	172	1	liu	liu	PROPN
aiua-11242	172	2	z	z	PROPN
aiua-11242	172	3	,	,	PUNCT
aiua-11242	172	4	shi	shi	PROPN
aiua-11242	172	5	h	h	PROPN
aiua-11242	172	6	,	,	PUNCT
aiua-11242	172	7	chen	chen	PROPN
aiua-11242	172	8	l.	l.	PROPN
aiua-11242	172	9	prognostic	prognostic	PROPN
aiua-11242	172	10	role	role	NOUN
aiua-11242	172	11	of	of	ADP
aiua-11242	172	12	pre	pre	ADJ
aiua-11242	172	13	-	-	NOUN
aiua-11242	172	14	treatment	treatment	ADJ
aiua-11242	172	15	c	c	NOUN
aiua-11242	172	16	-	-	PUNCT
aiua-11242	172	17	reactive	reactive	ADJ
aiua-11242	172	18	protein	protein	NOUN
aiua-11242	172	19	/	/	SYM
aiua-11242	172	20	albumin	albumin	ADJ
aiua-11242	172	21	ratio	ratio	NOUN
aiua-11242	172	22	in	in	ADP
aiua-11242	172	23	esophageal	esophageal	ADJ
aiua-11242	172	24	cancer	cancer	NOUN
aiua-11242	172	25	:	:	PUNCT
aiua-11242	172	26	a	a	DET
aiua-11242	172	27	meta	meta	ADJ
aiua-11242	172	28	-	-	PUNCT
aiua-11242	172	29	analysis	analysis	NOUN
aiua-11242	172	30	.	.	PUNCT
aiua-11242	173	1	bmc	bmc	NOUN
aiua-11242	173	2	cancer	cancer	NOUN
aiua-11242	173	3	.	.	PUNCT
aiua-11242	174	1	2019	2019	NUM
aiua-11242	174	2	;	;	PUNCT
aiua-11242	174	3	19:1161	19:1161	NUM
aiua-11242	174	4	.	.	NOUN
aiua-11242	174	5	19	19	NUM
aiua-11242	174	6	.	.	PUNCT
aiua-11242	175	1	bodner	bodn	ADJ
aiua-11242	175	2	-	-	PUNCT
aiua-11242	175	3	adler	adler	PROPN
aiua-11242	175	4	b	b	PROPN
aiua-11242	175	5	,	,	PUNCT
aiua-11242	175	6	kimberger	kimberger	NOUN
aiua-11242	175	7	o	o	NOUN
aiua-11242	175	8	,	,	PUNCT
aiua-11242	175	9	schneidinger	schneidinger	NOUN
aiua-11242	175	10	c	c	NOUN
aiua-11242	175	11	,	,	PUNCT
aiua-11242	175	12	et	et	PROPN
aiua-11242	175	13	al	al	PROPN
aiua-11242	175	14	.	.	PROPN
aiua-11242	176	1	prognostic	prognostic	ADJ
aiua-11242	176	2	significance	significance	NOUN
aiua-11242	176	3	of	of	ADP
aiua-11242	176	4	pre	pre	ADJ
aiua-11242	176	5	-	-	NOUN
aiua-11242	176	6	treatment	treatment	ADJ
aiua-11242	176	7	serum	serum	NOUN
aiua-11242	176	8	c	c	NOUN
aiua-11242	176	9	-	-	ADJ
aiua-11242	176	10	reactive	reactive	ADJ
aiua-11242	176	11	protein	protein	NOUN
aiua-11242	176	12	level	level	NOUN
aiua-11242	176	13	in	in	ADP
aiua-11242	176	14	patients	patient	NOUN
aiua-11242	176	15	with	with	ADP
aiua-11242	176	16	adenocarcinoma	adenocarcinoma	NOUN
aiua-11242	176	17	of	of	ADP
aiua-11242	176	18	the	the	DET
aiua-11242	176	19	uterine	uterine	ADJ
aiua-11242	176	20	cervix	cervix	NOUN
aiua-11242	176	21	.	.	PUNCT
aiua-11242	177	1	anticancer	anticancer	NOUN
aiua-11242	177	2	res	re	NOUN
aiua-11242	177	3	.	.	PROPN
aiua-11242	177	4	2016	2016	NUM
aiua-11242	177	5	;	;	PUNCT
aiua-11242	177	6	36:4691	36:4691	NUM
aiua-11242	177	7	-	-	SYM
aiua-11242	177	8	6	6	NUM
aiua-11242	177	9	.	.	NOUN
aiua-11242	177	10	20	20	NUM
aiua-11242	177	11	.	.	PUNCT
aiua-11242	178	1	he	he	PRON
aiua-11242	178	2	x	x	PROPN
aiua-11242	178	3	,	,	PUNCT
aiua-11242	178	4	li	li	PROPN
aiua-11242	178	5	j	j	PROPN
aiua-11242	178	6	-	-	PROPN
aiua-11242	178	7	p	p	PROPN
aiua-11242	178	8	,	,	PUNCT
aiua-11242	178	9	liu	liu	PROPN
aiua-11242	178	10	x	x	PROPN
aiua-11242	178	11	-	-	PROPN
aiua-11242	178	12	h	h	PROPN
aiua-11242	178	13	,	,	PUNCT
aiua-11242	178	14	et	et	PROPN
aiua-11242	178	15	al	al	PROPN
aiua-11242	178	16	.	.	PUNCT
aiua-11242	178	17	prognostic	prognostic	ADJ
aiua-11242	178	18	value	value	NOUN
aiua-11242	178	19	of	of	ADP
aiua-11242	178	20	c	c	NOUN
aiua-11242	178	21	-	-	PUNCT
aiua-11242	178	22	reactive	reactive	ADJ
aiua-11242	178	23	protein	protein	NOUN
aiua-11242	178	24	/	/	SYM
aiua-11242	178	25	albumin	albumin	ADJ
aiua-11242	178	26	ratio	ratio	NOUN
aiua-11242	178	27	in	in	ADP
aiua-11242	178	28	predicting	predict	VERB
aiua-11242	178	29	overall	overall	ADJ
aiua-11242	178	30	survival	survival	NOUN
aiua-11242	178	31	of	of	ADP
aiua-11242	178	32	chinese	chinese	ADJ
aiua-11242	178	33	cervical	cervical	ADJ
aiua-11242	178	34	cancer	cancer	NOUN
aiua-11242	178	35	patients	patient	NOUN
aiua-11242	178	36	overall	overall	ADJ
aiua-11242	178	37	survival	survival	NOUN
aiua-11242	178	38	:	:	PUNCT
aiua-11242	178	39	comparison	comparison	NOUN
aiua-11242	178	40	among	among	ADP
aiua-11242	178	41	various	various	ADJ
aiua-11242	178	42	inflammation	inflammation	NOUN
aiua-11242	178	43	based	base	VERB
aiua-11242	178	44	factors	factor	NOUN
aiua-11242	178	45	.	.	PUNCT
aiua-11242	179	1	j	j	NOUN
aiua-11242	179	2	cancer	cancer	NOUN
aiua-11242	179	3	.	.	PUNCT
aiua-11242	180	1	2018	2018	NUM
aiua-11242	180	2	;	;	PUNCT
aiua-11242	180	3	9:1877	9:1877	X
aiua-11242	180	4	-	-	SYM
aiua-11242	180	5	84	84	NUM
aiua-11242	180	6	.	.	PUNCT
aiua-11242	181	1	21	21	NUM
aiua-11242	181	2	.	.	PUNCT
aiua-11242	182	1	haruki	haruki	PROPN
aiua-11242	182	2	k	k	PROPN
aiua-11242	182	3	,	,	PUNCT
aiua-11242	182	4	shiba	shiba	PROPN
aiua-11242	182	5	h	h	PROPN
aiua-11242	182	6	,	,	PUNCT
aiua-11242	182	7	horiuchi	horiuchi	PROPN
aiua-11242	182	8	t	t	PROPN
aiua-11242	182	9	,	,	PUNCT
aiua-11242	182	10	et	et	PROPN
aiua-11242	182	11	al	al	PROPN
aiua-11242	182	12	.	.	PROPN
aiua-11242	182	13	impact	impact	NOUN
aiua-11242	182	14	of	of	ADP
aiua-11242	182	15	the	the	DET
aiua-11242	182	16	c	c	NOUN
aiua-11242	182	17	-	-	PUNCT
aiua-11242	182	18	reactive	reactive	ADJ
aiua-11242	182	19	protein	protein	NOUN
aiua-11242	182	20	to	to	ADP
aiua-11242	182	21	albumin	albumin	ADJ
aiua-11242	182	22	ratio	ratio	NOUN
aiua-11242	182	23	on	on	ADP
aiua-11242	182	24	long	long	ADJ
aiua-11242	182	25	-	-	PUNCT
aiua-11242	182	26	term	term	NOUN
aiua-11242	182	27	outcomes	outcome	NOUN
aiua-11242	182	28	after	after	ADP
aiua-11242	182	29	hepatic	hepatic	ADJ
aiua-11242	182	30	resection	resection	NOUN
aiua-11242	182	31	for	for	ADP
aiua-11242	182	32	colorectal	colorectal	ADJ
aiua-11242	182	33	liver	liver	NOUN
aiua-11242	182	34	metastases	metastasis	NOUN
aiua-11242	182	35	.	.	PUNCT
aiua-11242	182	36	am	be	AUX
aiua-11242	182	37	j	j	PROPN
aiua-11242	182	38	surg	surg	NOUN
aiua-11242	182	39	.	.	PUNCT
aiua-11242	183	1	2017	2017	NUM
aiua-11242	183	2	;	;	PUNCT
aiua-11242	183	3	214:752	214:752	NOUN
aiua-11242	183	4	-	-	SYM
aiua-11242	183	5	6	6	NUM
aiua-11242	183	6	.	.	NOUN
aiua-11242	184	1	22	22	NUM
aiua-11242	184	2	.	.	PUNCT
aiua-11242	185	1	wu	wu	PROPN
aiua-11242	185	2	m	m	PROPN
aiua-11242	185	3	,	,	PUNCT
aiua-11242	185	4	guo	guo	PROPN
aiua-11242	185	5	j	j	PROPN
aiua-11242	185	6	,	,	PUNCT
aiua-11242	185	7	guo	guo	PROPN
aiua-11242	185	8	l	l	PROPN
aiua-11242	185	9	,	,	PUNCT
aiua-11242	185	10	zuo	zuo	PROPN
aiua-11242	185	11	q.	q.	VERB
aiua-11242	185	12	the	the	DET
aiua-11242	185	13	c	c	NOUN
aiua-11242	185	14	-	-	PUNCT
aiua-11242	185	15	reactive	reactive	ADJ
aiua-11242	185	16	protein	protein	NOUN
aiua-11242	185	17	/	/	SYM
aiua-11242	185	18	albumin	albumin	NOUN
aiua-11242	185	19	ratio	ratio	NOUN
aiua-11242	185	20	predicts	predict	VERB
aiua-11242	185	21	overall	overall	ADJ
aiua-11242	185	22	survival	survival	NOUN
aiua-11242	185	23	of	of	ADP
aiua-11242	185	24	patients	patient	NOUN
aiua-11242	185	25	with	with	ADP
aiua-11242	185	26	advanced	advanced	ADJ
aiua-11242	185	27	pancreatic	pancreatic	ADJ
aiua-11242	185	28	cancer	cancer	NOUN
aiua-11242	185	29	.	.	PUNCT
aiua-11242	186	1	tumour	tumour	ADJ
aiua-11242	186	2	biol	biol	PROPN
aiua-11242	186	3	2016	2016	NUM
aiua-11242	186	4	;	;	PUNCT
aiua-11242	186	5	37:12525	37:12525	NUM
aiua-11242	186	6	-	-	SYM
aiua-11242	186	7	33	33	NUM
aiua-11242	186	8	.	.	NOUN
aiua-11242	186	9	23	23	NUM
aiua-11242	186	10	.	.	PUNCT
aiua-11242	187	1	uchimoto	uchimoto	PROPN
aiua-11242	187	2	t	t	PROPN
aiua-11242	187	3	,	,	PUNCT
aiua-11242	187	4	komura	komura	NOUN
aiua-11242	187	5	k	k	PROPN
aiua-11242	187	6	,	,	PUNCT
aiua-11242	187	7	fujiwara	fujiwara	PROPN
aiua-11242	187	8	y	y	PROPN
aiua-11242	187	9	,	,	PUNCT
aiua-11242	187	10	et	et	PROPN
aiua-11242	187	11	al	al	PROPN
aiua-11242	187	12	.	.	PUNCT
aiua-11242	188	1	prognostic	prognostic	ADJ
aiua-11242	188	2	impact	impact	NOUN
aiua-11242	188	3	of	of	ADP
aiua-11242	188	4	c	c	NOUN
aiua-11242	188	5	-	-	PUNCT
aiua-11242	188	6	reactive	reactive	ADJ
aiua-11242	188	7	protein	protein	NOUN
aiua-11242	188	8	-	-	PUNCT
aiua-11242	188	9	albumin	albumin	ADJ
aiua-11242	188	10	ratio	ratio	NOUN
aiua-11242	188	11	for	for	ADP
aiua-11242	188	12	the	the	DET
aiua-11242	188	13	lethality	lethality	NOUN
aiua-11242	188	14	in	in	ADP
aiua-11242	188	15	castration	castration	NOUN
aiua-11242	188	16	-	-	PUNCT
aiua-11242	188	17	resistant	resistant	ADJ
aiua-11242	188	18	prostate	prostate	NOUN
aiua-11242	188	19	cancer	cancer	NOUN
aiua-11242	188	20	.	.	PUNCT
aiua-11242	189	1	med	med	PROPN
aiua-11242	189	2	oncol	oncol	ADJ
aiua-11242	189	3	.	.	PUNCT
aiua-11242	190	1	2019	2019	NUM
aiua-11242	190	2	;	;	PUNCT
aiua-11242	190	3	37:9	37:9	NUM
aiua-11242	190	4	.	.	X
aiua-11242	190	5	24	24	NUM
aiua-11242	190	6	.	.	PUNCT
aiua-11242	191	1	o’brian	o’brian	PROPN
aiua-11242	191	2	d	d	NOUN
aiua-11242	191	3	,	,	PUNCT
aiua-11242	191	4	prunty	prunty	NOUN
aiua-11242	191	5	m	m	PROPN
aiua-11242	191	6	,	,	PUNCT
aiua-11242	191	7	hill	hill	PROPN
aiua-11242	191	8	a	a	PROPN
aiua-11242	191	9	,	,	PUNCT
aiua-11242	191	10	et	et	PROPN
aiua-11242	191	11	al	al	PROPN
aiua-11242	191	12	.	.	PUNCT
aiua-11242	192	1	the	the	DET
aiua-11242	192	2	role	role	NOUN
aiua-11242	192	3	of	of	ADP
aiua-11242	192	4	c	c	NOUN
aiua-11242	192	5	-	-	PUNCT
aiua-11242	192	6	reactive	reactive	ADJ
aiua-11242	192	7	protein	protein	NOUN
aiua-11242	192	8	in	in	ADP
aiua-11242	192	9	kidney	kidney	NOUN
aiua-11242	192	10	,	,	PUNCT
aiua-11242	192	11	bladder	bladder	NOUN
aiua-11242	192	12	,	,	PUNCT
aiua-11242	192	13	and	and	CCONJ
aiua-11242	192	14	prostate	prostate	NOUN
aiua-11242	192	15	cancers	cancer	NOUN
aiua-11242	192	16	.	.	PUNCT
aiua-11242	193	1	front	front	ADJ
aiua-11242	193	2	immunol	immunol	NOUN
aiua-11242	193	3	.	.	PUNCT
aiua-11242	193	4	2021	2021	NUM
aiua-11242	193	5	;	;	PUNCT
aiua-11242	193	6	12:721989	12:721989	NUM
aiua-11242	193	7	.	.	PUNCT
aiua-11242	194	1	25	25	NUM
aiua-11242	194	2	.	.	PUNCT
aiua-11242	195	1	guo	guo	PROPN
aiua-11242	195	2	s	s	PROPN
aiua-11242	195	3	,	,	PUNCT
aiua-11242	195	4	he	he	PRON
aiua-11242	195	5	x	x	PROPN
aiua-11242	195	6	,	,	PUNCT
aiua-11242	195	7	chen	chen	PROPN
aiua-11242	195	8	q	q	PROPN
aiua-11242	195	9	,	,	PUNCT
aiua-11242	195	10	et	et	PROPN
aiua-11242	195	11	al	al	PROPN
aiua-11242	195	12	.	.	PUNCT
aiua-11242	196	1	the	the	DET
aiua-11242	196	2	c	c	NOUN
aiua-11242	196	3	-	-	PUNCT
aiua-11242	196	4	reactive	reactive	ADJ
aiua-11242	196	5	protein	protein	NOUN
aiua-11242	196	6	/	/	SYM
aiua-11242	196	7	albumin	albumin	NOUN
aiua-11242	196	8	ratio	ratio	NOUN
aiua-11242	196	9	,	,	PUNCT
aiua-11242	196	10	a	a	DET
aiua-11242	196	11	validated	validate	VERB
aiua-11242	196	12	prognostic	prognostic	ADJ
aiua-11242	196	13	score	score	NOUN
aiua-11242	196	14	,	,	PUNCT
aiua-11242	196	15	predicts	predict	VERB
aiua-11242	196	16	outcome	outcome	NOUN
aiua-11242	196	17	of	of	ADP
aiua-11242	196	18	surgical	surgical	ADJ
aiua-11242	196	19	renal	renal	ADJ
aiua-11242	196	20	cell	cell	NOUN
aiua-11242	196	21	carcinoma	carcinoma	NOUN
aiua-11242	196	22	patients	patient	NOUN
aiua-11242	196	23	.	.	PUNCT
aiua-11242	197	1	bmc	bmc	ADJ
aiua-11242	197	2	cancer	cancer	NOUN
aiua-11242	197	3	.	.	PUNCT
aiua-11242	198	1	2017	2017	NUM
aiua-11242	198	2	;	;	PUNCT
aiua-11242	198	3	17:171	17:171	NUM
aiua-11242	198	4	.	.	PUNCT
aiua-11242	199	1	26	26	NUM
aiua-11242	199	2	.	.	PUNCT
aiua-11242	200	1	wu	wu	PROPN
aiua-11242	200	2	m	m	PROPN
aiua-11242	200	3	,	,	PUNCT
aiua-11242	200	4	zhou	zhou	PROPN
aiua-11242	200	5	y	y	PROPN
aiua-11242	200	6	,	,	PUNCT
aiua-11242	200	7	chen	chen	PROPN
aiua-11242	200	8	q	q	PROPN
aiua-11242	200	9	,	,	PUNCT
aiua-11242	200	10	et	et	PROPN
aiua-11242	200	11	al	al	PROPN
aiua-11242	200	12	.	.	PUNCT
aiua-11242	200	13	prognostic	prognostic	ADJ
aiua-11242	200	14	role	role	NOUN
aiua-11242	200	15	of	of	ADP
aiua-11242	200	16	pretreatment	pretreatment	NOUN
aiua-11242	200	17	creactive	creactive	ADJ
aiua-11242	200	18	protein	protein	NOUN
aiua-11242	200	19	to	to	ADP
aiua-11242	200	20	albumin	albumin	ADJ
aiua-11242	200	21	ratio	ratio	NOUN
aiua-11242	200	22	in	in	ADP
aiua-11242	200	23	urological	urological	ADJ
aiua-11242	200	24	cancers	cancer	NOUN
aiua-11242	200	25	:	:	PUNCT
aiua-11242	200	26	a	a	DET
aiua-11242	200	27	systematic	systematic	ADJ
aiua-11242	200	28	review	review	NOUN
aiua-11242	200	29	and	and	CCONJ
aiua-11242	200	30	meta	meta	ADJ
aiua-11242	200	31	-	-	PUNCT
aiua-11242	200	32	analysis	analysis	NOUN
aiua-11242	200	33	.	.	PUNCT
aiua-11242	201	1	front	front	ADJ
aiua-11242	201	2	oncol	oncol	ADJ
aiua-11242	201	3	.	.	PUNCT
aiua-11242	202	1	2022	2022	NUM
aiua-11242	202	2	;	;	PUNCT
aiua-11242	202	3	12:879803	12:879803	NUM
aiua-11242	202	4	.	.	PROPN
aiua-11242	203	1	27	27	NUM
aiua-11242	203	2	.	.	PUNCT
aiua-11242	203	3	berthold	berthold	PROPN
aiua-11242	203	4	dr	dr	PROPN
aiua-11242	203	5	,	,	PUNCT
aiua-11242	203	6	pond	pond	PROPN
aiua-11242	203	7	gr	gr	PROPN
aiua-11242	203	8	,	,	PUNCT
aiua-11242	203	9	soban	soban	ADJ
aiua-11242	203	10	f	f	NOUN
aiua-11242	203	11	,	,	PUNCT
aiua-11242	203	12	et	et	PROPN
aiua-11242	203	13	al	al	PROPN
aiua-11242	203	14	.	.	PROPN
aiua-11242	203	15	docetaxel	docetaxel	PROPN
aiua-11242	203	16	plus	plus	CCONJ
aiua-11242	203	17	prednisone	prednisone	NOUN
aiua-11242	203	18	or	or	CCONJ
aiua-11242	203	19	mitoxantrone	mitoxantrone	NOUN
aiua-11242	203	20	plus	plus	CCONJ
aiua-11242	203	21	prednisone	prednisone	NOUN
aiua-11242	203	22	for	for	ADP
aiua-11242	203	23	advanced	advanced	ADJ
aiua-11242	203	24	prostate	prostate	NOUN
aiua-11242	203	25	cancer	cancer	NOUN
aiua-11242	203	26	:	:	PUNCT
aiua-11242	203	27	updated	update	VERB
aiua-11242	203	28	survival	survival	NOUN
aiua-11242	203	29	in	in	ADP
aiua-11242	203	30	the	the	DET
aiua-11242	203	31	tax	tax	NOUN
aiua-11242	203	32	327	327	NUM
aiua-11242	203	33	study	study	NOUN
aiua-11242	203	34	.	.	PUNCT
aiua-11242	204	1	j	j	PROPN
aiua-11242	204	2	clin	clin	PROPN
aiua-11242	204	3	oncol	oncol	PROPN
aiua-11242	204	4	.	.	PUNCT
aiua-11242	205	1	2008	2008	NUM
aiua-11242	205	2	;	;	PUNCT
aiua-11242	205	3	26:242	26:242	NUM
aiua-11242	205	4	-	-	SYM
aiua-11242	205	5	5	5	NUM
aiua-11242	205	6	.	.	NOUN
aiua-11242	205	7	28	28	NUM
aiua-11242	205	8	.	.	PUNCT
aiua-11242	206	1	beer	beer	PROPN
aiua-11242	206	2	tm	tm	PROPN
aiua-11242	206	3	,	,	PUNCT
aiua-11242	206	4	armstrong	armstrong	PROPN
aiua-11242	206	5	aj	aj	PROPN
aiua-11242	206	6	,	,	PUNCT
aiua-11242	206	7	rathkopf	rathkopf	VERB
aiua-11242	207	1	d	d	NOUN
aiua-11242	207	2	,	,	PUNCT
aiua-11242	207	3	et	et	PROPN
aiua-11242	207	4	al	al	PROPN
aiua-11242	207	5	.	.	PROPN
aiua-11242	207	6	enzalutamide	enzalutamide	PROPN
aiua-11242	207	7	in	in	ADP
aiua-11242	207	8	men	man	NOUN
aiua-11242	207	9	with	with	ADP
aiua-11242	207	10	chemotherapy	chemotherapy	NOUN
aiua-11242	207	11	-	-	ADJ
aiua-11242	207	12	naïve	naïve	ADJ
aiua-11242	207	13	metastatic	metastatic	ADJ
aiua-11242	207	14	castration	castration	NOUN
aiua-11242	207	15	-	-	PUNCT
aiua-11242	207	16	resistant	resistant	ADJ
aiua-11242	207	17	prostate	prostate	NOUN
aiua-11242	207	18	cancer	cancer	NOUN
aiua-11242	207	19	:	:	PUNCT
aiua-11242	207	20	extended	extend	VERB
aiua-11242	207	21	analysis	analysis	NOUN
aiua-11242	207	22	of	of	ADP
aiua-11242	207	23	the	the	DET
aiua-11242	207	24	phase	phase	NOUN
aiua-11242	207	25	3	3	NUM
aiua-11242	207	26	prevail	prevail	NOUN
aiua-11242	207	27	study	study	NOUN
aiua-11242	207	28	.	.	PUNCT
aiua-11242	208	1	eur	eur	PROPN
aiua-11242	208	2	urol	urol	PROPN
aiua-11242	208	3	.	.	PROPN
aiua-11242	209	1	2017	2017	NUM
aiua-11242	209	2	;	;	PUNCT
aiua-11242	209	3	71:151	71:151	NUM
aiua-11242	209	4	-	-	SYM
aiua-11242	209	5	4	4	NUM
aiua-11242	209	6	.	.	NOUN
aiua-11242	209	7	29	29	NUM
aiua-11242	209	8	.	.	PUNCT
aiua-11242	209	9	ryan	ryan	PROPN
aiua-11242	209	10	cj	cj	PROPN
aiua-11242	209	11	,	,	PUNCT
aiua-11242	209	12	smith	smith	PROPN
aiua-11242	209	13	mr	mr	PROPN
aiua-11242	209	14	,	,	PUNCT
aiua-11242	209	15	fizazi	fizazi	PROPN
aiua-11242	209	16	k	k	PROPN
aiua-11242	209	17	,	,	PUNCT
aiua-11242	209	18	et	et	PROPN
aiua-11242	209	19	al	al	PROPN
aiua-11242	209	20	.	.	PUNCT
aiua-11242	210	1	abiraterone	abiraterone	NOUN
aiua-11242	210	2	acetate	acetate	NOUN
aiua-11242	210	3	plus	plus	CCONJ
aiua-11242	210	4	prednisone	prednisone	NOUN
aiua-11242	210	5	versus	versus	ADP
aiua-11242	210	6	placebo	placebo	NOUN
aiua-11242	210	7	plus	plus	CCONJ
aiua-11242	210	8	prednisone	prednisone	NOUN
aiua-11242	210	9	in	in	ADP
aiua-11242	210	10	chemotherapy	chemotherapy	NOUN
aiua-11242	210	11	-	-	ADJ
aiua-11242	210	12	naive	naive	ADJ
aiua-11242	210	13	men	man	NOUN
aiua-11242	210	14	with	with	ADP
aiua-11242	210	15	metastatic	metastatic	ADJ
aiua-11242	210	16	castration	castration	NOUN
aiua-11242	210	17	-	-	PUNCT
aiua-11242	210	18	resistant	resistant	ADJ
aiua-11242	210	19	prostate	prostate	NOUN
aiua-11242	210	20	cancer	cancer	NOUN
aiua-11242	210	21	(	(	PUNCT
aiua-11242	210	22	cou	cou	NOUN
aiua-11242	210	23	-	-	PUNCT
aiua-11242	210	24	aa302	aa302	ADJ
aiua-11242	210	25	):	):	PUNCT
aiua-11242	210	26	final	final	ADJ
aiua-11242	210	27	overall	overall	ADJ
aiua-11242	210	28	survival	survival	NOUN
aiua-11242	210	29	analysis	analysis	NOUN
aiua-11242	210	30	of	of	ADP
aiua-11242	210	31	a	a	DET
aiua-11242	210	32	randomised	randomised	ADJ
aiua-11242	210	33	,	,	PUNCT
aiua-11242	210	34	double	double	ADJ
aiua-11242	210	35	-	-	PUNCT
aiua-11242	210	36	blind	blind	ADJ
aiua-11242	210	37	,	,	PUNCT
aiua-11242	210	38	placebo	placebo	NOUN
aiua-11242	210	39	-	-	PUNCT
aiua-11242	210	40	controlled	control	VERB
aiua-11242	210	41	phase	phase	NOUN
aiua-11242	210	42	3	3	NUM
aiua-11242	210	43	study	study	NOUN
aiua-11242	210	44	.	.	PUNCT
aiua-11242	211	1	lancet	lancet	PROPN
aiua-11242	211	2	oncol	oncol	PROPN
aiua-11242	211	3	.	.	PUNCT
aiua-11242	212	1	2015	2015	NUM
aiua-11242	212	2	;	;	PUNCT
aiua-11242	212	3	16:152	16:152	NUM
aiua-11242	212	4	-	-	SYM
aiua-11242	212	5	60	60	NUM
aiua-11242	212	6	.	.	PUNCT
aiua-11242	213	1	30	30	NUM
aiua-11242	213	2	.	.	PUNCT
aiua-11242	214	1	jarimba	jarimba	NOUN
aiua-11242	214	2	rs	rs	PROPN
aiua-11242	214	3	,	,	PUNCT
aiua-11242	214	4	eliseu	eliseu	PROPN
aiua-11242	214	5	mn	mn	PROPN
aiua-11242	214	6	,	,	PUNCT
aiua-11242	214	7	pedroso	pedroso	VERB
aiua-11242	214	8	lima	lima	PROPN
aiua-11242	214	9	j	j	PROPN
aiua-11242	214	10	,	,	PUNCT
aiua-11242	214	11	et	et	PROPN
aiua-11242	214	12	al	al	PROPN
aiua-11242	214	13	.	.	PROPN
aiua-11242	214	14	novel	novel	ADJ
aiua-11242	214	15	hormonal	hormonal	ADJ
aiua-11242	214	16	agents	agent	NOUN
aiua-11242	214	17	for	for	ADP
aiua-11242	214	18	metastatic	metastatic	ADJ
aiua-11242	214	19	castration	castration	NOUN
aiua-11242	214	20	-	-	PUNCT
aiua-11242	214	21	resistant	resistant	ADJ
aiua-11242	214	22	prostate	prostate	NOUN
aiua-11242	214	23	cancer	cancer	NOUN
aiua-11242	214	24	:	:	PUNCT
aiua-11242	214	25	comparing	compare	VERB
aiua-11242	214	26	outcomes	outcome	NOUN
aiua-11242	214	27	.	.	PUNCT
aiua-11242	215	1	a	a	DET
aiua-11242	215	2	single	single	ADJ
aiua-11242	215	3	-	-	PUNCT
aiua-11242	215	4	center	center	NOUN
aiua-11242	215	5	retrospective	retrospective	ADJ
aiua-11242	215	6	study	study	NOUN
aiua-11242	215	7	.	.	PUNCT
aiua-11242	216	1	arch	arch	PROPN
aiua-11242	216	2	ital	ital	PROPN
aiua-11242	216	3	urol	urol	PROPN
aiua-11242	216	4	androl	androl	PROPN
aiua-11242	216	5	.	.	PROPN
aiua-11242	216	6	2021	2021	NUM
aiua-11242	216	7	;	;	PUNCT
aiua-11242	216	8	93:393	93:393	NUM
aiua-11242	216	9	-	-	SYM
aiua-11242	216	10	8	8	NUM
aiua-11242	216	11	.	.	PUNCT
aiua-11242	217	1	correspondence	correspondence	NOUN
aiua-11242	217	2	joão	joão	PROPN
aiua-11242	217	3	diogo	diogo	PROPN
aiua-11242	217	4	abreu	abreu	PROPN
aiua-11242	217	5	lorigo	lorigo	PROPN
aiua-11242	217	6	,	,	PUNCT
aiua-11242	217	7	md	md	PROPN
aiua-11242	217	8	(	(	PUNCT
aiua-11242	217	9	corresponding	correspond	VERB
aiua-11242	217	10	author	author	NOUN
aiua-11242	217	11	)	)	PUNCT
aiua-11242	218	1	joaolorigo@gmail.com	joaolorigo@gmail.com	PROPN
aiua-11242	218	2	department	department	PROPN
aiua-11242	218	3	urology	urology	NOUN
aiua-11242	218	4	-	-	PUNCT
aiua-11242	218	5	centro	centro	NOUN
aiua-11242	218	6	hospitalar	hospitalar	PROPN
aiua-11242	218	7	e	e	PROPN
aiua-11242	218	8	universitário	universitário	PROPN
aiua-11242	218	9	de	de	PROPN
aiua-11242	218	10	coimbra	coimbra	PROPN
aiua-11242	218	11	praceta	praceta	PROPN
aiua-11242	218	12	professor	professor	NOUN
aiua-11242	218	13	mota	mota	NOUN
aiua-11242	218	14	pinto	pinto	NOUN
aiua-11242	218	15	,	,	PUNCT
aiua-11242	218	16	3004	3004	NUM
aiua-11242	218	17	-	-	SYM
aiua-11242	218	18	561	561	NUM
aiua-11242	218	19	coimbra	coimbra	NOUN
aiua-11242	218	20	,	,	PUNCT
aiua-11242	218	21	portugal	portugal	PROPN
aiua-11242	218	22	edgar	edgar	PROPN
aiua-11242	218	23	tavares	tavares	PROPN
aiua-11242	218	24	silva	silva	PROPN
aiua-11242	218	25	,	,	PUNCT
aiua-11242	218	26	md	md	PROPN
aiua-11242	218	27	edsilvaelv@gmail.com	edsilvaelv@gmail.com	PROPN
aiua-11242	218	28	joão	joão	PROPN
aiua-11242	218	29	pedroso	pedroso	PROPN
aiua-11242	218	30	lima	lima	PROPN
aiua-11242	218	31	,	,	PUNCT
aiua-11242	218	32	md	md	PROPN
aiua-11242	218	33	joaopedrosolima@gmail.com	joaopedrosolima@gmail.com	PROPN
aiua-11242	219	1	vasco	vasco	PROPN
aiua-11242	219	2	quaresma	quaresma	PROPN
aiua-11242	219	3	,	,	PUNCT
aiua-11242	219	4	md	md	PROPN
aiua-11242	219	5	vpdquaresma@gmail.com	vpdquaresma@gmail.com	PROPN
aiua-11242	219	6	rui	rui	PROPN
aiua-11242	219	7	pedrosa	pedrosa	PROPN
aiua-11242	219	8	,	,	PUNCT
aiua-11242	219	9	md	md	PROPN
aiua-11242	219	10	ruimdp93@gmail.com	ruimdp93@gmail.com	PROPN
aiua-11242	219	11	arnaldo	arnaldo	PROPN
aiua-11242	219	12	figueiredo	figueiredo	PROPN
aiua-11242	219	13	,	,	PUNCT
aiua-11242	219	14	md	md	PROPN
aiua-11242	219	15	ajcfigueiredo@gmail.com	ajcfigueiredo@gmail.com	PROPN
aiua-11242	219	16	praceta	praceta	PROPN
aiua-11242	219	17	professor	professor	NOUN
aiua-11242	219	18	mota	mota	NOUN
aiua-11242	219	19	pinto	pinto	NOUN
aiua-11242	219	20	,	,	PUNCT
aiua-11242	219	21	3004	3004	NUM
aiua-11242	219	22	-	-	SYM
aiua-11242	219	23	561	561	NUM
aiua-11242	219	24	coimbra	coimbra	PROPN
aiua-11242	219	25	conflict	conflict	NOUN
aiua-11242	219	26	of	of	ADP
aiua-11242	219	27	interest	interest	NOUN
aiua-11242	219	28	:	:	PUNCT
aiua-11242	219	29	the	the	DET
aiua-11242	219	30	authors	author	NOUN
aiua-11242	219	31	declare	declare	VERB
aiua-11242	219	32	no	no	DET
aiua-11242	219	33	potential	potential	ADJ
aiua-11242	219	34	conflict	conflict	NOUN
aiua-11242	219	35	of	of	ADP
aiua-11242	219	36	interest	interest	NOUN
aiua-11242	219	37	.	.	PUNCT